,Conditions,Drug,Smiles,Disease
0,Multiple Myeloma,Bortezomib,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,cardiovascular_disease
1,Multiple Myeloma,Dexamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cardiovascular_disease
2,Myeloma,Minocycline,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,cardiovascular_disease
3,Myeloma,Ciclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cardiovascular_disease
4,Myeloma,Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,cardiovascular_disease
5,Progressive Familial Intrahepatic Cholestasis|Alagille Syndrome|Cholestatic Liver Disease,Maralixibat,CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)C(C1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC,cardiovascular_disease
8,Myeloma,Gemcitabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,cardiovascular_disease
9,Myeloma,Busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,cardiovascular_disease
10,Myeloma,Melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,cardiovascular_disease
11,Hypertension,Azilsartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,cardiovascular_disease
16,Hypertension,Olmesartan,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,cardiovascular_disease
17,Cardiovascular Disease|Sudden Cardiac Death,Alfacalcidol,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,cardiovascular_disease
18,Cardiovascular Disease|Sudden Cardiac Death,Ergocalciferol,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,cardiovascular_disease
21,"Fascicular Block|Motor Activity|Pain, Postoperative|Latency Period",Clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,cardiovascular_disease
22,"Fascicular Block|Motor Activity|Pain, Postoperative|Latency Period",Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,cardiovascular_disease
24,Sturge-Weber Syndrome,Cannabidiol,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,cardiovascular_disease
31,Essential Hypertension|Hyperlipidemia,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,cardiovascular_disease
32,Essential Hypertension|Hyperlipidemia,Atorvastatin,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,cardiovascular_disease
34,"Hypertension|Hypertension, Essential",Trimethaphan,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5,cardiovascular_disease
35,"Hypertension|Hypertension, Essential",Phenylephrine,CNCC(C1=CC(=CC=C1)O)O,cardiovascular_disease
36,Multiple Myeloma,Cobimetinib,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,cardiovascular_disease
37,Multiple Myeloma,Venetoclax,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,cardiovascular_disease
39,Hypertension,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,cardiovascular_disease
42,Mild Hypertension,Hydrochlorothiazide,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,cardiovascular_disease
43,Coronary Artery Disease,Vericiguat,COC(=O)NC1=C(N=C(N=C1N)C2=NN(C3=C2C=C(C=N3)F)CC4=CC=CC=C4F)N,cardiovascular_disease
44,Coronary Artery Disease,Isosorbide,C1C(C2C(O1)C(CO2)O)O,cardiovascular_disease
45,Hypertension,Daglutril,CCOC(=O)C(CCC1=CC=CC=C1)CC2(CCCC2)C(=O)NC3CCC4=CC=CC=C4N(C3=O)CC(=O)O,cardiovascular_disease
46,"Arrhythmia, Cardiac",Propafenone,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,cardiovascular_disease
47,Chronic Stable Angina,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,cardiovascular_disease
48,Patients With Pace Makers But no Evidence of Ischemic Heart Disease,Moxifloxacin,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,cardiovascular_disease
53,ANCA Associated Vasculitis|Granulomatosis With Polyangiitis,Prednisolone,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,cardiovascular_disease
54,Acute Coronary Syndrome,Losmapimod,CC1=C(C=C(C=C1F)C(=O)NC2CC2)C3=NC=C(C=C3)C(=O)NCC(C)(C)C,cardiovascular_disease
56,Acute Coronary Syndrome,Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,cardiovascular_disease
57,Acute Coronary Syndrome,Aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,cardiovascular_disease
58,Dyslipidemia|Coronary Artery Disease,Rosuvastatin,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,cardiovascular_disease
62,Multiple Myeloma|Non-Hodgkins Lymphoma|Hodgkins Disease,Plerixafor,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,cardiovascular_disease
65,Non-Hodgkin's Lymphoma|Leukemia|Multiple Myeloma|Acute Myeloid Leukemia|Hodgkin Lymphoma|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Myelodysplastic Syndrome,Tacrolimus,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,cardiovascular_disease
66,Non-Hodgkin's Lymphoma|Leukemia|Multiple Myeloma|Acute Myeloid Leukemia|Hodgkin Lymphoma|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Myelodysplastic Syndrome,Mycophenolate,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,cardiovascular_disease
69,"Homocysteine|Coronary Disease|Angioplasty,Balloon,Coronary|Contrast Media|Nephropathy|Hypertension",Enalapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,cardiovascular_disease
71,Chronic Thromboembolic Pulmonary Hypertension,Macitentan,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,cardiovascular_disease
72,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,Dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,cardiovascular_disease
73,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,cardiovascular_disease
74,Ischemic Stroke,Donepezil,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,cardiovascular_disease
78,Multiple Myeloma,Carfilzomib,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,cardiovascular_disease
79,Multiple Myeloma,Cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,cardiovascular_disease
89,Hyperemia,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,cardiovascular_disease
94,Venous Thromboembolism|Cancer,Apixaban,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,cardiovascular_disease
96,Multiple Myeloma,Oprozomib,CC1=NC=C(S1)C(=O)NC(COC)C(=O)NC(COC)C(=O)NC(CC2=CC=CC=C2)C(=O)C3(CO3)C,cardiovascular_disease
97,Multiple Myeloma,Lenalidomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,cardiovascular_disease
100,Anemia|Cardiovascular Disease,Ferumoxytol,O[Fe]=O.O[Fe]=O.[Fe],cardiovascular_disease
101,"Non-Alcoholic Fatty Liver Disease|Obesity|Obesity, Abdominal|Liver Fat|Fatty Liver",Tesamorelin,CCC=CCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(C(C)CC)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N,cardiovascular_disease
106,Coronary Artery Disease,Ticagrelor,CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F,cardiovascular_disease
114,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Ixazomib,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,cardiovascular_disease
119,Pulmonary Hypertension,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,cardiovascular_disease
120,Pulmonary Hypertension,Ambrisentan,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,cardiovascular_disease
128,"Cardiomyopathy, Hypertrophic|Heart Hypertrophy",Cyclosporine,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,cardiovascular_disease
129,Hypertension|Vitamin D Deficiency,Cholecalciferol,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,cardiovascular_disease
132,Smoldering Multiple Myeloma,Hiltonol,C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O.C(CCNC(=O)O)CN.C(C(=O)O)O,cardiovascular_disease
133,Smoldering Multiple Myeloma,Citarinostat,C1=CC=C(C=C1)N(C2=CC=CC=C2Cl)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,cardiovascular_disease
135,Atherosclerosis,Darapladib,CCN(CC)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)C(F)(F)F)C(=O)CN3C4=C(CCC4)C(=O)N=C3SCC5=CC=C(C=C5)F,cardiovascular_disease
136,Atherosclerosis,Diltiazem,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,cardiovascular_disease
141,Mitral Valve Insufficiency|Aortic Valve Insufficiency|Cardiac Disease,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,cardiovascular_disease
142,Mitral Valve Insufficiency|Aortic Valve Insufficiency|Cardiac Disease,Isoflurane,C(C(F)(F)F)(OC(F)F)Cl,cardiovascular_disease
143,Mitral Valve Insufficiency|Aortic Valve Insufficiency|Cardiac Disease,Sevoflurane,C(OC(C(F)(F)F)C(F)(F)F)F,cardiovascular_disease
152,Glaucoma|Ocular Hypertension,Latanoprost,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,cardiovascular_disease
153,"Stroke, Acute",Desmopressin,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N,cardiovascular_disease
154,Hypertension,Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,cardiovascular_disease
156,Hypertension,Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cardiovascular_disease
157,Varicose Veins,Polidocanol,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,cardiovascular_disease
163,Congestive Heart Failure,Allopurinol,C1=NNC2=C1C(=O)NC=N2,cardiovascular_disease
164,Coronary Artery Disease,Bradykinin,C1CC(N(C1)C(=O)C2CCCN2C(=O)C(CCCN=C(N)N)N)C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(=O)O,cardiovascular_disease
174,Postural Orthostatic Tachycardia Syndrome|Orthostatic Intolerance,Droxidopa,C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O,cardiovascular_disease
175,Postural Orthostatic Tachycardia Syndrome|Orthostatic Intolerance,Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,cardiovascular_disease
176,Diabetic Retinopathy,Triamcinolone,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,cardiovascular_disease
177,Hypertension,Nebivolol,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,cardiovascular_disease
179,Heart Failure,Finerenone,CCOC1=NC=C(C2=C1C(C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C,cardiovascular_disease
180,Heart Failure,Eplerenone,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,cardiovascular_disease
181,Hypertension,Ramipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,cardiovascular_disease
186,Multiple Myeloma,Pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,cardiovascular_disease
187,Multiple Myeloma,Imetelstat,CCCCCCCCCCCCCCCC(=O)NCC(COP(=S)(O)OCC1C(CC(O1)N2C=C(C(=O)NC2=O)C)NP(=S)(O)OCC3C(CC(O3)N4C=NC5=C(N=CN=C54)N)NP(=S)(O)OCC6C(CC(O6)N7C=NC8=C7N=C(NC8=O)N)NP(=S)(O)OCC9C(CC(O9)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=O)(OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)N)S)O,cardiovascular_disease
191,Metabolic Syndrome x,Metformin,CN(C)C(=N)N=C(N)N,cardiovascular_disease
194,Metabolic Syndrome x,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,cardiovascular_disease
195,Persistent Pulmonary Hypertension|Respiratory Failure,Sildenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,cardiovascular_disease
202,Heart Failure|Inflammation|Colchicine,Colchicine,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,cardiovascular_disease
208,Multiple Myeloma,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,cardiovascular_disease
210,"Hypertension, Pulmonary",Simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cardiovascular_disease
214,Coronary Heart Disease,Pactimibe,CCCCCCCCN1CCC2=C(C(=C(C(=C21)NC(=O)C(C)(C)C)C)CC(=O)O)C,cardiovascular_disease
220,Multiple Myeloma,Fludeoxyglucose,C(C(C(C(C(C=O)F)O)O)O)O,cardiovascular_disease
223,Multiple Myeloma,Panobinostat,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,cardiovascular_disease
225,Hypertension,Lisinopril,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,cardiovascular_disease
226,High Altitude Pulmonary Hypertension,Bambuterol,CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)OC(=O)N(C)C)O,cardiovascular_disease
228,Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage III Breast Cancer,Doxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,cardiovascular_disease
229,Multiple Myeloma,Ibritumomab,CC(CN(CC(CC1=CC=C(C=C1)NC(=O)NC)N(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,cardiovascular_disease
243,Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Fludarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,cardiovascular_disease
245,Atrial Fibrillation,Isoproterenol,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,cardiovascular_disease
246,Atrial Fibrillation,Isoprenaline,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,cardiovascular_disease
247,Primary Hypertension,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,cardiovascular_disease
248,Primary Hypertension,Spironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,cardiovascular_disease
250,Single Ventricle Heart Disease After Fontan Surgery,Udenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C,cardiovascular_disease
251,Multiple Myeloma,Selinexor,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,cardiovascular_disease
260,Multiple Myeloma,Clarithromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,cardiovascular_disease
265,Cardiovascular Diseases|Heart Diseases|Hypertension,Fosinopril,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)O)C3CCCCC3,cardiovascular_disease
274,Stroke|Cerebrovascular Accident,Citrulline,C(CC(C(=O)O)N)CNC(=O)N,cardiovascular_disease
275,Multiple Myeloma,Ibrutinib,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,cardiovascular_disease
278,Stroke,Exenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N,cardiovascular_disease
283,"Follicular Lymphoma|Marginal Zone Lymphoma|Mantle Cell Lymphoma|Small Lymphocytic Lymphoma|Lymphoplasmacytic Lymphoma|Low Grade B-cell Lymphoma, Not Otherwise Specified|Diffuse Large B-cell Lymphoma|Peripheral T-cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Anaplastic Large-cell Lymphoma",Clofarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,cardiovascular_disease
287,Multiple Myeloma,Prednisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,cardiovascular_disease
291,"Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary",Riociguat,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,cardiovascular_disease
299,Thromboembolic Disorders,Rivaroxaban,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,cardiovascular_disease
303,Intracerebral Hemorrhage,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,cardiovascular_disease
304,Open-angle Glaucoma|Ocular Hypertension,Travoprost,CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O,cardiovascular_disease
310,Myeloma,Topotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,cardiovascular_disease
317,Venous Thromboembolism|Deep Venous Thrombosis|Pulmonary Embolus|Reconstructive Surgery,Enoxaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cardiovascular_disease
320,Cardiac Arrest,Ubiquinol,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,cardiovascular_disease
321,Cardiac Catheterization|Blood Pressure|Heart Ventricles|Echocardiography|Heart Failure,Perflubutane,C(C(C(F)(F)F)(F)F)(C(F)(F)F)(F)F,cardiovascular_disease
322,Hypertension,Rostafuroxin,CC12CCC(CC1CCC3C2CCC4(C3(CCC4(C5=COC=C5)O)O)C)O,cardiovascular_disease
323,Hypertension,Losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,cardiovascular_disease
332,Multiple Myeloma in Relapse|Multiple Myeloma Progression|Multiple Myeloma With Failed Remission,Tinostamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCCCCC(=O)NO,cardiovascular_disease
334,Coronary Artery Disease,Iopamidol,CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O,cardiovascular_disease
344,Intermittent Claudication,Cilostazol,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,cardiovascular_disease
349,Coronary Stenosis|Diabetes Mellitus,Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,cardiovascular_disease
360,Non Hodgkin Lymphoma|Follicular Lymphoma|Indolent Lymphoma|B-cell Lymphoma|Transformed Lymphoma|Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia|Small Lymphocytic Lymphoma|Lymphoplasmacytic Lymphoma,Idelalisib,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,cardiovascular_disease
374,Atrial Fibrillation,Warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,cardiovascular_disease
378,Heart Failure,Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,cardiovascular_disease
385,Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes,Thiotepa,C1CN1P(=S)(N2CC2)N3CC3,cardiovascular_disease
393,Recurrent Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Recurrent Waldenstrom Macroglobulinemia|Refractory Follicular Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Marginal Zone Lymphoma|Refractory Non-Hodgkin Lymphoma|Refractory Small Lymphocytic Lymphoma,Temsirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,cardiovascular_disease
398,Acute Stroke|Visual Field Loss,Fluoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,cardiovascular_disease
403,Open-angle Glaucoma|Ocular Hypertension,Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,cardiovascular_disease
408,Stroke,Enecadin,CC1=NC(=CC(=N1)OCCCCCN2CCCCC2)C3=CC=C(C=C3)F,cardiovascular_disease
412,Advanced Multiple Myeloma,Filanesib,CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC,cardiovascular_disease
429,Acute Coronary Syndromes,Everolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,cardiovascular_disease
430,Relapsed or Refractory Multiple Myeloma,Vorinostat,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,cardiovascular_disease
452,"Hypertension Pulmonary Secondary|Heart Failure, Right Sided|Heart Failure With Normal Ejection Fraction",Simendan,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,cardiovascular_disease
453,"Hypertension Pulmonary Secondary|Heart Failure, Right Sided|Heart Failure With Normal Ejection Fraction",Levosimendan,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,cardiovascular_disease
463,Drug-induced QT Prolongation|Pharmacokinetics|Pharmacodynamics,Pimozide,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,cardiovascular_disease
465,Drug-induced QT Prolongation|Pharmacokinetics|Pharmacodynamics,Cobicistat,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,cardiovascular_disease
468,"Hypertension, Essential",Nifedipine,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,cardiovascular_disease
473,Obstructive Sleep Apnea|Sleep-Disordered Breathing|Blood Pressure|Hypertension,Acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,cardiovascular_disease
480,Chronic Heart Failure,Serelaxin,CCC(C)C1C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C)C(C)CC)CCC(=O)N)C)CCCNC(=N)N)C(C)C)CC(C)C)CCC(=O)O)CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CO)NC(=O)C(CC(=O)O)N)C(=O)NC(C(=O)NC(C(=O)NCC(=O)N2)C(C)C)CC5=CN=CN5)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CC(C)C)NC(=O)C7CCC(=O)N7)C(C)O)CCCCN)CCCNC(=N)N)CO)CC(C)C)C)CCCNC(=N)N)CC8=CC=CC=C8)C(=O)O)C(=O)NCC(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CC9=CNC1=CC=CC=C19)C(=O)NC(CO)C(=O)O,cardiovascular_disease
481,Follicular Lymphoma|Small Lymphocytic Lymphoma|Marginal Zone Lymphoma|Lymphoplasmacytic Lymphoma|Diffuse Large B Cell Lymphoma|Mantle Cell Lymphoma|Burkitt's Lymphoma,Imexon,C1C2N1C(=O)N=C2N,cardiovascular_disease
491,Septic Shock|Hypotension|Tachycardia,Esmolol,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,cardiovascular_disease
497,Thrombocytopenia|Multiple Myeloma,Eltrombopag,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C,cardiovascular_disease
520,Atrial Fibrillation,Vernakalant,COC1=C(C=C(C=C1)CCOC2CCCCC2N3CCC(C3)O)OC,cardiovascular_disease
523,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,Defactinib,CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F,cardiovascular_disease
524,Aneurysmal Subarachnoid Hemorrhage,Tiopronin,CC(C(=O)NCC(=O)O)S,cardiovascular_disease
528,Postmenopause|Hypertension|Pre-Hypertension,Drospirenone,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C,cardiovascular_disease
530,Postmenopause|Hypertension|Pre-Hypertension,Medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,cardiovascular_disease
532,Coronary Artery Bypass Surgery|Coronary Heart Disease|Coronary Artery Bypass Grafting|Cardiopulmonary Bypass|Ischemic Heart Disease|Congestive Heart Failure,Nesiritide,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCCN)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C3CCCN3C(=O)C(CO)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4=CN=CN4)C(=O)O)CC(C)C)CO)CO)CO)CO,cardiovascular_disease
533,Pulmonary Complication,Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,cardiovascular_disease
534,Cyanotic Congenital Heart Disease,Topiramate,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,cardiovascular_disease
546,Acute Myelogenous Leukemia|Acute Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Chronic Lymphocytic Leukemia|Myelodysplastic Syndromes|Multiple Myeloma|Non-Hodgkins Lymphoma|Hodgkins Disease|Peripheral T-cell Lymphoma,Pentostatin,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,cardiovascular_disease
551,Wet Macular Degeneration|Age-related Macular Degeneration|Diabetic Macular Edema|Retinal Vein Occlusion,Dorzolamide,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,cardiovascular_disease
564,Right Hemisphere Stroke|Hemispatial Neglect|Motor Deficit,Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O,cardiovascular_disease
565,DS Stage II Plasma Cell Myeloma|DS Stage III Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Romidepsin,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,cardiovascular_disease
570,HIV Infections|Non-Alcoholic Fatty Liver Disease,Semaglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,cardiovascular_disease
573,Pulmonary Embolism,Diclofenac,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,cardiovascular_disease
574,"Ischemic Reperfusion Injury|Insufficiency; Hepatic, Postoperative|Liver Tumour",Methylprednisolone,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,cardiovascular_disease
577,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Azacitidine,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,cardiovascular_disease
580,"Fibrillation, Atrial|Atrial Fibrillation",Odiparcil,CC1=CC(=O)OC2=C1C=CC(=C2)OC3C(C(C(CS3)O)O)O,cardiovascular_disease
585,Atrial Fibrillation,Digoxin,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,cardiovascular_disease
586,Orthostatic Hypotension|Spinal Cord Injury,Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,cardiovascular_disease
588,"Lymphoma, Non-Hodgkin|Lymphoma, Follicular|Lymphoma, Mantle-Cell|Lymphoma, Small-Cell|Waldenstrom Macroglobulinemia|Lymphoma, B-Cell, Marginal Zone",Bendamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,cardiovascular_disease
589,"Lymphoma, Non-Hodgkin|Lymphoma, Follicular|Lymphoma, Mantle-Cell|Lymphoma, Small-Cell|Waldenstrom Macroglobulinemia|Lymphoma, B-Cell, Marginal Zone",Vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,cardiovascular_disease
591,Multiple Myeloma,Sirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,cardiovascular_disease
606,Coronary Heart Disease,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,cardiovascular_disease
611,Takotsubo Cardiomyopathy,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,cardiovascular_disease
613,Transthyretin Amyloidosis|Cardiomyopathy,Doxycycline,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,cardiovascular_disease
628,Polymyalgia Rheumatica|Effect of Drug|Safety Issues,Tofacitinib,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,cardiovascular_disease
633,MELAS Syndrome,Idebenone,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,cardiovascular_disease
650,Multiple Myeloma,Tipifarnib,CN1C=NC=C1C(C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N,cardiovascular_disease
651,Hypertension,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,cardiovascular_disease
657,Lymphoma|Multiple Myeloma,Tinzaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cardiovascular_disease
660,Cerebral Cavernous Malformation,Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,cardiovascular_disease
663,Heart Failure With Preserved Ejection Fraction,Dapagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,cardiovascular_disease
669,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,cardiovascular_disease
676,Multiple Myeloma,Mesna,C(CS(=O)(=O)[O-])S.[Na+],cardiovascular_disease
686,Diabetic Foot Ulcer,Dalteparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cardiovascular_disease
710,Myocardial Ischemia,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,cardiovascular_disease
723,End Stage Heart Disease|Right Ventricular Dysfunction,Milrinone,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,cardiovascular_disease
747,Multiple Myeloma,Etoposide,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,cardiovascular_disease
751,Chronic Heart Failure,Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,cardiovascular_disease
760,VHL - Von Hippel-Lindau Syndrome|VHL Gene Mutation|VHL Syndrome|VHL Gene Inactivation|VHL-Associated Renal Cell Carcinoma|VHL-Associated Clear Cell Renal Cell Carcinoma,Belzutifan,CS(=O)(=O)C1=C2C(C(C(C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O,cardiovascular_disease
769,Atherosclerosis|Inflammation,Sitagliptin,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N,cardiovascular_disease
773,Congestive Heart Failure,Oxypurinol,C1=NNC2=C1C(=O)NC(=O)N2,cardiovascular_disease
774,Precapillary Pulmonary Hypertension,Trimetazidine,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC,cardiovascular_disease
779,Venous Thrombosis|Pulmonary Embolism,Fondaparinux,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O,cardiovascular_disease
789,Cardiovascular Disease,Evacetrapib,CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,cardiovascular_disease
791,Ischemic Stroke,Argatroban,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,cardiovascular_disease
795,Pregnancy|Severe Pre-eclampsia,Remifentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,cardiovascular_disease
796,Pregnancy|Severe Pre-eclampsia,Dexmedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,cardiovascular_disease
807,Acute Stroke|Endovascular Thrombectomy,Nicardipine,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,cardiovascular_disease
808,Acute Stroke|Endovascular Thrombectomy,Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,cardiovascular_disease
809,Acute Stroke|Endovascular Thrombectomy,Hydralazine,C1=CC=C2C(=C1)C=NN=C2NN,cardiovascular_disease
817,Acute Cerebrovascular Accident|Cerebral Edema,Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,cardiovascular_disease
818,Acute Cerebrovascular Accident|Cerebral Edema,Pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,cardiovascular_disease
819,Acute Cerebrovascular Accident|Cerebral Edema,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,cardiovascular_disease
820,Acute Cerebrovascular Accident|Cerebral Edema,Dextromethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC,cardiovascular_disease
823,Multiple Myeloma,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],cardiovascular_disease
831,Fabry Disease,Lucerastat,CCCCN1CC(C(C(C1CO)O)O)O,cardiovascular_disease
843,Cardiovascular Diseases|Cardiovascular Risk Factor|Vasodilation,Tempol,CC1(CC(CC(N1[O])(C)C)O)C,cardiovascular_disease
844,Cardiovascular Diseases|Cardiovascular Risk Factor|Vasodilation,Apocynin,CC(=O)C1=CC(=C(C=C1)O)OC,cardiovascular_disease
853,Acute Ischemic Stroke,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,cardiovascular_disease
855,Hypertension,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,cardiovascular_disease
869,Cirrhosis|Portal Hypertension|Non-alcoholic Steatohepatitis,Emricasan,CC(C(=O)NC(CC(=O)O)C(=O)COC1=C(C(=CC(=C1F)F)F)F)NC(=O)C(=O)NC2=CC=CC=C2C(C)(C)C,cardiovascular_disease
871,Coagulation Defect; Bleeding,Morphine,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,cardiovascular_disease
872,Coagulation Defect; Bleeding,Atropine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,cardiovascular_disease
889,Aortic Aneurysm,Melatonin,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,cardiovascular_disease
909,Macular Edema,Nepafenac,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,cardiovascular_disease
916,Multiple Myeloma,Opaganib,C1C2CC3(CC1CC(C2)(C3)C(=O)NCC4=CC=NC=C4)C5=CC=C(C=C5)Cl,cardiovascular_disease
922,"Subarachnoid Hemorrhage, Aneurysmal",Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,cardiovascular_disease
927,Coronary Artery Disease,Methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cardiovascular_disease
929,Clinically Significant Portal Hypertension,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,cardiovascular_disease
941,Thrombosis,Itraconazole,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,cardiovascular_disease
944,Multiple Myeloma,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,cardiovascular_disease
963,Thromboembolism,Betrixaban,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl,cardiovascular_disease
970,Hypertension,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,cardiovascular_disease
977,Primary Open Angle Glaucoma or Ocular Hypertension,Netarsudil,CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)C(CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C,cardiovascular_disease
980,Cardiovascular Disease,Midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,cardiovascular_disease
988,Atrial Fibrillation,Dabigatran,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,cardiovascular_disease
998,Myocardial Infarction|Acute Coronary Syndromes|Unstable Angina,Eptifibatide,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,cardiovascular_disease
1007,Open-angle Glaucoma|Oular Hypertension,Anecortave,CC12CCC(=O)C=C1CCC3C2=CCC4(C3CCC4(C(=O)CO)O)C,cardiovascular_disease
1031,Von Hippel-Lindau Syndrome,Pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,cardiovascular_disease
1032,Heart Failure,Cenderitide,CCC(C)C(C(=O)NCC(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NCC(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CS)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(=O)O)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)N3CCCC3C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)N4CCCC4C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)NC(C)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CC5=CC=CC=C5)NC(=O)C(CS)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)CN,cardiovascular_disease
1034,Behavioural Disturbances|Pain|Dementia|Alzheimer's Dementia|Vascular Dementia,Acetaminophen,CC(=O)NC1=CC=C(C=C1)O,cardiovascular_disease
1036,Multiple Myeloma,Rimiducid,CCC(C1=CC(=C(C(=C1)OC)OC)OC)C(=O)N2CCCCC2C(=O)OC(CCC3=CC(=C(C=C3)OC)OC)C4=CC(=CC=C4)OCC(=O)NCCNC(=O)COC5=CC=CC(=C5)C(CCC6=CC(=C(C=C6)OC)OC)OC(=O)C7CCCCN7C(=O)C(CC)C8=CC(=C(C(=C8)OC)OC)OC,cardiovascular_disease
1048,"Hypertension, Pulmonary|Pulmonary Arterial Hypertension",Treprostinil,CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O,cardiovascular_disease
1049,"Hypertension, Pulmonary|Pulmonary Arterial Hypertension",Esomeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,cardiovascular_disease
1050,"Atrial Fibrillation|Atrial Fibrillation, Persistent",Ivabradine,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC,cardiovascular_disease
1063,Conscious Sedation,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,cardiovascular_disease
1065,Stroke,Basmisanil,CC1=C(C(=NO1)C2=CC=C(C=C2)F)COC3=NC=C(C=C3)C(=O)N4CCS(=O)(=O)CC4,cardiovascular_disease
1069,Multiple Myeloma,Pralatrexate,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cardiovascular_disease
1079,Multiple Myeloma,Pamidronate,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,cardiovascular_disease
1093,Hypertension,Chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,cardiovascular_disease
1104,Acute Myeloid Leukemia|Diffuse Large B-cell Lymphoma|Acute Lymphoblastic Leukemia|Multiple Myeloma,Birabresib,CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C,cardiovascular_disease
1111,Essential Hypertension,Aprocitentan,C1=CC(=CC=C1C2=C(N=CN=C2OCCOC3=NC=C(C=N3)Br)NS(=O)(=O)N)Br,cardiovascular_disease
1134,"Arteritis, Giant Cell",Baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,cardiovascular_disease
1167,Congestive Heart Failure,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,cardiovascular_disease
1171,Thrombosis Prophylaxis (Risk of Thrombosis Due to Central Venous Line (CVL),Semuloparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,cardiovascular_disease
1172,"Heart Failure, Congestive|Edema",Tolvaptan,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,cardiovascular_disease
1176,Autonomic Failure|Orthostatic Hypotension,Atomoxetine,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,cardiovascular_disease
1177,Autonomic Failure|Orthostatic Hypotension,Acarbose,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,cardiovascular_disease
1179,Autonomic Failure|Orthostatic Hypotension,Yohimbine,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O,cardiovascular_disease
1181,Autonomic Failure|Orthostatic Hypotension,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,cardiovascular_disease
1182,Autonomic Failure|Orthostatic Hypotension,Octreotide,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,cardiovascular_disease
1186,Autonomic Failure|Orthostatic Hypotension,Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,cardiovascular_disease
1187,Autonomic Failure|Orthostatic Hypotension,Tranylcypromine,C1C(C1N)C2=CC=CC=C2,cardiovascular_disease
1188,Autonomic Failure|Orthostatic Hypotension,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,cardiovascular_disease
1189,Autonomic Failure|Orthostatic Hypotension,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,cardiovascular_disease
1190,Autonomic Failure|Orthostatic Hypotension,Indomethacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,cardiovascular_disease
1191,Autonomic Failure|Orthostatic Hypotension,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,cardiovascular_disease
1192,Autonomic Failure|Orthostatic Hypotension,Oxymetazoline,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,cardiovascular_disease
1194,Autonomic Failure|Orthostatic Hypotension,Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,cardiovascular_disease
1195,Autonomic Failure|Orthostatic Hypotension,Carbidopa,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,cardiovascular_disease
1198,Mantle Cell Lymphoma|B Cell Lymphoma|Multiple Myeloma,Canfosfamide,C1=CC=C(C=C1)C(C(=O)O)NC(=O)C(CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)NC(=O)CCC(C(=O)O)N,cardiovascular_disease
1204,Adult B Acute Lymphoblastic Leukemia|Adult T Acute Lymphoblastic Leukemia|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-Cell Lymphoma|Chronic Lymphocytic Leukemia|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Hepatosplenic T-Cell Lymphoma|Intraocular Lymphoma|Lymphomatous Involvement of Non-Cutaneous Extranodal Site|Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Nodal Marginal Zone Lymphoma|Primary Cutaneous B-Cell Non-Hodgkin Lymphoma|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-Cell Leukemia/Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides and Sezary Syndrome|Recurrent Non-Hodgkin Lymphoma|Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Small Intestinal Lymphoma|Splenic Marginal Zone Lymphoma|T-Cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Waldenstrom Macroglobulinemia,Alisertib,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,cardiovascular_disease
1212,Orthostatic Hypertension,Norepinephrine,C1=CC(=C(C=C1C(CN)O)O)O,cardiovascular_disease
1218,Acute Coronary Syndrome,Bisoprolol,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,cardiovascular_disease
1226,Behcet Syndrome,Apremilast,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,cardiovascular_disease
1227,Glaucoma|Ocular Hypertension,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,cardiovascular_disease
1235,Velo-cardio-facial Syndrome|Psychosis,Metyrosine,CC(CC1=CC=C(C=C1)O)(C(=O)O)N,cardiovascular_disease
1236,Atrial Fibrillation|Coronary Artery Disease,Regadenoson,CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N,cardiovascular_disease
1239,Plasma Cell Leukemia|Recurrent Plasma Cell Myeloma,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,cardiovascular_disease
1240,Plasma Cell Leukemia|Recurrent Plasma Cell Myeloma,Cytarabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,cardiovascular_disease
1264,Compartment Syndrome of Leg|Healthy,Mepivacaine,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C,cardiovascular_disease
1275,Chronic Obstructive Pulmonary Disease,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,cardiovascular_disease
1285,Atrial Fibrillation|Atrial Flutter,Amiodarone,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,cardiovascular_disease
1291,Multiple Myeloma,Plitidepsin,CCC(C)C1C(CC(=O)OC(C(=O)C(C(=O)NC(C(=O)N2CCCC2C(=O)N(C(C(=O)OC(C(C(=O)N1)NC(=O)C(CC(C)C)N(C)C(=O)C3CCCN3C(=O)C(=O)C)C)CC4=CC=C(C=C4)OC)C)CC(C)C)C)C(C)C)O,cardiovascular_disease
1317,Heart Failure With Reduced Ejection Fraction NYHA Class III-IV,Mirabegron,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,cardiovascular_disease
1354,Hemorrhoids,Hydrocortisone,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,cardiovascular_disease
1371,Peripartum Cardiomyopathy,Bromocriptine,CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,cardiovascular_disease
1373,Atrial Fibrillation|Thromboembolism,Edoxaban,CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,cardiovascular_disease
1383,Multiple Myeloma|Non-Hodgkin Lymphoma|Hodgkin Disease|Acute Myeloid Leukemia|Myeloproliferative Disorders,Leuprolide,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,cardiovascular_disease
1384,Vasoplegic Syndrome,Hydroxocobalamin,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2],cardiovascular_disease
1388,Hypertension,Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,cardiovascular_disease
1397,"Stroke, Ischemic",Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,cardiovascular_disease
1399,Acute Heart Failure,Liraglutide,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N)C(=O)O,cardiovascular_disease
1400,Coronary Artery Bypass Graft Surgery|Myocardial Ischemia|Reperfusion Injury|Myocardial Revascularization,Pyridoxal,CC1=NC=C(C(=C1O)C=O)CO,cardiovascular_disease
1411,HIV Infections|Cardiovascular Diseases|Hypertension,Indinavir,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,cardiovascular_disease
1412,HIV Infections|Cardiovascular Diseases|Hypertension,Ritonavir,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,cardiovascular_disease
1472,Pulmonary Arterial Hypertension,Zamicastat,C1C(COC2=C1C=C(C=C2F)F)N3C(=CNC3=S)CCNCC4=CC=CC=C4,cardiovascular_disease
1478,Multiple Myeloma,Ruxolitinib,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,cardiovascular_disease
1485,Reperfusion Injury,Epoprostenol,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,cardiovascular_disease
1491,Dwarfism|Turner's Syndrome,Oxandrolone,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,cardiovascular_disease
1494,Diabetic Foot Ulcer,Levofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,cardiovascular_disease
1509,Essential Hypertension,Fimasartan,CCCCC1=NC(=C(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CC(=S)N(C)C)C,cardiovascular_disease
1517,Pulmonary Arterial Hypertension,Tezosentan,CC(C)C1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC,cardiovascular_disease
1518,Parkinson's Disease|Multiple System Atrophy|Orthostatic Hypotension,Fludrocortisone,CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C(=O)CO)O)C)O)F,cardiovascular_disease
1519,Parkinson's Disease|Multiple System Atrophy|Orthostatic Hypotension,Domperidone,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,cardiovascular_disease
1554,Thrombosis,Lepirudin,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC2C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C3CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(C)C)CC(=O)N)CCC(=O)N)CO)CCC(=O)O)C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)N)C(=O)N1)CCCCN)CC(=O)N)CCC(=O)N)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)NC(CCCCN)C(=O)N6CCCC6C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC7=CNC=N7)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)N9CCCC9C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCCN)CCC(=O)O)CC(=O)O)CO)CC(C)C,cardiovascular_disease
1568,"Diabetes Mellitus, Type 2|Hypertension",Ertugliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C34C(C(C(C(O3)(CO4)CO)O)O)O)Cl,cardiovascular_disease
1575,Relapsed/Refractory Multiple Myeloma,Nirogacestat,CCCC(C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C)NC2CCC3=C(C2)C(=CC(=C3)F)F,cardiovascular_disease
1576,Peripheral Arterial Diseases,Levocarnitine,C[N+](C)(C)CC(CC(=O)[O-])O,cardiovascular_disease
1577,Peripheral Arterial Diseases,Carnitine,C[N+](C)(C)CC(CC(=O)[O-])O,cardiovascular_disease
1589,Hypertension|Heart Failure,Prazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,cardiovascular_disease
1594,Essential Hypertension,Lercanidipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC,cardiovascular_disease
1609,Cardiovascular Diseases,Fasudil,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3,cardiovascular_disease
1625,Arterial Ischemic Stroke,Afamelanotide,CCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)NC(CCCCN)C(=O)N5CCCC5C(=O)NC(C(C)C)C(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)NC(=O)C,cardiovascular_disease
1626,Endocarditis|Bacteremia,Dalbavancin,CC(C)CCCCCCCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=C(C(=CC(=C7)O)OC8C(C(C(C(O8)CO)O)O)O)C9=C(C=CC(=C9)C(C(=O)N6)NC(=O)C4NC(=O)C1C2=C(C(=CC(=C2)OC2=C(C=CC(=C2)C(C(=O)NC(CC2=CC=C(O3)C=C2)C(=O)N1)NC)O)O)Cl)O)C(=O)NCCCN(C)C)O)Cl)C(=O)O)O)O,cardiovascular_disease
1633,Cerebrovascular Accident|Hemiparesis,Ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,cardiovascular_disease
1635,Atherosclerosis|Myocardial Ischemia|Myocardial Infarction,Vorapaxar,CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C,cardiovascular_disease
1641,Subacute/Chronic Myocardial Infarction,Gadobutrol,C1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])C(CO)C(CO)O)CC(=O)[O-].[Gd+3],cardiovascular_disease
1642,Aortic Valve Stenosis,Ataciguat,C1COCCN1S(=O)(=O)C2=CC=C(C=C2)NC(=O)C3=C(C=CC(=C3)Cl)NS(=O)(=O)C4=CC=C(S4)Cl,cardiovascular_disease
1647,Myocardial Infarction,Fulacimstat,CN1C2=C(C=C(C=C2)N3C=C(C(=O)N(C3=O)C4CCC5=C4C=CC=C5C(F)(F)F)C(=O)O)OC1=O,cardiovascular_disease
1672,Congestive Heart Failure|Renal Impairment,Pecavaptan,CC(C1=NC(=NN1C2=CC(=CC=C2)Cl)CN3C(=O)N(C(=N3)C4=CC=C(C=C4)Cl)CC(C(F)(F)F)O)O,cardiovascular_disease
1676,Coronary Artery Disease,Ezetimibe,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,cardiovascular_disease
1678,Healthy Volunteer,Vardenafil,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,cardiovascular_disease
1711,Open-Angle Glaucoma|Ocular Hypertension,Brinzolamide,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC,cardiovascular_disease
1729,Solid Tumors|Lymphoma|Multiple Myeloma,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,cardiovascular_disease
1730,Ataxia Telangiectasia,Betamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,cardiovascular_disease
1751,Myeloma,Nelfinavir,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,cardiovascular_disease
1765,Subclinical Hypothyroidism,Levothyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,cardiovascular_disease
1783,STEMI,Acetylcysteine,CC(=O)NC(CS)C(=O)O,cardiovascular_disease
1784,"Ductus Arteriosus, Patent",Paracetamol,CC(=O)NC1=CC=C(C=C1)O,cardiovascular_disease
1793,Coronary Artery Stenosis,Alendronate,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,cardiovascular_disease
1795,Hepatic Veno-Occlusive Disease,Defibrotide,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O,cardiovascular_disease
1810,Multiple Myeloma,Tecemotide,CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NCC(=O)O)NC(=O)C1CCCN1C(=O)C2CCCN2C(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)CNC(=O)C3CCCN3C(=O)C(C)NC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C5CCCN5C(=O)C(C)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CC6=CN=CN6)NC(=O)C(C)NC(=O)C7CCCN7C(=O)C8CCCN8C(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CO)N,cardiovascular_disease
1849,Systolic Heart Failure,Probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,cardiovascular_disease
1862,Preeclampsia,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,cardiovascular_disease
1863,Preeclampsia,Torsemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,cardiovascular_disease
1881,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Plasma Cell Myeloma,Crizotinib,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,cardiovascular_disease
1886,Coronary Artery Disease,Rifampin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,cardiovascular_disease
1887,Coronary Artery Disease,Rifampicin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,cardiovascular_disease
1912,Heart Failure With Reduced Ejection Fraction,Empagliflozin,C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,cardiovascular_disease
1926,"Lymphoma, T-Cell, Cutaneous|Lymphoma, T-Cell, Peripheral|Chronic Lymphocytic Leukemia|Lymphoproliferative Disorders|Waldenstrom Macroglobulinemia|Lymphoplasmacytic Lymphoma|Mantle Cell Lymphoma",Pacritinib,C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2,cardiovascular_disease
1943,Multiple Myeloma,Cisplatin,N.N.Cl[Pt]Cl,cardiovascular_disease
1953,Diabetic Retinopathy|Macular Edema,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,cardiovascular_disease
1968,Cardiac Failure,Pirfenidone,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,cardiovascular_disease
1996,Multiple Myeloma at First Relapse,Iberdomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCOCC5,cardiovascular_disease
1998,"Heart Failure, Congestive|Chronic Heart Failure|Depression",Sertraline,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,cardiovascular_disease
2015,Multiple Myeloma,Vactosertib,CC1=NC(=CC=C1)C2=C(N=C(N2)CNC3=CC=CC=C3F)C4=CN5C(=NC=N5)C=C4,cardiovascular_disease
2022,Coronary Artery Disease,Cangrelor,CSCCNC1=C2C(=NC(=N1)SCCC(F)(F)F)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O,cardiovascular_disease
2023,Coronary Artery Disease,Prasugrel,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,cardiovascular_disease
2034,Multiple Myeloma,Acetylcarnitine,CC(=O)OC(CC(=O)[O-])C[N+](C)(C)C,cardiovascular_disease
2037,Cerebral Vasospasm After Subarachnoid Hemorrhage,Dantrolene,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-],cardiovascular_disease
2040,Open Angle Glaucoma|Ocular Hypertension,Phentolamine,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O,cardiovascular_disease
2057,Stable Coronary Artery Disease,Selatogrel,CCCCOC(=O)N1CCN(CC1)C(=O)C(CP(=O)(O)O)NC(=O)C2=CC(=NC(=N2)C3=CC=CC=C3)N4CCC(C4)OC,cardiovascular_disease
2067,Drug-induced QT Prolongation|Pharmacokinetics|Pharmacodynamics,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,cardiovascular_disease
2068,Drug-induced QT Prolongation|Pharmacokinetics|Pharmacodynamics,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,cardiovascular_disease
2077,Lung Cancer|Solid Tumor|Gastric Cancer|Urothelial Cancer|Endometrial Cancer|Multiple Myeloma|Myeloproliferative Neoplasms|Breast Cancer|Cholangiocarcinoma|UC|MPN,Pemigatinib,CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5,cardiovascular_disease
2080,Lung Cancer|Solid Tumor|Gastric Cancer|Urothelial Cancer|Endometrial Cancer|Multiple Myeloma|Myeloproliferative Neoplasms|Breast Cancer|Cholangiocarcinoma|UC|MPN,Docetaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,cardiovascular_disease
2089,Atrial Fibrillation,Dronedarone,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC,cardiovascular_disease
2108,Congestive Heart Failure,Lixivaptan,CC1=C(C=C(C=C1)F)C(=O)NC2=CC(=C(C=C2)C(=O)N3CC4=CC=CN4CC5=CC=CC=C53)Cl,cardiovascular_disease
2125,Waldenstrom's Macroglobulinemia|Multiple Myeloma,Enzastaurin,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7,cardiovascular_disease
2126,"Hypertension, Pulmonary",Iloprost,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,cardiovascular_disease
2142,Cardiovascular Diseases,Alprostadil,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,cardiovascular_disease
2144,Cirrhosis|Ascites,Terlipressin,C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)NC(CCCCN)C(=O)NCC(=O)N,cardiovascular_disease
2149,Williams Beuren Syndrome,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,cardiovascular_disease
2155,Schizophrenia|Schizoaffective Disorder,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,cardiovascular_disease
2159,Microvascular Angina,Zibotentan,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,cardiovascular_disease
2171,Non-hodgkins Lymphoma|Hodgkins Lymphoma|Multiple Myeloma,Pegaspargase,CC1=CC(=C(C=C1)C(=O)C(=C)CN(C)C)C,cardiovascular_disease
2178,Hereditary Hemorrhagic Telangiectasia,Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,cardiovascular_disease
2188,Subarachnoid Hemorrhage|Hypertension,Clevidipine,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cardiovascular_disease
2189,HIV|Cardiovascular Diseases|Atherosclerosis,Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,cardiovascular_disease
2206,Pulmonary Arterial Hypertension,Beraprost,CC#CCC(C)C(C=CC1C(CC2C1C3=CC=CC(=C3O2)CCCC(=O)O)O)O,cardiovascular_disease
2213,Myeloma Multiple|Lymphoma,Pegfilgrastim,CC(C(C(=O)O)N)OC1C(C(C(C(O1)COC2(CC(C(C(O2)C(C(CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C,cardiovascular_disease
2217,Refractory Multiple Myeloma,Tivantinib,C1CC2=C3C(=CC=C2)C(=CN3C1)C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,cardiovascular_disease
2255,Postural Tachycardia Syndrome,Galantamine,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,cardiovascular_disease
2268,"Myocardial Reperfusion Injury|Cardiac Output, Low",Perhexiline,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,cardiovascular_disease
2269,Acute Leukemia|Chronic Myeloproliferative Disease|Chronic Lymphoproliferative Disease|Multiple Myeloma|Lymphoma|Poor-risk Myelodysplasia (MDS),Darinaparsin,C[As](C)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N,cardiovascular_disease
2272,Multiple Myeloma,Vinorelbine,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,cardiovascular_disease
2274,Heart Failure,Istaroxime,CC12CCC(=NOCCN)CC1C(=O)CC3C2CCC4(C3CCC4=O)C,cardiovascular_disease
2281,High Altitude Pulmonary Hypertension,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,cardiovascular_disease
2297,Out-of-hospital Cardiac Arrest,Rocuronium,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,cardiovascular_disease
2305,Congestive Heart Failure,Piboserod,CCCCN1CCC(CC1)CNC(=O)C2=C3N(CCCO3)C4=CC=CC=C42,cardiovascular_disease
2313,Relapsed or Refractory Multiple Myeloma|Patients With BRAFV600 E or BRAFV600K Mutation,Encorafenib,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,cardiovascular_disease
2314,Relapsed or Refractory Multiple Myeloma|Patients With BRAFV600 E or BRAFV600K Mutation,Binimetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,cardiovascular_disease
2337,Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia|Non Follicular Indolent Non-Hodgkin Lymphoma,Umbralisib,CC(C)OC1=C(C=C(C=C1)C2=NN(C3=NC=NC(=C23)N)C(C)C4=C(C(=O)C5=C(O4)C=CC(=C5)F)C6=CC(=CC=C6)F)F,cardiovascular_disease
2361,Atrial Fibrillation|Atrial Flutter,Celivarone,CCCCC1=C(C2=C(O1)C=CC(=C2)C(=O)OC(C)C)C(=O)C3=CC=C(C=C3)CCCN(CCCC)CCCC,cardiovascular_disease
2369,"Solid Tumors|Lymphoma, Non-Hodgkin|Multiple Myeloma",Aprepitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,cardiovascular_disease
2370,"Solid Tumors|Lymphoma, Non-Hodgkin|Multiple Myeloma",Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,cardiovascular_disease
2400,Essential Hypertension,Ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,cardiovascular_disease
2403,Anaphylaxis|Hypotension|Bronchospasm|Angioedema,Epinephrine,CNCC(C1=CC(=C(C=C1)O)O)O,cardiovascular_disease
2451,Aneurysmal Subarachnoid Hemorrhage,Clazosentan,CC1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC,cardiovascular_disease
2485,Angina Pectoris,Glyburide,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,cardiovascular_disease
2558,Angioedema,Icatibant,C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O,cardiovascular_disease
2559,Angioedema,Cortisone,CC12CCC(=O)C=C1CCC3C2C(=O)CC4(C3CCC4(C(=O)CO)O)C,cardiovascular_disease
2576,Patent Ductus Arteriosus (PDA)|Acute Kidney Injury (AKI),Fenoldopam,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,cardiovascular_disease
2584,Coronary Artery Disease,Quercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,cardiovascular_disease
2621,Acute Heart Failure,Dopamine,C1=CC(=C(C=C1CCN)O)O,cardiovascular_disease
2637,Cardiac Disease,Perflutren,C(C(F)(F)F)(C(F)(F)F)(F)F,cardiovascular_disease
2644,Symptomatic Neurogenic Orthostatic Hypertension|nOH,Ampreloxetine,C1CNCCC1C2=CC=CC=C2COC3=C(C=C(C=C3F)F)F,cardiovascular_disease
2647,Waldenstrm's Macroglobulinemia (WM),Zanubrutinib,C=CC(=O)N1CCC(CC1)C2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N,cardiovascular_disease
2658,Coronary Heart Disease,Dalcetrapib,CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C,cardiovascular_disease
2664,Intracranial Hemorrhage|Periventricular Leukomalacia|Cerebral Palsy|Developmental Psychomotor Disorders,Erythropoietin,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+],cardiovascular_disease
2665,DS Stage I Plasma Cell Myeloma|DS Stage II Plasma Cell Myeloma|DS Stage III Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Vismodegib,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,cardiovascular_disease
2674,Multiple Myeloma,Perifosine,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C,cardiovascular_disease
2708,Obesity|Metabolic Syndrome X,Orlistat,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,cardiovascular_disease
2724,Cardiac Failure Aggravated,Sotagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)SC)O)O)O)Cl,cardiovascular_disease
2755,Transfusional Iron Overload|Transfusional Hemosiderosis,Deferasirox,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,cardiovascular_disease
2756,Transfusional Iron Overload|Transfusional Hemosiderosis,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,cardiovascular_disease
2810,Refractory Hypertension,Reserpine,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,cardiovascular_disease
2811,Liver Transplant With Clinically Significant Portal Hypertension,Somatostatin,CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)C(C)O)CC6=CC=CC=C6)O,cardiovascular_disease
2847,Atherosclerotic Cardiovascular Disease|Symptomatic Atherosclerosis|Type2 Diabetes|Familial Hypercholesterolemia,Inclisiran,CC(=O)NC1C(C(C(OC1OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)NC(=O)CCCCCCCCCCC(=O)N4CC(CC4COP(=O)(O)O)O)CO)O)O,cardiovascular_disease
2868,Diabetic Foot Ulcer,Ketanserin,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O,cardiovascular_disease
2872,Angina,Febuxostat,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,cardiovascular_disease
2893,Cardiovascular Diseases|Vascular Dilation,Ifetroban,CCCCCNC(=O)C1=COC(=N1)C2C3CCC(C2CC4=CC=CC=C4CCC(=O)O)O3,cardiovascular_disease
2925,Acute Coronary Syndrome,Varespladib,CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N,cardiovascular_disease
2928,Ventricular Premature Complexes|Blood Pressure,Flecainide,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,cardiovascular_disease
2930,Obesity|Hypoandrogenism,Clomifene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,cardiovascular_disease
2931,Obesity|Hypoandrogenism,Clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,cardiovascular_disease
2937,Tobacco Use Disorder,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,cardiovascular_disease
2967,Macular Edema|Central Retinal Vein Occlusion,Ecallantide,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NCC(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N5CCCC5C(=O)N3)CC(=O)O)CC(=O)O)C)CCCCN)CC6=CC=CC=C6)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(CCSC)NC(=O)C(C)NC(=O)C(CCC(=O)O)N)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)O)CCSC)CCCCN)CCCCN)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCC(=O)O)CC(=O)N)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CC9=CC=CC=C9)CCC(=O)O)CO)CC(C)C)CCC(=O)O)CCC(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC1=CC=CC=C1)CCC(=O)O)CCC(=O)O)CCC(=O)N)CCCNC(=N)N)C(C)O)CC1=CC=CC=C1)C(C)CC)CC(=O)N)CC1=CC=CC=C1)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CCCNC(=N)N)CC1=CN=CN1)C)C)CCCNC(=N)N)CC1=CC=C(C=C1)O,cardiovascular_disease
3000,Heart Disease,Pentobarbital,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC,cardiovascular_disease
3010,Myocardial Infarction,Mangafodipir,[H+].[H+].[H+].[H+].CC1=NC=C(C(=C1O)CN(CCN(CC2=C(C(=NC=C2COP(=O)([O-])[O-])C)O)CC(=O)[O-])CC(=O)[O-])COP(=O)([O-])[O-].[Mn+2],cardiovascular_disease
3011,Relapsed or Refractory Multiple Myeloma,Cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,cardiovascular_disease
3014,Cardiorenal Syndrome,Chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,cardiovascular_disease
3049,Pulmonary Veno Occlusive Disease,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,cardiovascular_disease
3058,Heart Failure,Glutamine,C(CC(=O)N)C(C(=O)O)N,cardiovascular_disease
3077,Multiple System Atrophy,Safinamide,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F,cardiovascular_disease
3084,Ischemic Stroke,Verapamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cardiovascular_disease
3111,Medical Oncology,Copanlisib,COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5,cardiovascular_disease
3172,High Blood Pressure|Migraine Headaches|Chest Pain,Nadolol,CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O,cardiovascular_disease
3178,Renal Insufficiency|Heart Failure,Tonapofylline,CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C34CCC(CC3)(CC4)CCC(=O)O,cardiovascular_disease
3194,Cardiovascular Diseases,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,cardiovascular_disease
3195,Cardiovascular Diseases,Lorcaserin,CC1CNCCC2=C1C=C(C=C2)Cl,cardiovascular_disease
3196,Pulmonary Arterial Hypertension,Ralinepag,C1CC(CCC1COCC(=O)O)COC(=O)N(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,cardiovascular_disease
3205,Atrial Fibrillation,Capadenoson,C1=CC(=CC=C1C2=C(C(=NC(=C2C#N)SCC3=CSC(=N3)C4=CC=C(C=C4)Cl)N)C#N)OCCO,cardiovascular_disease
3220,B-Cell Prolymphocytic Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Follicular Lymphoma|Recurrent Lymphoplasmacytic Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Diffuse Large B-Cell Lymphoma|Refractory Follicular Lymphoma|Refractory Lymphoplasmacytic Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Marginal Zone Lymphoma|Refractory Non-Hodgkin Lymphoma|Refractory Small Lymphocytic Lymphoma|Richter Syndrome,Pevonedistat,C1CC2=CC=CC=C2C1NC3=C4C=CN(C4=NC=N3)C5CC(C(C5)O)COS(=O)(=O)N,cardiovascular_disease
3256,Cushing Syndrome|Endocrine Disease,Pentetreotide,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(CO)C(C)O)O,cardiovascular_disease
3268,Thrombosis|Bleeding,Phenprocoumon,CCC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,cardiovascular_disease
3273,Leukemia|Multiple Myeloma|Myelodysplastic Syndrome|Non-Hodgkin's Lymphoma,Leuprorelin,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,cardiovascular_disease
3277,Leukemia|Multiple Myeloma|Myelodysplastic Syndrome|Non-Hodgkin's Lymphoma,Degarelix,CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C,cardiovascular_disease
3320,Cardiovascular Diseases|Heart Diseases|Beta-Thalassemia,Deferiprone,CC1=C(C(=O)C=CN1C)O,cardiovascular_disease
3378,Hypertrophic Cardiomyopathy,Mavacamten,CC(C)N1C(=O)C=C(NC1=O)NC(C)C2=CC=CC=C2,cardiovascular_disease
3396,Multiple Myeloma,Montelukast,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,cardiovascular_disease
3399,Stroke,Dextroamphetamine,CC(CC1=CC=CC=C1)N,cardiovascular_disease
3414,Diabetic Retinopathy,Runcaciguat,CC(C(C1=CC=C(C=C1)Cl)C(=O)NC2=C(C=CC(=C2)C(CC(=O)O)C3CC3)Cl)C(F)(F)F,cardiovascular_disease
3432,Multiple System Atrophy,Inosine,C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O,cardiovascular_disease
3448,Coronary Heart Disease|Chlamydophila Pneumoniae Infections,Azithromycin,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,cardiovascular_disease
3449,Coronary Heart Disease|Chlamydophila Pneumoniae Infections,Rifabutin,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=NC6(CCN(CC6)CC(C)C)N=C25)O)C,cardiovascular_disease
3457,Heart Failure,Glucagon,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N,cardiovascular_disease
3473,Stroke,Maraviroc,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,cardiovascular_disease
3496,Fabry Disease,Iohexol,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I,cardiovascular_disease
3548,Marijuana Dependence,Dronabinol,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,cardiovascular_disease
3576,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Sonidegib,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,cardiovascular_disease
3620,Fabry Disease,Migalastat,C1C(C(C(C(N1)CO)O)O)O,cardiovascular_disease
3651,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Leflunomide,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,cardiovascular_disease
3681,Cardiac Remodeling|Myocardial Infarction,Paroxetine,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,cardiovascular_disease
3694,Congestive Heart Failure Chronic,Resveratrol,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,cardiovascular_disease
3720,HepatoCellular Carcinoma|Portal Vein Tumor Thrombosis,Lipotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)OC(=O)C(C)ON=C6C7=C(C(=CC(=C7)[N+](=O)[O-])[N+](=O)[O-])C8=C6C=C(C=C8[N+](=O)[O-])[N+](=O)[O-],cardiovascular_disease
3727,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,Taselisib,CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C,cardiovascular_disease
3739,Congestive Heart Failure,Cinaciguat,C1=CC=C(C=C1)CCC2=CC=C(C=C2)COC3=CC=CC=C3CCN(CCCCC(=O)O)CC4=CC=C(C=C4)C(=O)O,cardiovascular_disease
3743,Loss of Chromosome 17p|Recurrent Plasma Cell Myeloma,Idasanutlin,CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,cardiovascular_disease
3799,Hypertension,Levamlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,cardiovascular_disease
3821,Waldenstrom's Macroglobulinemia,Valaciclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,cardiovascular_disease
3822,Waldenstrom's Macroglobulinemia,Valacyclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,cardiovascular_disease
3849,Hypertension,Cilnidipine,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC,cardiovascular_disease
3868,Stroke|Acute Ischemic Stroke,Repinotan,C1CC2=CC=CC=C2OC1CNCCCCN3C(=O)C4=CC=CC=C4S3(=O)=O,cardiovascular_disease
3880,Chronic Obstructive Pulmonary Disease,Indacaterol,CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC,cardiovascular_disease
3881,Chronic Obstructive Pulmonary Disease,Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,cardiovascular_disease
3902,Multiple Myeloma,Amrubicin,CC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)OC5CC(C(CO5)O)O)N,cardiovascular_disease
3907,Multiple Myeloma,Uproleselan,CCC1CC(CC(C1OC2C(C(C(C(O2)C)O)O)O)OC3C(C(C(C(O3)CO)O)OC(CC4CCCCC4)C(=O)O)NC(=O)C)C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,cardiovascular_disease
3969,Heart Failure With Reduced Ejection Fraction HFrEF,Lenomorelin,CCCCCCCC(=O)OCC(C(=O)NC(CO)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N2CCCC2C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC=N3)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)N6CCCC6C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)CN,cardiovascular_disease
3973,Cerebrovascular Accident,Isoxaflutole,CS(=O)(=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C2=C(ON=C2)C3CC3,cardiovascular_disease
3997,Multiple Myeloma,Fosaprepitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NN(C(=O)N3)P(=O)(O)O)C4=CC=C(C=C4)F,cardiovascular_disease
4013,Angiodysplasia,Pasireotide,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,cardiovascular_disease
4022,LQT2 Syndrome,Eleclazine,C1COC2=C(C=C(C=C2)C3=CC=C(C=C3)OC(F)(F)F)C(=O)N1CC4=NC=CC=N4,cardiovascular_disease
4049,Venous Thromboembolism|Anticoagulant-induced Bleeding|Venous Thromboses|Pulmonary Embolism,Acenocoumarol,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(C3=CC=CC=C3OC2=O)O,cardiovascular_disease
4062,Vascular Anomalies,Marimastat,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,cardiovascular_disease
4099,Multiple Myeloma,Atiprimod,CCCC1(CCC2(CC1)CCN(C2)CCCN(CC)CC)CCC,cardiovascular_disease
4100,Renal Cell Carcinoma|Metastatic Renal Cell Carcinoma|Non-metastatic Renal Cell Carcinoma,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,cardiovascular_disease
4104,Von Hippel-Lindau Syndrome,Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,cardiovascular_disease
4116,"Neoplasms, Haematologic",Afuresertib,CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl,cardiovascular_disease
4154,Multiple Myeloma,Plinabulin,CC(C)(C)C1=C(N=CN1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2,cardiovascular_disease
4159,"Telangiectasia, Hereditary Hemorrhagic|Rendu Osler Disease",Nintedanib,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O,cardiovascular_disease
4166,Paroxysmal Supraventricular Tachycardia (PSVT),Etripamil,CC(C)C(CCCN(C)CCC1=CC(=CC=C1)C(=O)OC)(C#N)C2=CC(=C(C=C2)OC)OC,cardiovascular_disease
4167,"Stroke|Vascular Accident|Cerebral Stroke|Ischemic Cerebrovascular Accident|Stroke, Acute",Fingolimod,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,cardiovascular_disease
4176,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,cardiovascular_disease
4186,Wegener's Granulomatosis|Renal Limited Vasculitis|Microscopic Polyangiitis,Azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],cardiovascular_disease
4195,Wegener's Granulomatosis,Gusperimus,C(CCCN=C(N)N)CCC(=O)NC(C(=O)NCCCCNCCCN)O,cardiovascular_disease
4226,Barth Syndrome,Elamipretide,CC1=CC(=CC(=C1CC(C(=O)NC(CCCCN)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CCCN=C(N)N)N)C)O,cardiovascular_disease
4242,Non-Hodgkins Lymphoma|Multiple Myeloma|B-All,Acalabrutinib,CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,cardiovascular_disease
4243,Pulmonary Arterial Hypertension,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,cardiovascular_disease
4245,Neuroendocrine Tumors|Von Hippel-Lindau Syndrome|Hippel-Lindau Disease,Dotatate,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(C(C)O)C(=O)O)O,cardiovascular_disease
4249,Atrial Fibrillation,Triiodothyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,cardiovascular_disease
4250,Atrial Fibrillation,Liothyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,cardiovascular_disease
4261,Primary Open-Angle Glaucoma (POAG)|Ocular Hypertension (OHT),Trabodenoson,C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO[N+](=O)[O-])O)O,cardiovascular_disease
4272,Hemorrhoids,Iferanserin,CN1CCCCC1CCC2=CC=CC=C2NC(=O)C=CC3=CC=CC=C3,cardiovascular_disease
4291,Multiple Myeloma,Palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,cardiovascular_disease
4295,Cerebral Hemorrhage|Cerebral Edema|Intracerebral Hemorrhage|Stroke,Conivaptan,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,cardiovascular_disease
4300,Prolonged QT Interval in EKG and Sudden Death,Ibutilide,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,cardiovascular_disease
4303,Deep Venous Thrombosis,Desirudin,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC2C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C3CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(C)C)CC(=O)N)CCC(=O)N)CO)CCC(=O)O)C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(C(C)C)N)C(=O)N1)CCCCN)CC(=O)N)CCC(=O)N)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)NC(CCCCN)C(=O)N6CCCC6C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC7=CN=CN7)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)N9CCCC9C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCCN)CCC(=O)O)CC(=O)O)CO)CC(C)C,cardiovascular_disease
4311,Heart Failure,Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,cardiovascular_disease
4313,Heart Failure,Chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,cardiovascular_disease
4360,Angina Pectoris,Lacidipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,cardiovascular_disease
4413,Retinal Neovascularization,Squalamine,CC(C)C(CCC(C)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)NCCCNCCCCN)C)O)C)OS(=O)(=O)O,cardiovascular_disease
4434,Gastrointestinal Cancer|Cancer of Unknown Primary Site|Pancreatic Cancer|Bile Duct Neoplasms,Gimeracil,C1=C(C(=CNC1=O)Cl)O,cardiovascular_disease
4435,Gastrointestinal Cancer|Cancer of Unknown Primary Site|Pancreatic Cancer|Bile Duct Neoplasms,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,cardiovascular_disease
4436,Hypertension,Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,cardiovascular_disease
4438,Pulmonary Arterial Hypertension,Cicletanine,CC1=NC=C2C(OCC2=C1O)C3=CC=C(C=C3)Cl,cardiovascular_disease
4457,Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Precancerous Condition,Phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,cardiovascular_disease
4468,Atherosclerosis|Cardiovascular Disease|Inflammation|Insulin Resistance|Noninsulin-dependent Diabetes Mellitus,Salsalate,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,cardiovascular_disease
4473,Atrial Fibrillation,Sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,cardiovascular_disease
4479,Renal Cancer|Von Hippel Lindau,Vandetanib,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,cardiovascular_disease
4511,Stroke|Hemispatial Neglect,Guanfacine,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,cardiovascular_disease
4518,Hypertrophic Cardiomyopathy,Sacubitril,CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O,cardiovascular_disease
4520,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Afatinib,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,cardiovascular_disease
4523,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Capivasertib,C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,cardiovascular_disease
4534,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Erdafitinib,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,cardiovascular_disease
4535,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Ipatasertib,CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O,cardiovascular_disease
4538,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Larotrectinib,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,cardiovascular_disease
4541,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,cardiovascular_disease
4545,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Sapanisertib,CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N,cardiovascular_disease
4551,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Ulixertinib,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,cardiovascular_disease
4568,Ectopic Pregnancy,Letrozole,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,cardiovascular_disease
4570,Multiple Myeloma|Non-Hodgkin's Lymphoma,Meloxicam,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,cardiovascular_disease
4579,Hypercholesterolemia|Statin-Associated Myopathy,Pravastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,cardiovascular_disease
4633,Carney Complex|Chondrosarcoma|Gastrointestinal Stromal Tumor|Paraganglioma,Linsitinib,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,cardiovascular_disease
4638,Peripheral Artery Disease,Sulfasalazine,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,cardiovascular_disease
4640,Hypertension Secondary to Kidney Transplant,Isradipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,cardiovascular_disease
4642,Portal Hypertension,Cobiprostone,CCC(C)CC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,cardiovascular_disease
4646,Subarachnoid Hemorrhage,Prostacyclin,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,cardiovascular_disease
4677,Pulmonary Arterial Hypertension,Selexipag,CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,cardiovascular_disease
4700,Pulmonary Hypertension,Hymecromone,CC1=CC(=O)OC2=C1C=CC(=C2)O,cardiovascular_disease
4702,Lumbar Spine Surgery|Thoracic Spine Surgery,Ropivacaine,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,cardiovascular_disease
4714,Acute Pancreatitis|Intra-abdominal Hypertension,Neostigmine,CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,cardiovascular_disease
4730,Vascular Dementia,Ergoloid,CCC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,cardiovascular_disease
4828,Intermittent Claudication,Sapropterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,cardiovascular_disease
4832,"Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Leukemia|Lymphoma|Multiple Myeloma|MDS|Myelodysplastic/Myeloproliferative Diseases",Ganciclovir,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,cardiovascular_disease
4839,Cardiopulmonary Arrest|Fungal Infection,Fluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,cardiovascular_disease
4855,Sickle Cell Disease|Chronic Kidney Disease|Pulmonary Hypertension,Hydroxyurea,C(=O)(N)NO,cardiovascular_disease
4860,Adult B Acute Lymphoblastic Leukemia|Adult Nasal Type Extranodal NK/T-Cell Lymphoma|Adult Solid Neoplasm|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-Cell Lymphoma|Chronic Lymphocytic Leukemia|Cutaneous B-Cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Hepatosplenic T-Cell Lymphoma|Intraocular Lymphoma|Lymphomatous Involvement of Non-Cutaneous Extranodal Site|Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Nodal Marginal Zone Lymphoma|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-Cell Leukemia/Lymphoma|Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides and Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Plasma Cell Myeloma|Small Intestinal Lymphoma|Splenic Marginal Zone Lymphoma|Testicular Lymphoma|Waldenstrom Macroglobulinemia,Veliparib,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,cardiovascular_disease
4862,Ataxia Telangiectasia,Triheptanoin,CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,cardiovascular_disease
4881,Thromboembolism of Vein VTE in Colorectal Cancer|Thromboembolism of Vein in Pancreatic Cancer|Thromboembolism of Vein in Non-small Cell Lung Cancer,Isoquercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O,cardiovascular_disease
4889,Pulmonary Hypertension,Salbutamol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cardiovascular_disease
4890,Pulmonary Hypertension,Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,cardiovascular_disease
4921,Thrombosis,Valproate,CCCC(CCC)C(=O)O,cardiovascular_disease
4933,Recurrent Multiple Myeloma|Refractory Multiple Myeloma,Telaglenastat,C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F,cardiovascular_disease
4948,Arterial Calcification|CD73 Deficiency,Etidronate,CC(O)(P(=O)(O)O)P(=O)(O)O,cardiovascular_disease
4986,Coarctation of Aorta,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,cardiovascular_disease
4992,Intraluminal Pulmonary Vein Stenosis,Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,cardiovascular_disease
5142,"Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Chronic Lymphocytic Leukemia|Myelodysplasia|Lymphoma, Non-Hodgkin|Hodgkin's Lymphoma|Multiple Myeloma",Clioquinol,C1=CC2=C(C(=C(C=C2Cl)I)O)N=C1,cardiovascular_disease
5145,Coronary Artery Disease|Percutaneous Coronary Intervention|Platelet Aggregation Inhibitors,Vicagrel,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3Cl)C(=O)OC,cardiovascular_disease
5171,Stroke|Rhabdomyolysis|Jaundice,Lovastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,cardiovascular_disease
5179,Coronary Disease,Otamixaban,CC(C(CC1=CC(=CC=C1)C(=N)N)C(=O)OC)NC(=O)C2=CC=C(C=C2)C3=CC=[N+](C=C3)[O-],cardiovascular_disease
5198,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,cardiovascular_disease
5199,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Abiraterone,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,cardiovascular_disease
5202,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,cardiovascular_disease
5204,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Cabazitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,cardiovascular_disease
5207,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Carboplatin,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],cardiovascular_disease
5212,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Dacomitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,cardiovascular_disease
5213,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Darolutamide,CC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,cardiovascular_disease
5217,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Enasidenib,CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O,cardiovascular_disease
5218,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Entrectinib,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,cardiovascular_disease
5219,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Enzalutamide,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,cardiovascular_disease
5220,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,cardiovascular_disease
5222,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Fluorouracil,C1=C(C(=O)NC(=O)N1)F,cardiovascular_disease
5226,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,cardiovascular_disease
5227,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Leucovorin,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,cardiovascular_disease
5228,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Lorlatinib,CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,cardiovascular_disease
5230,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,cardiovascular_disease
5232,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Olaparib,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,cardiovascular_disease
5233,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Oxaliplatin,C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],cardiovascular_disease
5238,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,cardiovascular_disease
5241,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,cardiovascular_disease
5248,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Tretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,cardiovascular_disease
5249,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,cardiovascular_disease
5258,Systemic Lupus Erythematosus,Prasterone,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,cardiovascular_disease
5259,Systemic Lupus Erythematosus,Dehydroepiandrosterone,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,cardiovascular_disease
5274,Heart Failure With Preserved Ejection Fraction (HFpEF),Verinurad,CC(C)(C(=O)O)SC1=C(C=NC=C1)C2=CC=C(C3=CC=CC=C32)C#N,cardiovascular_disease
5276,"Irradiated Bone Marrow|Transplant-Related Hematologic Malignancy|Leukemia, Acute|Multiple Myeloma|Graft Vs Host Disease",Treosulfan,CS(=O)(=O)OCC(C(COS(=O)(=O)C)O)O,cardiovascular_disease
5282,Multiple Myeloma,Ricolinostat,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,cardiovascular_disease
5301,Pulmonary Arterial Hypertension,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,cardiovascular_disease
5312,Ischemia-Reperfusion Injury|Kidney Diseases,Reparixin,CC(C)CC1=CC=C(C=C1)C(C)C(=O)NS(=O)(=O)C,cardiovascular_disease
5349,"Hypertension, Pulmonary",Terbogrel,CC(C)(C)N=C(NC#N)NC1=CC=CC(=C1)C(=CCCCC(=O)O)C2=CN=CC=C2,cardiovascular_disease
5351,Diabetic Foot Infections,Nemonoxacin,CC1CC(CN(C1)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)OC)N,cardiovascular_disease
5372,"Kidney Failure, Chronic|Cardiovascular Diseases",Sevelamer,C=CCN.C1C(O1)CCl,cardiovascular_disease
5426,Diabetic Retinopathy,Pimagedine,C(=NN)(N)N,cardiovascular_disease
5456,Drug-Related Side Effects and Adverse Reactions|Cardiovascular System Disease,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,cardiovascular_disease
5530,Chronic Hepatitis B|Chronic Hepatitis D|Glomerulonephritis|Polyarteritis Nodosa,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,cardiovascular_disease
5536,Healthy Subjects|Atherosclerosis,Rilapladib,COCCN1CCC(CC1)N(CC2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C(=O)CN4C5=CC=CC=C5C(=O)C=C4SCC6=C(C(=CC=C6)F)F,cardiovascular_disease
5556,Adult Non-Hodgkin Lymphoma|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Nodal Marginal Zone Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia,Agatolimod,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1CO)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC(=C1C)C(=O)NC(=C)N)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)O,cardiovascular_disease
5562,Acute Myocardial Infarction|Acute Myocardial Ischemia|STEMI - ST Elevation Myocardial Infarction,Dutogliptin,B(C1CCCN1C(=O)CNC2CCNC2)(O)O,cardiovascular_disease
5652,Iris Neovascularization|Diabetic Retinopathy,Pegaptanib,COCCOC(=O)NCCCCC(C(=O)NCCCCCCCOP(=O)(C)O)NC(=O)OCCOC,cardiovascular_disease
5655,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Nodal Marginal Zone Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Refractory Plasma Cell Myeloma|Splenic Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia,Alvocidib,CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,cardiovascular_disease
5673,Multiple Myeloma,Ciforadenant,CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)COC5CCOC5,cardiovascular_disease
5696,Essential Hypertension,Bexagliflozin,C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,cardiovascular_disease
5732,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Uprosertib,CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)NC(CC3=CC(=C(C=C3)F)F)CN)Cl,cardiovascular_disease
5735,Hemorrhoid Pain|Hemorrhoids,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],cardiovascular_disease
5769,Cardiomyopathy|Congestive Heart Failure,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,cardiovascular_disease
5784,Renal Transplantation,Fluvastatin,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,cardiovascular_disease
5802,Pulmonary Arterial Hypertension,Anastrozole,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,cardiovascular_disease
5860,Anemia|B-Cell Prolymphocytic Leukemia|Grade 1 Follicular Lymphoma|Grade 2 Follicular Lymphoma|Grade 3a Follicular Lymphoma|Hairy Cell Leukemia|Lymphoplasmacytic Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Small Lymphocytic Lymphoma|Richter Syndrome,Entospletinib,C1COCCN1C2=CC=C(C=C2)NC3=NC(=CN4C3=NC=C4)C5=CC6=C(C=C5)C=NN6,cardiovascular_disease
5881,Multiple Myeloma|Hodgkin Lymphoma|Non-Hodgkin Lymphoma|HDT-AHCT,Romiplostim,CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C,cardiovascular_disease
5911,TTR Cardiomyopathy,Tafamidis,C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl,cardiovascular_disease
5914,Von Hippel-Lindau Syndrome,Dovitinib,CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=C(C5=C(C=CC=C5F)NC4=O)N,cardiovascular_disease
5915,Diabetic Foot Ulcer,Chlorhexidine,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,cardiovascular_disease
5936,Human Immunodeficiency Virus 1,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,cardiovascular_disease
5950,Multiple Myeloma,Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,cardiovascular_disease
5975,"Abnormalities, Cardiovascular",Volanesorsen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5C(OC(C5OCCOC)N6C=C(C(=O)NC6=O)C)COP(=S)(O)OC7C(OC(C7OCCOC)N8C=C(C(=O)NC8=O)C)COP(=S)(O)OC9C(OC(C9OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C(N=CN=C21)N)CO)N1C=C(C(=NC1=O)N)C)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)O,cardiovascular_disease
6009,Multiple Myeloma,Ganetespib,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)O,cardiovascular_disease
6014,"Heart Defects, Congenital",Dexrazoxane,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,cardiovascular_disease
6052,Macular Edema|Retinal Vein Occlusion,Fluocinolone,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CC(C4=CC(=O)C=CC43C)F)F)O,cardiovascular_disease
6073,Cardiovascular Disease Risk Factors,Puerarin,C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3C4C(C(C(C(O4)CO)O)O)O)O)O,cardiovascular_disease
6080,Multiple Myeloma,Disulfiram,CCN(CC)C(=S)SSC(=S)N(CC)CC,cardiovascular_disease
6098,Granulomatosis With Polyangiitis|Wegener Granulomatosis,Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,cardiovascular_disease
6099,Granulomatosis With Polyangiitis|Wegener Granulomatosis,Sulfamethoxazole,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,cardiovascular_disease
6103,Acute Ischemic Stroke,Edaravone,CC1=NN(C(=O)C1)C2=CC=CC=C2,cardiovascular_disease
6107,Congestive Heart Failure,Azimilide,CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)N=CC3=CC=C(O3)C4=CC=C(C=C4)Cl,cardiovascular_disease
6147,Multiple Myeloma,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,cardiovascular_disease
6168,Congestive Heart Failure,Fenoterol,CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O,cardiovascular_disease
6170,Symptomatic Atrial Fibrillation|Atrial Flutter,Vanoxerine,C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,cardiovascular_disease
6186,Hypertension|Pure Autonomic Failure|Multiple System Atrophy,Captopril,CC(CS)C(=O)N1CCCC1C(=O)O,cardiovascular_disease
6225,Hypertension|Diabetes,Linagliptin,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,cardiovascular_disease
6281,Diabetic Foot|Arterial Occlusive Disease|Ischemia,Urokinase,CC(C)OC(=O)NC1=CC2=C(C=C1)N=C(N2)C3=CSC=N3,cardiovascular_disease
6330,Peripheral Artery Disease,Probucol,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,cardiovascular_disease
6343,Recurrent Plasma Cell Myeloma,Dinaciclib,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,cardiovascular_disease
6394,Diastolic Heart Failure,Alagebrium,CC1=C(SC=[N+]1CC(=O)C2=CC=CC=C2)C,cardiovascular_disease
6396,Cushing's Syndrome,Mifepristone,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,cardiovascular_disease
6404,Multiple Myeloma,Roneparstat,CC(=O)NC1C(C(C(OC1OC2C(C(C(OC2C(=O)O)OC3C(OC(C(C3O)NC(=O)C)OC(CO)C(C(=O)O)OC(CO)O)CO)OS(=O)(=O)O)O)CO)O)O,cardiovascular_disease
6415,Atrial Fibrillation,Tecadenoson,C1COCC1NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O,cardiovascular_disease
6440,Congestive Heart Failure,Icodextrin,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,cardiovascular_disease
6441,Pulmonary Arterial Hypertension,Selonsertib,CC1=CC(=C(C=C1N2C=C(N=C2)C3CC3)C(=O)NC4=CC=CC(=N4)C5=NN=CN5C(C)C)F,cardiovascular_disease
6505,Stroke|Cerebrovascular Accident|Hemiparesis,Armodafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,cardiovascular_disease
6510,Diabetic Foot Ulcers,Gentamicin,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,cardiovascular_disease
6511,Diabetic Foot Ulcers,Ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,cardiovascular_disease
6556,Deep Venous Thrombosis,Bivalirudin,CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C5CCCN5C(=O)C(CC6=CC=CC=C6)N,cardiovascular_disease
6569,Refractory Multiple Myeloma,Noscapine,CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3,cardiovascular_disease
6588,Tachycardia|Chronic Orthostatic Intolerance,Entacapone,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,cardiovascular_disease
6594,Tachycardia|Chronic Orthostatic Intolerance,Mecamylamine,CC1(C2CCC(C2)C1(C)NC)C,cardiovascular_disease
6609,Glaucoma|Ocular Hypertension,Benzalkonium,CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1,cardiovascular_disease
6636,Major Depression|Cancer|Diabetes|Cardiovascular Diseases,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,cardiovascular_disease
6637,Cerebrovascular Disorders|Memory|Functional Recovery|Drug Intervention,Roflumilast,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,cardiovascular_disease
6647,Pulmonary Arterial Hypertension|Pulmonary Hypertension|Interstitial Lung Disease|Idiopathic Interstitial Pneumonia|Idiopathic Pulmonary Fibrosis|Sarcoidosis|Respiratory Bronchiolitis Associated Interstitial Lung Disease|Desquamative Interstitial Pneumonia|Cryptogenic Organizing Pneumonia|Acute Interstitial Pneumonitis|Idiopathic Lymphoid Interstitial Pneumonia|Idiopathic Pleuroparenchymal Fibroelastosis,Bardoxolone,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C,cardiovascular_disease
6652,Drug-induced QT Prolongation|Pharmacokinetics|Pharmacodynamics,Lopinavir,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,cardiovascular_disease
6662,High Blood Pressure,Calcitriol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,cardiovascular_disease
6704,Hypotension,Metaraminol,CC(C(C1=CC(=CC=C1)O)O)N,cardiovascular_disease
6741,Borderline Hypertension,Catechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,cardiovascular_disease
6742,Borderline Hypertension,Epicatechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,cardiovascular_disease
6756,Hypertension|Peripheral Artery Disease,Sarpogrelate,CN(C)CC(COC1=CC=CC=C1CCC2=CC(=CC=C2)OC)OC(=O)CCC(=O)O,cardiovascular_disease
6768,Coma|Heart Arrest|Anoxia,Amantadine,C1C2CC3CC1CC(C2)(C3)N,cardiovascular_disease
6,Muscle-invasive Urothelial Cancer of the Bladder,Tricyclazole,CC1=C2C(=CC=C1)SC3=NN=CN23,urinary_system_disease
10,Parkinson Disease,Preladenant,COCCOC1=CC=C(C=C1)N2CCN(CC2)CCN3C4=C(C=N3)C5=NC(=NN5C(=N4)N)C6=CC=CO6,urinary_system_disease
17,Renal Impairment|Healthy Volunteers,Mobocertinib,CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,urinary_system_disease
18,Schistosomiasis Haematobia,Artesunate,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC(=O)CCC(=O)O)C,urinary_system_disease
19,Schistosomiasis Haematobia,Pyronaridine,COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC(=C(C(=C4)CN5CCCC5)O)CN6CCCC6,urinary_system_disease
20,Schistosomiasis Haematobia,Artemether,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC)C,urinary_system_disease
21,Schistosomiasis Haematobia,Lumefantrine,CCCCN(CCCC)CC(C1=CC(=CC2=C1C3=C(C2=CC4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O,urinary_system_disease
22,Schistosomiasis Haematobia,Artefenomel,C1CC2(CCC1C3=CC=C(C=C3)OCCN4CCOCC4)OC5(C6CC7CC(C6)CC5C7)OO2,urinary_system_disease
36,Chronic Kidney Disease|End Stage Renal Disease|Anemia,Roxadustat,CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3,urinary_system_disease
53,Autosomal Dominant Polycystic Kidney|ADPKD,Tesevatinib,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,urinary_system_disease
69,Acute Urinary Retention,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,urinary_system_disease
72,Overactive Bladder,Tolterodine,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,urinary_system_disease
79,Urethritis,Tinidazole,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,urinary_system_disease
88,Kidney Transplantation|Primary Focal Segmental Glomerulosclerosis (FSGS),Methylprednisone,CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C,urinary_system_disease
95,Renal Impairment,Surufatinib,CC1=CC2=C(N1)C=CC(=C2)OC3=NC(=NC=C3)NC4=CC=CC(=C4)CS(=O)(=O)NCCN(C)C,urinary_system_disease
114,Phase 1|Healthy|Benign Prostatic Hyperplasia|Lower Urinary Tract Symptoms,Tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,urinary_system_disease
115,Phase 1|Healthy|Benign Prostatic Hyperplasia|Lower Urinary Tract Symptoms,Solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,urinary_system_disease
120,Urinary Tract Infections|Bladder Cancer|Urologic Surgical Procedures,Fosfomycin,CC1C(O1)P(=O)(O)O,urinary_system_disease
121,Urinary Tract Infections|Bladder Cancer|Urologic Surgical Procedures,Tromethamine,C(C(CO)(CO)N)O,urinary_system_disease
122,Urinary Tract Infections|Bladder Cancer|Urologic Surgical Procedures,Amikacin,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,urinary_system_disease
139,IGA Nephropathy,Budesonide,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,urinary_system_disease
143,End Stage Renal Disease,Escitalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,urinary_system_disease
149,Renal Cell Carcinoma,Ixabepilone,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,urinary_system_disease
152,Renal Impairment,Teriflunomide,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,urinary_system_disease
153,Renal Impairment,Cholestyramine,CCC(C)C.CCC(CC(C)C1=CC=CC=C1)C2=CC=C(C=C2)C[N+](C)(C)C.N.[Cl-],urinary_system_disease
161,Prostate Cancer|Erectile Dysfunction|Lower Urinary Tract Symptoms,Dutasteride,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,urinary_system_disease
166,"Healthy Volunteers|Polycystic Kidney, Autosomal Dominant",Venglustat,CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)OC3CN4CCC3CC4,urinary_system_disease
172,Healthy,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,urinary_system_disease
178,Wilms' Tumor|Sarcoma|Adenaocortical Carcinoma|Refractory Cancer|Coldrhood Cancer,Tariquidar,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC,urinary_system_disease
191,Healthy|Renal Insufficiency,Selpercatinib,CC(C)(COC1=CN2C(=C(C=N2)C#N)C(=C1)C3=CN=C(C=C3)N4CC5CC(C4)N5CC6=CN=C(C=C6)OC)O,urinary_system_disease
196,Type2 Diabetes Mellitus|Albuminuria|Renal Insufficiency,Evogliptin,CC(C)(C)OCC1C(=O)NCCN1C(=O)CC(CC2=CC(=C(C=C2F)F)F)N,urinary_system_disease
198,Metastatic Renal Cell Carcinoma|Fumarate Hydratase Deficient Renal Cell Carcinoma|Succinate Dehydrogenase Deficient Renal Cell Carcinoma,Talazoparib,CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,urinary_system_disease
200,Relapsed/Refractory Solid Tumors/Hematological Malignancies,Belinostat,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,urinary_system_disease
219,Bladder Neoplasms,Apaziquone,CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO,urinary_system_disease
220,"Infections, Bacterial",Gepotidacin,C1CC2=CC(=NC=C2OC1)CNC3CCN(CC3)CC4CN5C(=O)C=CC6=C5N4C(=O)C=N6,urinary_system_disease
221,Healthy|Renal Impairment,Lacosamide,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,urinary_system_disease
223,"Urinary Bladder, Overactive",Vibegron,C1CC(NC1CC2=CC=C(C=C2)NC(=O)C3CCC4=NC=CC(=O)N34)C(C5=CC=CC=C5)O,urinary_system_disease
226,Multiple Sclerosis|Overactive Detrusor,Darifenacin,C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,urinary_system_disease
229,Healthy|Renal Insufficiency,Erythromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,urinary_system_disease
231,"Neoplasm, Ureter|Neoplasm, Bladder",Epirubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,urinary_system_disease
236,Renal Disease,Ceftaroline,CCON=C(C1=NSC(=N1)NP(=O)(O)O)C(=O)NC2C3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-],urinary_system_disease
238,End Stage Renal Disease,Vancomycin,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,urinary_system_disease
241,Chronic Kidney Disease,Flucloxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,urinary_system_disease
242,Chronic Kidney Disease,Floxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,urinary_system_disease
245,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Low Grade Glioma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Hodgkin Lymphoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Refractory Hodgkin Lymphoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Rhabdoid Tumor|Refractory Soft Tissue Sarcoma|Rhabdoid Tumor|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Wilms Tumor,Tazemetostat,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,urinary_system_disease
248,Stage I Bladder Cancer|Stage II Bladder Cancer|Stage III Bladder Cancer,Cianidanol,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,urinary_system_disease
258,Urinary Tract Infections,Doripenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,urinary_system_disease
259,Migraine,Lasmiditan,CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F,urinary_system_disease
265,Anaemia,Daprodustat,C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O,urinary_system_disease
268,Diabetic Nephropathy,Bindarit,CC(C)(C(=O)O)OCC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3,urinary_system_disease
271,Primary Hyperoxaluria,Stiripentol,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O,urinary_system_disease
274,Urinary Tract Infections|Urinary Retention Postoperative|Pelvic Organ Prolapse,Methenamine,C1N2CN3CN1CN(C2)C3,urinary_system_disease
279,Urinary Tract Infections,Cefepime,C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],urinary_system_disease
284,Urothelial Carcinoma|Bladder Cancer|Myelosuppression Adult|Chemotherapy-induced Neutropenia|Metastatic Bladder Cancer,Trilaciclib,CN1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C=C5C(=O)NCC6(N5C4=N3)CCCCC6,urinary_system_disease
290,Benign Prostatic Hyperplasia|Lower Urinary Tract Symptoms,Talaporfin,CCC1=C(C2=CC3=C(C(=C(N3)C=C4C(C(C(=N4)C(=C5C(=C(C(=N5)C=C1N2)C)C(=O)O)CC(=O)NC(CC(=O)O)C(=O)O)CCC(=O)O)C)C)C=C)C,urinary_system_disease
306,Treatment of Overactive Bladder,Fesoterodine,CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,urinary_system_disease
309,Paroxysmal Nocturnal Hemoglobinuria (PNH),Zilucoplan,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCCC(C(=O)O)NC(=O)C(C1CCCCC1)NC(=O)C2CCCN2C(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC4=CNC5=C4C=CC=N5)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(C(C)(C)C)NC(=O)C(CC(=O)O)N(C)C(=O)C7CC(=O)NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N7)CC8=CC=CC=C8)CCCNC(=N)N)CCC(=O)O)C(C)C)NC(=O)C)C(=O)O,urinary_system_disease
320,Renal Cell Carcinoma,Fluzoparib,C1CN2C(=NC(=N2)C(F)(F)F)CN1C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,urinary_system_disease
321,Renal Impairment,Buparlisib,C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4,urinary_system_disease
326,Stress Urinary Incontinence|Fecal Incontinence,Reboxetine,CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3,urinary_system_disease
332,IGA Nephropathy,Fostamatinib,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,urinary_system_disease
354,Renal Impairment,Phentermine,CC(C)(CC1=CC=CC=C1)N,urinary_system_disease
357,"Anemia|Renal Insufficiency, Chronic",Molidustat,C1COCCN1C2=NC=NC(=C2)N3C(=O)C(=CN3)N4C=CN=N4,urinary_system_disease
358,"Carcinoma, Renal Cell",Tivozanib,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,urinary_system_disease
394,Renal Impairment,Methylnaltrexone,C[N+]1(CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6,urinary_system_disease
395,Hematuria|Hematospermia,Finasteride,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,urinary_system_disease
418,Recurrent Renal Cell Carcinoma|Stage IV Renal Cell Cancer,Suramin,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C,urinary_system_disease
423,Urinary Urgency|Urinary Frequency|Nocturia|Incontinence|Detrusor Uninhibited Activity|Quality of Life,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,urinary_system_disease
450,Anemia|Dialysis-dependent Chronic Kidney Disease,Vadadustat,C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O,urinary_system_disease
477,"Renal Disease, End-Stage|Renal Insufficiency, Chronic|Renal Insufficiency, Acute",Bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,urinary_system_disease
507,Renal Insufficiency|Hepatic Insufficiency,Nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,urinary_system_disease
515,Overactive Bladder|Mild Cognitive Impairment,Oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,urinary_system_disease
525,Renal Impairment,Fruquintinib,CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC,urinary_system_disease
541,Kidney Transplantation|Kidney Disease,Acyclovir,C1=NC2=C(N1COCCO)N=C(NC2=O)N,urinary_system_disease
542,Kidney Transplantation|Kidney Disease,Pentamidine,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,urinary_system_disease
543,Kidney Transplantation|Kidney Disease,Clotrimazole,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,urinary_system_disease
544,Kidney Transplantation|Kidney Disease,Nystatin,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,urinary_system_disease
562,Stage III Cutaneous Melanoma|Stage IV Cutaneous Melanoma|Locally Advanced Melanoma|Locally Advanced Solid Neoplasm|Metastatic Head and Neck Squamous Cell Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Urothelial Carcinoma|Non-Small Cell Lung Carcinoma|Stage IB Lung Cancer AJCC v7|Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Ureter Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Ureter Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8,Abexinostat,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,urinary_system_disease
568,Renal Impairment,Brensocatib,CN1C2=C(C=CC(=C2)C3=CC=C(C=C3)CC(C#N)NC(=O)C4CNCCCO4)OC1=O,urinary_system_disease
572,Diabetic Nephropathy,Topiroxostat,C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N,urinary_system_disease
584,Bladder Cancer,Mitomycin,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,urinary_system_disease
587,Neurogenic Bladder,Methantheline,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13,urinary_system_disease
604,Advanced Cancer|Pancreatic Cancer|Renal Cell Cancer|Non Small Cell Lung Cancer|Colorectal Carcinoma|Endometrial|Uterine,Irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,urinary_system_disease
624,HIV,Bictegravir,C1CC2CC1N3C(O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F,urinary_system_disease
641,Lupus Nephritis,Laquinimod,CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O,urinary_system_disease
650,Renal Impairment,Glasdegib,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,urinary_system_disease
654,End Stage Renal Disease,Pibrentasvir,CC(C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C(=C3)F)C4CCC(N4C5=CC(=C(C(=C5)F)N6CCC(CC6)C7=CC=C(C=C7)F)F)C8=CC9=C(C=C8F)N=C(N9)C1CCCN1C(=O)C(C(C)OC)NC(=O)OC)NC(=O)OC)OC,urinary_system_disease
656,Paroxysmal Nocturnal Hemoglobinuria,Cemdisiran,CC(=O)NC1C(C(C(OC1OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)NC(=O)CCCCCCCCCCC(=O)N4CC(CC4COP(=O)(O)O)O)CO)O)O,urinary_system_disease
666,Uremic Pruritus,Nalfurafine,CN(C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O)C(=O)C=CC7=COC=C7,urinary_system_disease
675,Childhood Renal Cell Carcinoma|Clear Cell Renal Cell Carcinoma|Clear Cell Sarcoma of the Kidney|Papillary Renal Cell Carcinoma|Rhabdoid Tumor of the Kidney|Stage I Renal Cell Cancer|Stage I Renal Wilms Tumor|Stage II Renal Cell Cancer|Stage II Renal Wilms Tumor|Stage III Renal Cell Cancer|Stage III Renal Wilms Tumor|Stage IV Renal Cell Cancer|Stage IV Renal Wilms Tumor,Dactinomycin,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,urinary_system_disease
691,"Transplant; Failure, Kidney",Desflurane,C(C(F)(F)F)(OC(F)F)F,urinary_system_disease
693,"Chronic Kidney Disease|Hyperparathyroidism, Secondary",Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,urinary_system_disease
700,C3 Glomerulonephritis|C3 Glomerulopathy|Immune Complex Membranoproliferative Glomerulonephritis|IC-MPGN|Dense Deposit Disease,Danicopan,CC1=NC=C(C=N1)C2=CC3=C(C=C2)N(N=C3C(=O)C)CC(=O)N4CC(CC4C(=O)NC5=NC(=CC=C5)Br)F,urinary_system_disease
701,Renal Impairment,Doravirine,CN1C(=NNC1=O)CN2C=CC(=C(C2=O)OC3=CC(=CC(=C3)C#N)Cl)C(F)(F)F,urinary_system_disease
707,"Polycystic Liver Disease|Hepatomegaly|Liver Diseases|Polycystic Kidney, Autosomal Dominant",Lanreotide,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N,urinary_system_disease
716,Gout|Moderate Renal Impairment,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,urinary_system_disease
717,Gout|Moderate Renal Impairment,Lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,urinary_system_disease
726,Kidney Diseases|Kidney Transplantation|Kidney Transplant|Renal Transplantation|Renal Transplant,Valganciclovir,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,urinary_system_disease
735,Renal Function,Ulipristal,CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,urinary_system_disease
737,"Kidney Failure, Chronic",Alisporivir,CCC1C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)C)CC)C)C,urinary_system_disease
739,Bladder Cancer,Mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,urinary_system_disease
750,"Carcinoma, Renal Cell",Lactoferrin,CCC(C)C(C(=NC(C(C)O)C(=NC(CS)C(=NC(C(C)C)C(=NC(CCCNC(=N)N)C(=NC(CCCNC(=N)N)C(=NC(C)C(=NC(CC1=CC=CC=C1)C(=O)O)O)O)O)O)O)O)O)N=C(C(CO)N=C(C2CCCN2C(=O)C(C)N=C(CN=C(C(CC(C)C)N=C(C(CCCCN)N=C(C(CCCCN)N=C(C(CCSC)N=C(C(CCCNC(=N)N)N=C(C(CC3=CNC4=CC=CC=C43)N=C(C(CCC(=N)O)N=C(C(CC5=CNC6=CC=CC=C65)N=C(C(CCCNC(=N)N)N=C(C(CCCNC(=N)N)N=C(C(CS)N=C(C(CCCCN)N=C(C(CC7=CC=CC=C7)N)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O,urinary_system_disease
757,Chronic Kidney Disease|Diabetic Nephropathy,Atrasentan,CCCCN(CCCC)C(=O)CN1CC(C(C1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4,urinary_system_disease
768,Renal Impairment,Hydrocodone,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4,urinary_system_disease
783,Insomnia,Suvorexant,CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl,urinary_system_disease
790,End Stage Renal Disease|Chronic Pain|Opioid Dependence,Buprenorphine,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,urinary_system_disease
792,Urinary Schistosomiasis,Mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,urinary_system_disease
797,"Kidney Failure, Chronic",Tetrahydrobiopterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,urinary_system_disease
798,"Kidney Failure, Chronic",Folate,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N,urinary_system_disease
816,Renal Impairment,Olorofim,CC1=CC(=C(N1C)C(=O)C(=O)NC2=CC=C(C=C2)N3CCN(CC3)C4=NC=C(C=N4)F)C5=CC=CC=C5,urinary_system_disease
838,Benign Prostatic Hypertrophy,Ozarelix,CCCCC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCCNC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N(C)C(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C,urinary_system_disease
849,Kidney Failure,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,urinary_system_disease
878,Urinary Tract Infection,Nitrofurantoin,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],urinary_system_disease
887,Renal Impairment,Nalmefene,C=C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O,urinary_system_disease
896,Healthy|Renal Impairment,Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,urinary_system_disease
918,Renal Cell Carcinoma,Decitabine,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,urinary_system_disease
920,Overactive Bladder,Solabegron,C1=CC(=CC(=C1)C(=O)O)C2=CC(=CC=C2)NCCNCC(C3=CC(=CC=C3)Cl)O,urinary_system_disease
930,Renal Impairment,Glepaglutide,CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(C)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC5=CNC=N5)N,urinary_system_disease
957,Urinary Tract Infections,Cefiderocol,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4(CCCC4)CCNC(=O)C5=C(C(=C(C=C5)O)O)Cl)C(=O)[O-],urinary_system_disease
958,Urinary Tract Infections,Imipenem,CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O,urinary_system_disease
959,Renal Impairment,Deflazacort,CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C,urinary_system_disease
960,Mesothelioma|Uveal Melanoma|Renal Cell Carcinoma|Cholangiocarcinoma,Niraparib,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,urinary_system_disease
974,Renal Insufficiency,Aztreonam,CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,urinary_system_disease
975,Renal Insufficiency,Avibactam,C1CC(N2CC1N(C2=O)OS(=O)(=O)O)C(=O)N,urinary_system_disease
978,Urinary Tract Infection Symptomatic|Acute Pyelonephritis|Urinary Tract Infection Complicated,Piperacillin,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,urinary_system_disease
992,Blood And Marrow Transplantation,Cidofovir,C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O,urinary_system_disease
1002,Muscle Invasive Bladder Cancer,Vistusertib,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)N5CCOCC5C,urinary_system_disease
1054,"Carcinoma, Renal Cell",Lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,urinary_system_disease
1066,Renal Insufficiency|Kidney Diseases|Urologic Diseases,Mirodenafil,CCCC1=CN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CCO)OCCC)CC,urinary_system_disease
1083,Renal Impairment,Tenofovir,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,urinary_system_disease
1107,Clear-Cell Renal Cell Carcinoma,Sitravatinib,COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,urinary_system_disease
1123,Diabetic Nephropathy,Pyridoxamine,CC1=NC=C(C(=C1O)CN)CO,urinary_system_disease
1129,Cognitive Disorders|Delirium|Acute Kidney Injury,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,urinary_system_disease
1135,Interstitial Cystitis|Painful Bladder Syndrome|Pain,Oxycodone,CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O,urinary_system_disease
1151,Lupus Nephritis,Voclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC=C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,urinary_system_disease
1158,Inflammatory Disease,Lanraplenib,C1CN(CCN1C2COC2)C3=CC=C(C=C3)NC4=NC(=CN5C4=NC=C5)C6=CN=CC(=N6)N,urinary_system_disease
1159,Secondary Hyperparathyroidism in Patients With ESRD on Hemodialysis,Etelcalcetide,CC(C(=O)NC(CCCN=C(N)N)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CSSCC(C(=O)O)N)NC(=O)C,urinary_system_disease
1163,Bladder Pain Syndrome,Gefapixant,CC(C)C1=CC(=C(C=C1OC2=CN=C(N=C2N)N)S(=O)(=O)N)OC,urinary_system_disease
1164,Complicated Urinary Tract Infection|Pyelonephritis,Ceftolozane,CC(C)(C(=O)O)ON=C(C1=NSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC(=C(N4C)N)NC(=O)NCCN)C(=O)[O-],urinary_system_disease
1165,Complicated Urinary Tract Infection|Pyelonephritis,Tazobactam,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,urinary_system_disease
1166,Complicated Urinary Tract Infection|Pyelonephritis,Meropenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,urinary_system_disease
1175,Renal Impairment,Asciminib,C1CN(CC1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4,urinary_system_disease
1185,Renal Impairment,Telotristat,CC1=NN(C=C1)C2=C(C=CC(=C2)Cl)C(C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)CC(C(=O)O)N)N,urinary_system_disease
1189,Renal Insufficiency,Dalfampridine,C1=CN=CC=C1N,urinary_system_disease
1191,Bladder Cancer|Transitional Cell Carcinoma|Metastasis,Vinflunine,CCC12C=CCN3C1C4(CC3)C(C(C2OC(=O)C)(C(=O)OC)O)N(C5=CC(=C(C=C45)C6(CC7CC(CN(C7)CC8=C6NC9=CC=CC=C89)C(C)(F)F)C(=O)OC)OC)C,urinary_system_disease
1196,Renal Impairment|Renal Insufficiency|Kidney Diseases|Pharmacokinetics,Elafibranor,CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)C=CC(=O)C2=CC=C(C=C2)SC,urinary_system_disease
1202,Secondary Hyperparathyroidism|Hemodialysis,Paricalcitol,CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C,urinary_system_disease
1214,Renal Impairment,Lemborexant,CC1=NC(=NC=C1OCC2(CC2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C,urinary_system_disease
1218,"Collapsing Glomerulopathy|Glomerulosclerosis, Focal Segmental",Isotretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,urinary_system_disease
1246,Urologic Neoplasms,Pemetrexed,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,urinary_system_disease
1256,"Anti-Infective Agents, Urinary|Escherichia Coli Infections|Klebsiella Infections|Kidney Transplantation|Urinary Tract Infections",Sitafloxacin,C1CC12CN(CC2N)C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)O)C5CC5F)F,urinary_system_disease
1257,"Anti-Infective Agents, Urinary|Escherichia Coli Infections|Klebsiella Infections|Kidney Transplantation|Urinary Tract Infections",Ertapenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)C(C)O,urinary_system_disease
1268,"Urinary Incontinence, Stress|Fecal Incontinence",Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,urinary_system_disease
1315,Type 2 Diabetes Mellitus|Chronic Kidney Diseases,Cotadutide,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CNC=N6)N)C(=O)O,urinary_system_disease
1347,Neoplasms|Solid Tumors|Bone Cancer|Kidney Tumor|Neuroblastoma,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,urinary_system_disease
1349,Neoplasms|Solid Tumors|Bone Cancer|Kidney Tumor|Neuroblastoma,Ifosfamide,C1CN(P(=O)(OC1)NCCCl)CCCl,urinary_system_disease
1358,Kidney Disease,Eprosartan,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O,urinary_system_disease
1360,Urinary Incontinence,Litoxetine,C1CNCCC1OCC2=CC3=CC=CC=C3C=C2,urinary_system_disease
1364,Prostatic Hyperplasia,Lemuteporfin,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5C6(C(C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OCCO)C(=C3C)CCC(=O)OCCO)C=C,urinary_system_disease
1365,Urinary Tract Infections|Catheter Infection|Catheter-Related Infections,Povidone,C=CN1CCCC1=O,urinary_system_disease
1423,"Neoplasms|Neoplasms, Glandular and Epithelial|Neoplasms by Histologic Type|Bronchial Neoplasms|Lung Neoplasms|Respiratory Tract Neoplasms|Thoracic Neoplasms|Digestive System Neoplasms|Endocrine Gland Neoplasms|Carcinoma, Non-Small-Cell Lung|Lung Diseases|Breast Diseases|Renal Neoplasm|Solid Tumors",Entinostat,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,urinary_system_disease
1446,Renal Insufficiency,Tiotropium,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,urinary_system_disease
1449,Renal Impairment|Diabetes,Vildagliptin,C1CC(N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N,urinary_system_disease
1471,HCV Infection,Voxilaprevir,CCC1C2CN(C1C(=O)NC3(CC3C(F)F)C(=O)NS(=O)(=O)C4(CC4)C)C(=O)C(NC(=O)OC5CC5CCCCC(C6=NC7=C(C=C(C=C7)OC)N=C6O2)(F)F)C(C)(C)C,urinary_system_disease
1478,Idiopathic Overactive Bladder With Urinary Incontinence,Trospium,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O,urinary_system_disease
1479,Diabetic Nephropathy,Nidufexor,CN1C2=C(COC3=C2C=C(C=C3)Cl)C(=N1)C(=O)N(CC4=CC=CC=C4)CC5=CC=C(C=C5)C(=O)O,urinary_system_disease
1485,"Diabetes Mellitus, Type 1",Benfotiamine,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOP(=O)(O)O)SC(=O)C2=CC=CC=C2)C,urinary_system_disease
1486,Urinary Stress Incontinence,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,urinary_system_disease
1494,Hepatitis C Virus,Grazoprevir,CC(C)(C)C1C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCCC7CC7OC(=O)N1,urinary_system_disease
1495,Hepatitis C Virus,Elbasvir,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC4=C(C=C3)N5C(OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC,urinary_system_disease
1512,Melanoma|Prostate Cancer|Renal Cancer,Naltrexone,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,urinary_system_disease
1519,Renal Insufficiency,Setmelanotide,CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)N1)NC(=O)C(CCCN=C(N)N)NC(=O)C)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CC5=CN=CN5,urinary_system_disease
1524,Neuromuscular Blockade|Renal Impairment,Cisatracurium,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C,urinary_system_disease
1527,Neuromuscular Blockade|Renal Impairment,Sugammadex,C(CSCC1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(O2)C(C9O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)O)O)C(=O)O,urinary_system_disease
1537,"Renal Disease, End Stage",Amisulpride,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,urinary_system_disease
1544,Head and Neck Neoplasms|Lung Neoplasms|Urinary Bladder Neoplasms|Breast Neoplasms,Tetrahydrouridine,C1CN(C(=O)NC1O)C2C(C(C(O2)CO)O)O,urinary_system_disease
1563,Ascites Infection,Rifaximin,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,urinary_system_disease
1576,End Stage Renal Disease,Plazomicin,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CNCCO)N)N)NC(=O)C(CCN)O)O,urinary_system_disease
1675,"Kidney Failure, Chronic",Pimodivir,C1CC2CCC1C(C2NC3=NC(=NC=C3F)C4=CNC5=C4C=C(C=N5)F)C(=O)O,urinary_system_disease
1696,Renal Cell Carcinoma,Brivanib,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)O)C,urinary_system_disease
1703,Renal Impairment,Teduglutide,CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC5=CN=CN5)N,urinary_system_disease
1760,Urinary Tract Infections|Acute Pyelonephritis,Finafloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4CC5C(C4)OCCN5)F)C(=O)O,urinary_system_disease
1772,Anemia of Chronic Kidney Disease|Chemotherapy Effect,Desidustat,C1CC1CON2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O,urinary_system_disease
1795,"Kidney Failure, Chronic|Arthralgia",Lumiracoxib,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,urinary_system_disease
1797,Recurrent Renal Cell Carcinoma|Stage IV Renal Cell Cancer,Cediranib,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,urinary_system_disease
1804,HIV Infections,Raltegravir,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,urinary_system_disease
1808,HIV Infections,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,urinary_system_disease
1811,HIV Infections,Atazanavir,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,urinary_system_disease
1884,Renal Insufficiency,Odalasvir,CC(C)C(C(=O)N1C2CCCCC2CC1C3=NC4=C(N3)C=C(C=C4)C5=C6CCC7=CC(=C(CCC(=C5)C=C6)C=C7)C8=CC9=C(C=C8)N=C(N9)C1CC2CCCCC2N1C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,urinary_system_disease
1893,Renal Impaired|Gilteritinib|Normal Renal Function|Pharmacokinetics of ASP2215,Gilteritinib,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,urinary_system_disease
1903,"Carcinoma, Renal Cell",Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,urinary_system_disease
1908,Renal Impairment,Molnupiravir,CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)NO)O)O,urinary_system_disease
1930,Critically Ill|Acute Kidney Injury,Calcifediol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,urinary_system_disease
1961,Renal Impairment,Evobrutinib,C=CC(=O)N1CCC(CC1)CNC2=NC=NC(=C2C3=CC=C(C=C3)OC4=CC=CC=C4)N,urinary_system_disease
2012,Renal Impairment|Healthy Participants,Linzagolix,COC1=C(C(=C(C=C1)F)F)COC2=C(C=C(C(=C2)N3C(=O)C4=C(SC=C4NC3=O)C(=O)O)F)OC,urinary_system_disease
2013,Bladder Cancer|Urothelial Carcinoma|Metastatic Urothelial Carcinoma|Renal Pelvis Carcinoma|Ureter Carcinoma|Urinary Bladder Carcinoma|Urethra Carcinoma|Muscle Invasive Bladder Cancer,Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,urinary_system_disease
2019,Complicated Urinary Tract Infection,Cilastatin,CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C,urinary_system_disease
2051,Renal Impairment,Tasimelteon,CCC(=O)NCC1CC1C2=C3CCOC3=CC=C2,urinary_system_disease
2069,Renal Insufficiency,Epetraborole,B1(C2=C(C=CC=C2OCCCO)C(O1)CN)O,urinary_system_disease
2074,Staphylococcal Skin Infections|Streptococcal Infections,Ceftobiprole,C1CNCC1N2CCC(=CC3=C(N4C(C(C4=O)NC(=O)C(=NO)C5=NSC(=N5)N)SC3)C(=O)O)C2=O,urinary_system_disease
2088,Urinary Tract Infection,Cefixime,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NOCC(=O)O)C3=CSC(=N3)N)SC1)C(=O)O,urinary_system_disease
2089,Urinary Tract Infection,Cephalexin,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,urinary_system_disease
2103,Nocturia,Fedovapagon,CC1=C(C=CC(=C1)C(=O)N2CCCCC3=CC=CC=C32)CNC(=O)N4CCCC4C(=O)N(C)C,urinary_system_disease
2113,Focal Segmental Glomerulosclerosis,Sparsentan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC,urinary_system_disease
2115,"Kidney Stone|Pain, Postoperative|Addiction|Opioid Use",Pregabalin,CC(C)CC(CC(=O)O)CN,urinary_system_disease
2116,Complicated Urinary Tract Infection|Acute Pyelonephritis,Sulbactam,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)C,urinary_system_disease
2121,Renal Insufficiency,Certoparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,urinary_system_disease
2125,Renal Cell Cancer|Metastatic Renal Cell Cancer,Famitinib,CCN(CC)CCN1CCC2=C(C1=O)C(=C(N2)C=C3C4=C(C=CC(=C4)F)NC3=O)C,urinary_system_disease
2129,Diabetic Nephropathy,Corticotropin,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C6CCCN6C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CN=CN1)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)N,urinary_system_disease
2143,"Renal Dialysis|Renal Failure, Chronic",Tobramycin,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,urinary_system_disease
2191,Complicated Urinary Tract Infection,Ceftazidime,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],urinary_system_disease
2193,Locally Advanced Bladder Urothelial Carcinoma|Locally Advanced Renal Pelvis Urothelial Carcinoma|Locally Advanced Ureter Urothelial Carcinoma|Locally Advanced Urethral Urothelial Carcinoma|Metastatic Bladder Urothelial Carcinoma|Metastatic Renal Pelvis Urothelial Carcinoma|Metastatic Ureter Urothelial Carcinoma|Metastatic Urethral Urothelial Carcinoma|Recurrent Bladder Urothelial Carcinoma|Recurrent Renal Pelvis Urothelial Carcinoma|Recurrent Ureter Urothelial Carcinoma|Recurrent Urethral Urothelial Carcinoma|Stage III Bladder Cancer AJCC v8|Stage III Renal Pelvis Cancer AJCC v8|Stage III Ureter Cancer AJCC v8|Stage III Urethral Cancer AJCC v8|Stage IV Bladder Cancer AJCC v8|Stage IV Renal Pelvis Cancer AJCC v8|Stage IV Ureter Cancer AJCC v8|Stage IV Urethral Cancer AJCC v8|Unresectable Bladder Urothelial Carcinoma|Unresectable Renal Pelvis Urothelial Carcinoma|Unresectable Ureter Urothelial Carcinoma|Unresectable Urethral Urothelial Carcinoma,Eribulin,CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O,urinary_system_disease
2198,Secondary Hypogonadism,Enclomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,urinary_system_disease
2210,Renal Impairment|Healthy,Rivipansel,CC1C(C(C(C(O1)OC2C(CC(CC2OC3C(C(C(C(O3)CO)O)OC(CC4CCCCC4)C(=O)O)OC(=O)C5=CC=CC=C5)C(=O)NCCNC(=O)COCCOCC(=O)NC6=C7C(=CC(=C6)S(=O)(=O)O)C=C(C=C7S(=O)(=O)O)S(=O)(=O)O)NC(=O)C8=CC(=O)NC(=O)N8)O)O)O,urinary_system_disease
2256,Chronic Kidney Disease stage3|Chronic Kidney Disease stage4,Sulforaphane,CS(=O)CCCCN=C=S,urinary_system_disease
2272,Urinary Tract Infections|Pyelonephritis,Relebactam,C1CC(N2CC1N(C2=O)OS(=O)(=O)O)C(=O)NC3CCNCC3,urinary_system_disease
2313,Alport Syndrome,Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,urinary_system_disease
2362,Renal Insufficiency|End Stage Renal Disease,Tirzepatide,CCC(C)C(C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)NC(C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)N4CCCC4C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N5CCCC5C(=O)N6CCCC6C(=O)N7CCCC7C(=O)NC(CO)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C)(C)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=CC=C9)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC1=CC=C(C=C1)O)N,urinary_system_disease
2375,Renal Dysfunction|Acute Renal Failure|Mortality,Ularitide,CCC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C3CCCN3C(=O)C(C)NC(=O)C(C(C)O)N)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)O)CC(C)C)CO)CCC(=O)N)C,urinary_system_disease
2380,Renal Impairment|Healthy,Esketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,urinary_system_disease
2430,Acute Pyelonephritis,Omadacycline,CC(C)(C)CNCC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,urinary_system_disease
2438,"Bladder Cancer|Brain and Central Nervous System Tumors|Carcinoma of Unknown Primary|Extragonadal Germ Cell Tumor|Head and Neck Cancer|Kidney Cancer|Lung Cancer|Ovarian Cancer|Sarcoma|Testicular Germ Cell Tumor|Unspecified Adult Solid Tumor, Protocol Specific",Amifostine,C(CN)CNCCSP(=O)(O)O,urinary_system_disease
2447,Chronic Kidney Disease|Secondary Hyperparathyroidism|Chronic Renal Insufficiency|Chronic Renal Failure,Doxercalciferol,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,urinary_system_disease
2456,Healthy,Licarbazepine,C1C(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O,urinary_system_disease
2473,"Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi",Silodosin,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,urinary_system_disease
2509,Renal Impairment,Elinogrel,CNC1=C(C=C2C(=C1)NC(=O)N(C2=O)C3=CC=C(C=C3)NC(=O)NS(=O)(=O)C4=CC=C(S4)Cl)F,urinary_system_disease
2573,Advanced Kidney Cancer|Kidney Cancer|Clear Cell Renal Cell Carcinoma,Guadecitabine,C1C(C(OC1N2C=NC3=C2N=C(NC3=O)N)COP(=O)(O)OC4CC(OC4CO)N5C=NC(=NC5=O)N)O,urinary_system_disease
2592,Renal Impairment|Renal Disease|Kidney Disease,Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],urinary_system_disease
2596,Breast Cancer|Breast Neoplasms|Colon Cancer|Colonic Cancer|Colon Neoplasms|Lung Cancer|Melanoma|Kidney Cancer,Dacarbazine,CN(C)N=NC1=C(NC=N1)C(=O)N,urinary_system_disease
2610,Growth Hormone Disorder|Adult Growth Hormone Deficiency|Growth Hormone Deficiency in Children,Somapacitan,C(CCCCCCCC1=NNN=N1)CCCCCCCC(=O)NS(=O)(=O)CCCC(=O)NCCOCCOCC(=O)NC(CCC(=O)NC(CCC(=O)NCCOCCOCC(=O)NC(CCCCNC(=O)CSCC(C(=O)O)N)C(=O)N)C(=O)O)C(=O)O,urinary_system_disease
2611,Renal Clear Cell Carcinoma|Renal Papillary Cell Carcinoma,Savolitinib,CC(C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C,urinary_system_disease
2645,Advanced or Metastatic Hepatocellular Cancer|Advanced or Metastatic Ovarian Cancer|Metastatic Renal Cell Cancer|Advanced or Metastatic Gastric Carcinoma,Tasquinimod,CN1C2=C(C(=CC=C2)OC)C(=C(C1=O)C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)O,urinary_system_disease
2655,"Type 2 Diabetes Mellitus, CKD and Albuminuria",Saxagliptin,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,urinary_system_disease
2706,End Stage Renal Disease,Oseltamivir,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,urinary_system_disease
2769,Advanced Cancer|Metastatic Cancer|Biliary Tract Carcinoma|Cholangiocarcinoma|Gall Bladder Carcinoma|Solid Tumor|Non-Hodgkin's Lymphoma,Merestinib,CC1=CC=C(C(=O)N1C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C=C5C(=C4)C=NN5C)C6=CNN=C6)F,urinary_system_disease
2788,Chronic Renal Insufficiency|Type 2 Diabetes Mellitus,Omarigliptin,CS(=O)(=O)N1C=C2CN(CC2=N1)C3CC(C(OC3)C4=C(C=CC(=C4)F)F)N,urinary_system_disease
2799,Renal Insufficiency|Healthy,Canagliflozin,CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,urinary_system_disease
2822,Infectious Disease,Omeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,urinary_system_disease
2857,Gout|Hyperuricemia|Arthritis|Joint Disease|Renal Insufficiency,Ulodesine,C1C(C(CN1CC2=CNC3=C2N=CNC3=O)O)CO,urinary_system_disease
2859,Amyotrophic Lateral Sclerosis|Renal Insufficiency,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,urinary_system_disease
2860,Amyotrophic Lateral Sclerosis|Renal Insufficiency,Pramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,urinary_system_disease
2871,Chronic Kidney Disease on Hemodialysis|Secondary Hyperparathyroidism,Maxacalcitol,CC(C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)OCCC(C)(C)O,urinary_system_disease
2887,Healthy|Renal Impairment,Cenerimod,CCC1=C(C(=CC(=C1)C2=NOC(=N2)C3=CC(=NC(=C3)OC)C4CCCC4)C)OCC(CO)O,urinary_system_disease
2888,Vomiting,Casopitant,CC1=C(C=CC(=C1)F)C2CC(CCN2C(=O)N(C)C(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN(CC4)C(=O)C,urinary_system_disease
2891,Lupus Membranous Nephropathy,Filgotinib,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,urinary_system_disease
4,Primary Biliary Cirrhosis (PBC),Seladelpar,CCOC(COC1=CC=C(C=C1)C(F)(F)F)CSC2=CC(=C(C=C2)OCC(=O)O)C,digestive_system_disease
16,Primary Sclerosing Cholangitis,Cenicriviroc,CCCCOCCOC1=CC=C(C=C1)C2=CC3=C(C=C2)N(CCCC(=C3)C(=O)NC4=CC=C(C=C4)S(=O)CC5=CN=CN5CCC)CC(C)C,digestive_system_disease
24,Crohn Disease,Methoxsalen,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,digestive_system_disease
25,"Hepatitis C, Chronic",Simeprevir,CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,digestive_system_disease
26,"Hepatitis C, Chronic",Daclatasvir,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,digestive_system_disease
27,"Hepatitis C, Chronic",Ribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,digestive_system_disease
54,Treatment of Hepatitis C,Ledipasvir,CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,digestive_system_disease
55,Treatment of Hepatitis C,Sofosbuvir,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,digestive_system_disease
57,Amoebiasis,Auranofin,CCP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+],digestive_system_disease
65,Gastroparesis,Velusetrag,CC(C)N1C2=CC=CC=C2C=C(C1=O)C(=O)NC3CC4CCC(C3)N4CC(CN(C)S(=O)(=O)C)O,digestive_system_disease
89,Opioid Induced Bowel Dysfunction,Naldemedine,CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O,digestive_system_disease
90,Ulcerative Colitis,Alicaforsen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)([O-])OC3CC(OC3COP(=S)([O-])OC4CC(OC4COP(=S)([O-])OC5CC(OC5COP(=S)([O-])OC6CC(OC6COP(=S)([O-])OC7CC(OC7COP(=S)([O-])OC8CC(OC8COP(=S)([O-])OC9CC(OC9COP(=S)([O-])OC1CC(OC1CO)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)O,digestive_system_disease
91,Cystic Fibrosis,Tezacaftor,CC(C)(CO)C1=CC2=CC(=C(C=C2N1CC(CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F,digestive_system_disease
92,Cystic Fibrosis,Ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,digestive_system_disease
111,Chronic Hepatitis B,Entecavir,C=C1C(CC(C1CO)O)N2C=NC3=C2N=C(NC3=O)N,digestive_system_disease
122,Prader-Willi Syndrome|Hyperphagia,Livoletide,CC(C)C1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCC(=O)N)CC3=CN=CN3)CCC(=O)O)CO)CCC(=O)N,digestive_system_disease
142,Pancreatic Cancer,Vatalanib,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4,digestive_system_disease
157,Hepatitis C|Chronic Hepatitis C,Miravirsen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3C4C(OC3(CO4)COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6C7C(OC6(CO7)CO)N8C=CC(=NC8=O)N)N9C=CC(=NC9=O)N)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC12COC(C1OP(=S)(O)OCC13COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC4=C(N=CN=C41)N)OP(=S)(O)OCC14COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=NC5=C(N=CN=C51)N)OP(=S)(O)OCC15COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC16COC(C1OP(=S)(O)OCC17COC(C1O)C(O7)N1C=CC(=NC1=O)N)C(O6)N1C=CC(=NC1=O)N)C(O5)N1C=CC(=NC1=O)N)C(O4)N1C=CC(=NC1=O)N)C(O3)N1C=C(C(=O)NC1=O)C)C(O2)N1C=NC2=C1N=C(NC2=O)N,digestive_system_disease
158,Hepatitis C|Chronic Hepatitis C,Telaprevir,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,digestive_system_disease
160,"Carcinoma, Hepatocellular",Refametinib,COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F,digestive_system_disease
174,"Carcinoma, Hepatocellular",Meclizine,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,digestive_system_disease
178,"Hepatitis B, Chronic",Adefovir,C1=NC(=C2C(=N1)N(C=N2)CCOCP(=O)(O)O)N,digestive_system_disease
190,Hepatic Insufficiency,Tipranavir,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4,digestive_system_disease
192,Colorectal Cancer|Metastatic Cancer,Floxuridine,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,digestive_system_disease
197,Advanced Gastrointestinal Tumors,Minnelide,CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2OCOP(=O)([O-])[O-])O7)COC6=O)C.[Na+].[Na+],digestive_system_disease
209,Chronic Hepatitis c,Ravidasvir,CC(C)C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)C=C(C=C5)C6=CN=C(N6)C7CCCN7C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,digestive_system_disease
225,Cystic Fibrosis|Methicillin-resistant Staphylococcus Aureus,Mupirocin,CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,digestive_system_disease
231,Solid Tumors|Non-small Cell Lung Cancer|Castration Resistant Prostate Cancer|Microsatellite Stable Colorectal Cancer,Navarixin,CCC(C1=CC=C(O1)C)NC2=C(C(=O)C2=O)NC3=CC=CC(=C3O)C(=O)N(C)C,digestive_system_disease
249,Infectious Diarrhoea,Rifamycin,CC1C=CC=C(C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C,digestive_system_disease
253,Gastric Cancer,Tegafur,C1CC(OC1)N2C=C(C(=O)NC2=O)F,digestive_system_disease
270,Spinal Cord Injuries|Constipation|Neurogenic Bowel,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-],digestive_system_disease
271,Metastatic Colorectal Cancer,Trifluridine,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,digestive_system_disease
283,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,digestive_system_disease
284,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Brigatinib,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,digestive_system_disease
287,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Itacitinib,C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F,digestive_system_disease
294,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Pralsetinib,CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)NC(C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC,digestive_system_disease
297,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Tepotinib,CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC=CC(=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N,digestive_system_disease
298,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Alpelisib,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,digestive_system_disease
325,Achalasia,Olinciguat,C1=CC=C(C(=C1)CN2C(=CC(=N2)C3=NC=C(C(=N3)NCC(C(=O)N)(C(F)(F)F)O)F)C4=NOC=C4)F,digestive_system_disease
330,Ulcerative Colitis|Inflammatory Bowel Diseases|Acute Severe Colitis,Ceftriaxone,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,digestive_system_disease
339,Nonalcoholic Steatohepatitis (NASH),Miricorilant,C1CC(CCC1C2=CC=CC=C2)C3=C(C(=O)NC(=O)N3)CC4=CC(=CC=C4)C(F)(F)F,digestive_system_disease
344,Thrombocytopenia,Avatrombopag,C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl,digestive_system_disease
347,Irritable Bowel Syndrome,Lubiprostone,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,digestive_system_disease
358,Hepatitis C Virus Genotype 4 Infection,Asunaprevir,CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C,digestive_system_disease
361,Hepatitis C,Ombitasvir,CC(C)C(C(=O)N1CCCC1C(=O)NC2=CC=C(C=C2)C3CCC(N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,digestive_system_disease
362,Hepatitis C,Paritaprevir,CC1=CN=C(C=N1)C(=O)NC2CCCCCC=CC3CC3(NC(=O)C4CC(CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8,digestive_system_disease
379,"Hepatitis B, Chronic",Thymalfasin,CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C,digestive_system_disease
405,Gastroparesis,Metoclopramide,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,digestive_system_disease
413,Indolent B-cell Lymphoma|Hepatitis C,Velpatasvir,CC1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)C8CC(CN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)COC,digestive_system_disease
414,Gallstones,Aramchol,CCCCCCCCCCCCCCCCCCCC(=O)NC1CCC2(C(C1)CC(C3C2CC(C4(C3CCC4C(C)CCC(=O)O)C)O)O)C,digestive_system_disease
452,Metastatic Colon Cancer,Tipiracil,C1CC(=N)N(C1)CC2=C(C(=O)NC(=O)N2)Cl,digestive_system_disease
470,Non-Alcoholic Fatty Liver Disease|Nonalcoholic Steatohepatitis,Saroglitazar,CCOC(CC1=CC=C(C=C1)OCCN2C(=CC=C2C3=CC=C(C=C3)SC)C)C(=O)O,digestive_system_disease
484,Cancer of Pancreas,Bemcentinib,C1CCN(C1)C2CCC3=C(CC2)C=C(C=C3)NC4=NN(C(=N4)N)C5=NN=C6C(=C5)CCCC7=CC=CC=C76,digestive_system_disease
503,Irritable Bowel Syndrome,Olorinab,CC(C)(C)C(CO)NC(=O)C1=NN(C2=C1CC3C2C3)C4=NC=C[N+](=C4)[O-],digestive_system_disease
521,"Carcinoma, Hepatocellular",Foretinib,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,digestive_system_disease
536,Gastrointestinal Stromal Tumor (GIST),Pexidartinib,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,digestive_system_disease
573,Crohn's Disease,Semapimod,CC(=NN=C(N)N)C1=CC(=CC(=C1)NC(=O)CCCCCCCCC(=O)NC2=CC(=CC(=C2)C(=NN=C(N)N)C)C(=NN=C(N)N)C)C(=NN=C(N)N)C,digestive_system_disease
592,Gastric Cancer|Breast Cancer,Imiquimod,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,digestive_system_disease
597,HCV,Danoprevir,CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(NC(=O)C3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,digestive_system_disease
658,"Hepatitis B|HBV|Hepatitis B, Chronic",Inarigivir,COC1C(C(OC1N2C=CC(=O)NC2=O)CO)OP(=S)(O)OCC3C(CC(O3)N4C=NC5=C(N=CN=C54)N)O,digestive_system_disease
701,Prolonged Postoperative Ileus,Diatrizoate,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I,digestive_system_disease
704,Morbid Obesity|Postoperative Pain|Postoperative Bowel Function|Postoperative Ambulation,Levobupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,digestive_system_disease
720,Gastroesophageal Reflux Disease,Atovaquone,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,digestive_system_disease
721,Gastroesophageal Reflux Disease,Proguanil,CC(C)N=C(N)N=C(N)NC1=CC=C(C=C1)Cl,digestive_system_disease
722,Gastroesophageal Reflux Disease,Tegoprazan,CC1=NC2=C(N1)C=C(C=C2OC3CCOC4=C3C(=CC(=C4)F)F)C(=O)N(C)C,digestive_system_disease
724,Gastroesophageal Reflux Disease,Vonoprazan,CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3,digestive_system_disease
763,Antipsychotic Induced Weight Gain|Non-alcoholic Steatohepatitis (NASH),Fluvoxamine,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,digestive_system_disease
773,Gastric Cancer|GastroEsophageal Cancer,Rivoceranib,C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4,digestive_system_disease
782,Gastroparesis,Buspirone,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,digestive_system_disease
784,Irritable Bowel Syndrome,Ethosuximide,CCC1(CC(=O)NC1=O)C,digestive_system_disease
817,"Liver Cirrhosis, Biliary",Ursodiol,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,digestive_system_disease
820,"Hepatitis C, Chronic",Sovaprevir,CC(C)(C)C(CC(=O)N1CCCCC1)C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=CC(=NC6=C5C=CC(=C6)OC)C7=CC=CC=C7,digestive_system_disease
840,Metastatic Colorectal Cancer|KRAS Gene Mutation,Onvansertib,CN1CCN(CC1)C2=CC(=C(C=C2)OC(F)(F)F)NC3=NC=C4CCC5=C(C4=N3)N(N=C5C(=O)N)CCO,digestive_system_disease
877,Metastatic Biliary Tract Carcinoma|Metastatic Colorectal Carcinoma|Metastatic Gastroesophageal Junction Adenocarcinoma|Metastatic Malignant Digestive System Neoplasm|Metastatic Pancreatic Adenocarcinoma|Stage IV Colorectal Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7,Sucrosofate,C(C1C(C(C(C(O1)OC2(C(C(C(O2)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O,digestive_system_disease
889,Digestive System Disorders,Ulimorelin,CC1CNC(C(=O)N(C(C(=O)NC(C(=O)NCCCC2=CC=CC=C2O1)CC3=CC=C(C=C3)F)C)C)C4CC4,digestive_system_disease
916,Metastatic Colorectal Carcinoma|Metastatic Lung Small Cell Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Carcinoma|Refractory Colorectal Carcinoma|Refractory Lung Small Cell Carcinoma|Refractory Malignant Solid Neoplasm|Refractory Pancreatic Carcinoma|Stage III Colorectal Cancer AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Unresectable Colorectal Carcinoma|Unresectable Lung Small Cell Carcinoma|Unresectable Malignant Solid Neoplasm|Unresectable Pancreatic Carcinoma,Berzosertib,CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N,digestive_system_disease
918,Hepatocellular Carcinoma,Resminostat,CN(C)CC1=CC=C(C=C1)S(=O)(=O)N2C=CC(=C2)C=CC(=O)NO,digestive_system_disease
923,Ulcerative Colitis|Inflammatory Bowel Diseases,Psyllium,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O,digestive_system_disease
943,Irritable Bowel Syndrome,Asimadoline,CN(C(CN1CCC(C1)O)C2=CC=CC=C2)C(=O)C(C3=CC=CC=C3)C4=CC=CC=C4,digestive_system_disease
956,Primary Sclerosing Cholangitis|Compensated Cirrhosis,Cilofexor,C1CC1C2=C(C(=NO2)C3=C(C=CC=C3Cl)Cl)COC4=CC(=C(C=C4)C5(CN(C5)C6=NC=CC(=C6)C(=O)O)O)Cl,digestive_system_disease
958,Cystic Fibrosis,Miglustat,CCCCN1CC(C(C(C1CO)O)O)O,digestive_system_disease
960,Hepatic Failure,Icenticaftor,CC(CNC(=O)C1=C(C=C(C(=N1)OC)C(F)(F)F)N)(C(F)(F)F)O,digestive_system_disease
973,Chronic Hepatitis B,Vesatolimod,CCCCOC1=NC(=C2C(=N1)N(CC(=O)N2)CC3=CC=CC(=C3)CN4CCCC4)N,digestive_system_disease
1024,Familial Partial Lipodystrophy|Hypertriglyceridemia|Fatty Liver|NASH - Nonalcoholic Steatohepatitis,Gemcabene,CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O,digestive_system_disease
1026,Hepatic Impairment,Gemigliptin,C1CC(CN(C1=O)CC(CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C(F)(F)F)N)(F)F,digestive_system_disease
1066,Hepatitis C|HCV|HIV|AIDS,Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,digestive_system_disease
1071,Eosinophilic Esophagitis,Loratadine,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,digestive_system_disease
1077,Chronic Hepatitis C,Chlorcyclizine,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,digestive_system_disease
1090,Duodenal Ulcer,Rabeprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,digestive_system_disease
1105,Hepatocellular Carcinoma,Patupilone,CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,digestive_system_disease
1114,Non-alcoholic Fatty Liver Disease,Mitoquinone,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,digestive_system_disease
1119,Hepatitis C|Hepatitis,Merimepodib,COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)OC3CCOC3)C4=CN=CO4,digestive_system_disease
1167,Hepatic Impairment,Narlaprevir,CCCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3C(C3(C)C)CN2C(=O)C(C(C)(C)C)NC(=O)NC4(CCCCC4)CS(=O)(=O)C(C)(C)C,digestive_system_disease
1191,Gastroparesis,Nizatidine,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,digestive_system_disease
1226,Gastroenteritis Escherichia Coli,Aspartame,COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)N,digestive_system_disease
1259,Colon Cancer,Niclosamide,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,digestive_system_disease
1278,Irritable Bowel Syndrome,Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31,digestive_system_disease
1279,Irritable Bowel Syndrome,Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,digestive_system_disease
1282,Chronic Hepatitis C Virus,Samatasvir,CC(C)C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C=C3)C4=CSC5=C4SC=C5C6=CC=C(C=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)NC(=O)OC,digestive_system_disease
1317,Fatty Liver|Liver Dysfunction|Insulin Resistance,Amoxicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,digestive_system_disease
1325,Ulcerative Colitis,Etrasimod,C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CCC5CC(=O)O)C(F)(F)F,digestive_system_disease
1334,Advanced Solid Tumors|Hepatocellular Carcinoma,Pimasertib,C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NCC(CO)O,digestive_system_disease
1346,"Hepatitis C, Chronic",Faldaprevir,CC(C)C(=O)NC1=NC(=CS1)C2=NC3=C(C=CC(=C3Br)OC)C(=C2)OC4CC(N(C4)C(=O)C(C(C)(C)C)NC(=O)OC5CCCC5)C(=O)NC6(CC6C=C)C(=O)O,digestive_system_disease
1377,HCV Infection,Norgestimate,CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34,digestive_system_disease
1387,Chronic Hepatitis C Infection,Vaniprevir,CCC1CC1(C(=O)NS(=O)(=O)C2CC2)NC(=O)C3CC4CN3C(=O)C(NC(=O)OCC(CCCCC5=C6CN(CC6=CC=C5)C(=O)O4)(C)C)C(C)(C)C,digestive_system_disease
1388,Neoplasm Metastases|Hepatic Insufficiency,Trabectedin,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,digestive_system_disease
1403,Hepatitis C,Uprifosbuvir,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)Cl)O)OC3=CC=CC=C3,digestive_system_disease
1405,Hepatitis C,Ruzasvir,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC4=C(C=C3)N5C(OC6=C(C5=C4)C(=CC(=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C(C)C)NC(=O)OC)F)C9=CN=C(S9)C1CC1)NC(=O)OC,digestive_system_disease
1407,Severe Hepatic Impairment,Vortioxetine,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,digestive_system_disease
1441,Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer AJCC v6 and v7,Triapine,C1=CC(=C(N=C1)C=NNC(=S)N)N,digestive_system_disease
1489,Metastatic Colorectal Cancer,Napabucasin,CC(=O)C1=CC2=C(O1)C(=O)C3=CC=CC=C3C2=O,digestive_system_disease
1542,Advanced Digestive System Neuroendocrine Neoplasm|Duodenal Neuroendocrine Tumor G1|Functional Pancreatic Neuroendocrine Tumor|Gastric Neuroendocrine Tumor|Intermediate Grade Lung Neuroendocrine Neoplasm|Low Grade Lung Neuroendocrine Neoplasm|Nonfunctional Pancreatic Neuroendocrine Tumor|Thymus Neoplasm,Ribociclib,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,digestive_system_disease
1543,Crohn's Disease,Tamibarotene,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,digestive_system_disease
1570,Nonalcoholic Steatohepatitis (NASH),Firsocostat,CC1=C(SC2=C1C(=O)N(C(=O)N2CC(C3=CC=CC=C3OC)OC4CCOCC4)C(C)(C)C(=O)O)C5=NC=CO5,digestive_system_disease
1583,Gastrointestinal Stromal Tumors,Epacadostat,C1=CC(=C(C=C1N=C(C2=NON=C2NCCNS(=O)(=O)N)NO)Br)F,digestive_system_disease
1605,Herpes Simplex|HIV Infections|Hepatitis B,Fialuridine,C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)F)I,digestive_system_disease
1611,Adenocarcinoma of the Gastroesophageal Junction|Esophageal Carcinoma,Icotinib,C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4,digestive_system_disease
1664,Hepatic Impairment|Healthy Volunteers,Soticlestat,C1CN(CCC1(CC2=CC=CC=C2)O)C(=O)C3=C(N=CC=C3)C4=CC=NC=C4,digestive_system_disease
1768,HIV|Hepatitis C,Silibinin,COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O,digestive_system_disease
1769,"Hepatitis C, Chronic",Tegobuvir,C1=CC=C(C(=C1)C2=NC3=CN(C=CC3=N2)CC4=NN=C(C=C4)C5=C(C=C(C=C5)C(F)(F)F)C(F)(F)F)F,digestive_system_disease
1780,Non Alcoholic Steatohepatitis (NASH),Icosabutate,CCC=CCC=CCC=CCC=CCC=CCCCCOC(CC)C(=O)O,digestive_system_disease
1788,Rectal Cancer,Raltitrexed,CC1=NC2=C(C=C(C=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)N1,digestive_system_disease
1819,"Drug/Agent Toxicity by Tissue/Organ|Lymphoma|Neutropenia|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific",Phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,digestive_system_disease
1825,Stem Cell Transplantation|Graft vs Host Disease,Micafungin,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O,digestive_system_disease
1839,Non-alcoholic Fatty Liver Disease,Oltipraz,CC1=C(SSC1=S)C2=NC=CN=C2,digestive_system_disease
1843,"Hepatitis C, Chronic",Taribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=N)N,digestive_system_disease
1847,Irritable Bowel Syndrome,Ibodutant,CC1=CC2=C(C=C1)C=C(S2)C(=O)NC3(CCCC3)C(=O)NC(CC4=CC=CC=C4)C(=O)NCC5CCN(CC5)CC6CCOCC6,digestive_system_disease
1853,Ulcerative Colitis,Rivenprost,COCC1=CC=CC(=C1)CC(C=CC2C(CC(=O)C2CCSCCCC(=O)OC)O)O,digestive_system_disease
1856,Gastric Cancer,Varlitinib,CC1COC(=N1)NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=NC=CS5)Cl,digestive_system_disease
1863,Constipation|Fecal Incontinence|Multiple Sclerosis,Bisacodyl,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,digestive_system_disease
1922,Chronic Hepatitis C Infection|HBV Coinfection|Hepatitis B Reactivation,Dasabuvir,CC(C)(C)C1=CC(=CC(=C1OC)C2=CC3=C(C=C2)C=C(C=C3)NS(=O)(=O)C)N4C=CC(=O)NC4=O,digestive_system_disease
1931,Cryptosporidiosis,Clofazimine,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,digestive_system_disease
1948,Solid Tumor|Non-Small Cell Lung Cancer Recurrent|Hepatocellular Carcinoma Recurrent,Galunisertib,CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,digestive_system_disease
1955,Hepatocellular Carcinoma (HCC),Fisogatinib,COC1=CC(=C(C(=C1Cl)C2=CC3=CN=C(N=C3C=C2)NC4COCCC4NC(=O)C=C)Cl)OC,digestive_system_disease
1988,Gastric Cancer,Telatinib,CNC(=O)C1=NC=CC(=C1)COC2=NN=C(C3=C2OC=C3)NC4=CC=C(C=C4)Cl,digestive_system_disease
1996,Gastroesophageal Reflux,Fexofenadine,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,digestive_system_disease
2007,Hepatic Impairment,Delafloxacin,C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O,digestive_system_disease
2057,Colorectal Cancer|RAS and BRAF Wild-type|Colorectal Neoplasms|Intestinal Neoplasms|Gastrointestinal Neoplasms|Digestive System Neoplasms|Neoplasms by Site|Neoplasms|Digestive System Diseases|Gastrointestinal Diseases|Colonic Diseases|Intestinal Diseases|Rectal Diseases,Anlotinib,CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC,digestive_system_disease
2071,Esophageal Dysmotility,Bethanechol,CC(C[N+](C)(C)C)OC(=O)N,digestive_system_disease
2081,"HCV Infection|Liver Cirrhosis, Experimental",Boceprevir,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,digestive_system_disease
2093,Crohn Disease|Ulcerative Colitis,Deucravacitinib,CNC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4,digestive_system_disease
2118,"Colitis, Ulcerative",Tetomilast,CCOC1=C(C=C(C=C1)C2=NC(=CS2)C3=NC(=CC=C3)C(=O)O)OCC,digestive_system_disease
2120,Hepatitis C,Mericitabine,CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)(C)F)OC(=O)C(C)C,digestive_system_disease
2169,Eosinophilic Gastrointestinal Disorders (EGIDs)|Eosinophilic Esophagitis (EoE),Fluticasone,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,digestive_system_disease
2170,Eosinophilic Esophagitis,Mometasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,digestive_system_disease
2226,Hepatocellular Carcinoma,Chiauranib,COC1=CC2=NC=CC(=C2C=C1)OC3=CC4=C(C=C3)C(=CC=C4)C(=O)NC5=CC=CC=C5N,digestive_system_disease
2230,Lung Cancer|Esophageal Cancer|Mesothelioma|Gastrointestinal Neoplasms|Breast Cancer,Plicamycin,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,digestive_system_disease
2269,Metastatic Colorectal Carcinoma|Stage IV Colorectal Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,digestive_system_disease
2282,Hepatic Impairment,Midostaurin,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,digestive_system_disease
2292,Hepatic Impairment,Istradefylline,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C,digestive_system_disease
2410,Chronic Hepatitis B,Selgantolimod,CCCCC(C)(CO)NC1=NC(=NC2=C1N=CC(=C2)F)N,digestive_system_disease
2430,Cystic Fibrosis,Cysteamine,C(CS)N,digestive_system_disease
2624,Neoplasm Metastasis|Colorectal Neoplasms|Breast Cancer,Prexasertib,COC1=C(C(=CC=C1)OCCCN)C2=CC(=NN2)NC3=NC=C(N=C3)C#N,digestive_system_disease
2639,Gastric or Duodenal Ulcers Caused by Low-dose Aspirin,Teprenone,CC(=CCCC(=CCCC(=CCCC(=CCCC(=O)C)C)C)C)C,digestive_system_disease
2646,Symptomatic Gastroespohageal Reflux Disease,Tegaserod,CCCCCN=C(N)NN=CC1=CNC2=C1C=C(C=C2)OC,digestive_system_disease
2654,Hepatic Impairment,Fevipiprant,CC1=C(C2=C(N1CC3=C(C=C(C=C3)S(=O)(=O)C)C(F)(F)F)N=CC=C2)CC(=O)O,digestive_system_disease
2662,Pancreatitis,Aprotinin,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C(=O)NC(C(=O)NCC(=O)N6CCCC6C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)N)C(C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)C)CCCCN)C(C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)NC(=O)C1CCCN1C(=O)C(CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)NC(C)C(=O)O)C(C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)C(C)CC,digestive_system_disease
2712,Cirrhosis|Hepatic Encephalopathy,Lactulose,C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O,digestive_system_disease
2726,Diabetic Gastroparesis,Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,digestive_system_disease
2729,Irritable Bowel Syndrome,Mesalamine,C1=CC(=C(C=C1N)C(=O)O)O,digestive_system_disease
2730,Irritable Bowel Syndrome,Mesalazine,C1=CC(=C(C=C1N)C(=O)O)O,digestive_system_disease
2778,Alpha 1-Antitrypsin Deficiency|Emphysema|COPD,Alvelestat,CC1=C(C=C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C(=O)NCC3=NC=C(C=C3)S(=O)(=O)C)C4=CC=NN4C,digestive_system_disease
2780,Ileus,Alvimopan,CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O,digestive_system_disease
2781,Gastroparesis,Camicinal,CC1CN(CCN1)CC2=CC=C(C=C2)CC(=O)N3CCC(CC3)NC4=CC(=CC=C4)F,digestive_system_disease
2787,Esophageal Neoplasms,Nedaplatin,C(C(=O)O)O.N.N.[Pt],digestive_system_disease
2862,Esophageal Carcinoma,Tetrathiomolybdate,[SH-].[SH-].S=[Mo]=S,digestive_system_disease
2863,Solid Tumor|Hepatocellular Carcinoma|Gastric Cancer|Gastroesophageal Junction Adenocarcinoma,Vorolanib,CC1=C(NC(=C1C(=O)NC2CCN(C2)C(=O)N(C)C)C)C=C3C4=C(C=CC(=C4)F)NC3=O,digestive_system_disease
2943,Intestinal Obstruction,Loperamide,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,digestive_system_disease
2946,Intestinal Obstruction,Naloxone,C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,digestive_system_disease
2972,Non-alcoholic Steatohepatitis (NASH),Tropifexor,C1CC1C2=C(C(=NO2)C3=CC=CC=C3OC(F)(F)F)COC4CC5CCC(C4)N5C6=NC7=C(C=C(C=C7S6)C(=O)O)F,digestive_system_disease
3000,Advanced Cancer,Oteracil,C1(=NC(=O)NC(=O)N1)C(=O)O,digestive_system_disease
3057,Hepatitis D,Lonafarnib,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N,digestive_system_disease
3097,Hepatocellular Carcinoma (HCC),Icaritin,CC(=CCC1=C2C(=C(C=C1O)O)C(=O)C(=C(O2)C3=CC=C(C=C3)OC)O)C,digestive_system_disease
3106,Gastroesophageal Reflux,Dexlansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,digestive_system_disease
3110,Hyperinsulinemic Hypoglycemia|Postprandial Hypoglycemia,Dasiglucagon,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CNC=N7)N,digestive_system_disease
3111,Celiac Disease,Larazotide,CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)N1CCCC1C(=O)NCC(=O)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)CN,digestive_system_disease
3124,Colon Adenocarcinoma|Rectal Adenocarcinoma|Stage III Colorectal Cancer AJCC v7|Stage IIIA Colorectal Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IV Colorectal Cancer AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7,Clobetasol,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,digestive_system_disease
3143,Hepatic Impairment,Imeglimin,CC1N=C(NC(=N1)N(C)C)N,digestive_system_disease
3177,Colorectal Cancer|Liver Metastasis|Colorectal Adenocarcinoma,Sulindac,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,digestive_system_disease
3202,Gastritis,Rebamipide,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl,digestive_system_disease
3298,Colonic Neoplasms,Levoleucovorin,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,digestive_system_disease
3307,Chronic Hepatitis B,Levonorgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,digestive_system_disease
3323,Cystic Fibrosis,Lucinactant,CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCCN)N.CC(=O)O,digestive_system_disease
3351,Hepatic Impairment,Cenobamate,C1=CC=C(C(=C1)C(CN2N=CN=N2)OC(=O)N)Cl,digestive_system_disease
3354,Hepatic Impairment|Moderate Impaired Hepatic Function,Quizartinib,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,digestive_system_disease
3367,Hepatitis C,Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,digestive_system_disease
3371,Metastatic HER2+ Advanced Breast Cancer|Breast Neoplasms|Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)|Colorectal Cancer,Tucatinib,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,digestive_system_disease
3378,Healthy Volunteers|Hepatic Impairment,Fedratinib,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,digestive_system_disease
3391,Hepatic Impairment,Sotorasib,CC1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C,digestive_system_disease
3422,Solid Tumor|Pancreatic Cancer,Evofosfamide,CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr,digestive_system_disease
3467,Hepatic Impairment|Healthy Volunteers,Bocidelpar,CC1=CN=C(N1CC2=CC=CC=C2OCCCC(C)CC(=O)O)C3=CC=C(C=C3)C(F)(F)F,digestive_system_disease
3525,"Gastroesophageal Reflux Disease|Reflux, Gastroesophageal",Lavoltidine,CN1C(=NC(=N1)CO)NCCCOC2=CC=CC(=C2)CN3CCCCC3,digestive_system_disease
3531,Advanced Bile Duct Carcinoma|Stage II Esophageal Cancer AJCC v7|Stage II Pancreatic Cancer AJCC v6 and v7|Stage IIA Esophageal Cancer AJCC v7|Stage IIA Pancreatic Cancer AJCC v6 and v7|Stage IIB Esophageal Cancer AJCC v7|Stage IIB Pancreatic Cancer AJCC v6 and v7|Stage III Colon Cancer AJCC v7|Stage III Esophageal Cancer AJCC v7|Stage III Gastric Cancer AJCC v7|Stage III Liver Cancer|Stage III Pancreatic Cancer AJCC v6 and v7|Stage III Rectal Cancer AJCC v7|Stage III Small Intestinal Cancer AJCC v7|Stage IIIA Colon Cancer AJCC v7|Stage IIIA Esophageal Cancer AJCC v7|Stage IIIA Gastric Cancer AJCC v7|Stage IIIA Rectal Cancer AJCC v7|Stage IIIA Small Intestinal Cancer AJCC v7|Stage IIIB Colon Cancer AJCC v7|Stage IIIB Esophageal Cancer AJCC v7|Stage IIIB Gastric Cancer AJCC v7|Stage IIIB Rectal Cancer AJCC v7|Stage IIIB Small Intestinal Cancer AJCC v7|Stage IIIC Colon Cancer AJCC v7|Stage IIIC Esophageal Cancer AJCC v7|Stage IIIC Gastric Cancer AJCC v7|Stage IIIC Rectal Cancer AJCC v7|Stage IV Colon Cancer AJCC v7|Stage IV Esophageal Cancer AJCC v7|Stage IV Gastric Cancer AJCC v7|Stage IV Liver Cancer|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IV Rectal Cancer AJCC v7|Stage IV Small Intestinal Cancer AJCC v7|Stage IVA Colon Cancer AJCC v7|Stage IVA Liver Cancer|Stage IVA Rectal Cancer AJCC v7|Stage IVB Colon Cancer AJCC v7|Stage IVB Liver Cancer|Stage IVB Rectal Cancer AJCC v7,Ropidoxuridine,C1C(C(OC1N2C=C(C=NC2=O)I)CO)O,digestive_system_disease
3532,Ineffective Esophageal Motility|Dysphagia,Prucalopride,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,digestive_system_disease
3549,Hepatitis B,Carbamazepine,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,digestive_system_disease
3550,Hepatitis B,Quinidine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,digestive_system_disease
3551,"Acute Intermittent Porphyria (AIP)|Acute Hepatic Porphyria (AHP)|Porphyria, Acute Intermittent|Acute Porphyria",Givosiran,CC1CC(CN1C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)COCCC(=O)NCCCNC(=O)CCCCOC4C(C(C(C(O4)CO)O)O)NC(=O)C)O,digestive_system_disease
3562,Cystic Fibrosis|Pseudomonas Aeruginosa,Colistin,CCC(C)CCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)C(C)O,digestive_system_disease
3572,Hepatitis B,Clevudine,CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F,digestive_system_disease
3605,Colorectal Neoplasms,Levocetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,digestive_system_disease
3606,"Hepatitis B, Chronic",Hydronidone,CC1=CN(C(=O)C=C1)C2=CC=C(C=C2)O,digestive_system_disease
3633,Advanced Cancer|Anorexia|Weight Loss|Insomnia,Mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,digestive_system_disease
3643,Irritable Bowel Syndrome,Eluxadoline,CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N,digestive_system_disease
3662,Pancreatic Neoplasms,Tocotrienol,CC(=CCCC(=CCCC(=CCCC1(CCC2=C(O1)C=CC(=C2)O)C)C)C)C,digestive_system_disease
3741,Bladder Cancer|Breast Cancer|Colorectal Cancer|Gastrointestinal Neoplasm|Head and Neck Cancer|Lung Cancer|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer,Picoplatin,CC1=CC=CC=N1.N.[Cl-].[Cl-].[Pt+2],digestive_system_disease
3745,Hepatitis C|Telaprevir|HIV,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N,digestive_system_disease
3819,Hepatitis B,Birinapant,CCC(C(=O)N1CC(CC1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)CC6CC(CN6C(=O)C(CC)NC(=O)C(C)NC)O)O)NC(=O)C(C)NC,digestive_system_disease
3875,Duodenal Polyposis,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,digestive_system_disease
3949,Diabetes Mellitus|Diabetes Mellitus Complications|Gastroparesis,Relamorelin,C1CC(CNC1)C(=O)NC(CC2=CSC3=CC=CC=C32)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CC6=CC=CC=C6)C(=O)NC7(CCNCC7)C(=O)N,digestive_system_disease
4017,NAFLD|NASH,Elobixibat,CCCCC1(CN(C2=CC(=C(C=C2S(=O)(=O)C1)OCC(=O)NC(C3=CC=CC=C3)C(=O)NCC(=O)O)SC)C4=CC=CC=C4)CCCC,digestive_system_disease
4018,Ulcerative Colitis,Ozanimod,CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CCC(C4=CC=C3)NCCO)C#N,digestive_system_disease
4026,Primary Biliary Cholangitis,Bezafibrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,digestive_system_disease
4076,Muscle Cramps|Cirrhosis,Baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,digestive_system_disease
4112,Hepatocellular Carcinoma|Gastrointestinal Cancer Metastatic|Neuroendocrine Tumors,Tirapazamine,C1=CC=C2C(=C1)[N+](=C(N=[N+]2[O-])N)[O-],digestive_system_disease
4268,Cystic Fibrosis,Lumacaftor,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,digestive_system_disease
4307,ERCP|Pancreatitis,Valdecoxib,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,digestive_system_disease
4356,Gastrointestinal Motility Disorder,Talinolol,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,digestive_system_disease
4395,Crohn Disease,Neomycin,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,digestive_system_disease
4438,"Hepatitis C, Chronic",Celgosivir,CCCC(=O)OC1CN2CCC(C2C(C1O)O)O,digestive_system_disease
4456,HER-2 Positive Advanced Gastric Cancer,Poziotinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C,digestive_system_disease
4481,Hepatic Impairment|Healthy,Lazertinib,CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC,digestive_system_disease
4544,Primary Peritoneal Cancer|Advanced Epithelial Ovarian Cancer,Iniparib,C1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I,digestive_system_disease
4553,Cystic Fibrosis,Cavosonstat,C1=CC(=C(C=C1C(=O)O)Cl)C2=NC3=C(C=C2)C=C(C=C3)O,digestive_system_disease
4605,Cryptosporidiosis|HIV Infections,Paromomycin,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,digestive_system_disease
4609,Advanced Microsatellite Stable Colorectal Cancer|Metastatic Microsatellite-stable Colorectal Cancer,Tucidinostat,C1=CC(=CN=C1)C=CC(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)F)N,digestive_system_disease
4616,Colorectal Neoplasm|Digestive System Neoplasm,Flucytosine,C1=NC(=O)NC(=C1F)N,digestive_system_disease
4630,Hepatopulmonary Syndrome,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,digestive_system_disease
4637,Neoplasms|Pancreatic Neoplasms,Glufosfamide,C(CCl)NP(=O)(NCCCl)OC1C(C(C(C(O1)CO)O)O)O,digestive_system_disease
4697,Esophageal Squamous Cell Carcinoma,Endostar,CN(CC(=O)C1=CC=CC=C1)N=O,digestive_system_disease
4791,Erythropoietic Protoporphyria,Colestipol,C1C(O1)CCl.C(CNCCNCCNCCN)N,digestive_system_disease
4885,Liver Metastases,Bleomycin,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,digestive_system_disease
4916,Cystic Fibrosis,Lefamulin,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CCC(CC4O)N)C,digestive_system_disease
4950,Pancreatic Cancer,Rubitecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5[N+](=O)[O-])N=C4C3=C2)O,digestive_system_disease
4973,Hepatocellular Carcinoma,Orantinib,CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O,digestive_system_disease
4989,Colorectal Cancer Metastatic,Masitinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,digestive_system_disease
5069,Opioid-Induced Disorders|Esophagus Disorder,Naloxegol,COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O,digestive_system_disease
5094,Crohns Disease,Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,digestive_system_disease
5120,Irritable Bowel Syndrome,Milnacipran,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2,digestive_system_disease
5126,Acquired Hyperinsulinemic Hypoglycemia,Avexitide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)N,digestive_system_disease
5223,Irritable Bowel Syndrome With Constipation,Linaclotide,CC1C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)N5CCCC5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)O,digestive_system_disease
5293,Cystic Fibrosis,Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,digestive_system_disease
5302,Peptic Ulcer Hemorrhage,Ilaprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=C(N2)C=C(C=C3)N4C=CC=C4)OC,digestive_system_disease
5306,Stomach Neoplasms,Edotecarin,C1=CC2=C(C=C1O)NC3=C4C(=C5C(=C23)C(=O)N(C5=O)NC(CO)CO)C6=C(N4C7C(C(C(C(O7)CO)O)O)O)C=C(C=C6)O,digestive_system_disease
5324,Colorectal Neoplasms,Pelitrexol,CC1=C(SC(=C1)C(=O)NC(CCC(=O)O)C(=O)O)CCC2CC3=C(NC2)N=C(NC3=O)N,digestive_system_disease
5345,Cystic Fibrosis (CF),Galicaftor,C1CC1(C2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4CC(OC5=C4C=CC(=C5)OC(F)F)C6=CC=C(C=C6)C(=O)O,digestive_system_disease
5387,Gastroesophageal Junction Adenocarcinoma|Stage IB Esophageal Adenocarcinoma AJCC v7|Stage II Esophageal Adenocarcinoma AJCC v7|Stage IIA Esophageal Adenocarcinoma AJCC v7|Stage IIB Esophageal Adenocarcinoma AJCC v7|Stage IIIA Esophageal Adenocarcinoma AJCC v7|Stage IIIB Esophageal Adenocarcinoma AJCC v7,Taladegib,CN1C(=CC=N1)C2=NN=C(C3=CC=CC=C32)N4CCC(CC4)N(C)C(=O)C5=C(C=C(C=C5)F)C(F)(F)F,digestive_system_disease
5395,Infantile Colic|Infantile Functional Gastrointestinal Disorders,Nepadutant,CC(C)CC1C(=O)NC(C(=O)NC2CC(=O)NCC(C(=O)N1)NC(=O)C(NC(=O)C(NC2=O)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC(=O)NC6C(C(C(C(O6)CO)O)O)NC(=O)C,digestive_system_disease
5437,Hepatocellular Carcinoma,Menatetrenone,CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,digestive_system_disease
5445,Non-alcoholic Steatohepatitis,Mebrofenin,CC1=CC(=C(C(=C1NC(=O)CN(CC(=O)O)CC(=O)O)C)Br)C,digestive_system_disease
5553,Gastroesophageal Reflux|Respiratory Aspiration|Idiopathic Pulmonary Fibrosis|Lung Transplantation,Cromolyn,C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)O)O)C(=O)C=C(O2)C(=O)O,digestive_system_disease
5561,Colorectal Neoplasms,Vicriviroc,CC1CN(CCN1C(COC)C2=CC=C(C=C2)C(F)(F)F)C3(CCN(CC3)C(=O)C4=C(N=CN=C4C)C)C,digestive_system_disease
5568,Kidney Transplant|Hepatitis C|HCV,Glecaprevir,CC1(CC1)S(=O)(=O)NC(=O)C2(CC2C(F)F)NC(=O)C3CC4CN3C(=O)C(NC(=O)OC5CCCC5OCC=CC(C6=NC7=CC=CC=C7N=C6O4)(F)F)C(C)(C)C,digestive_system_disease
5591,Non-erosive Reflux Disease,Revaprazan,CC1C2=CC=CC=C2CCN1C3=NC(=NC(=C3C)C)NC4=CC=C(C=C4)F,digestive_system_disease
5631,Gastrointestinal Stromal Tumor(GIST),Ripretinib,CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC,digestive_system_disease
5641,Advanced HCC,Ningetinib,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)C(=O)NC3=CC(=C(C=C3)OC4=C5C=CC(=CC5=NC=C4)OCC(C)(C)O)F,digestive_system_disease
5648,Irritable Bowel Syndrome,Itopride,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C=C2)OC)OC,digestive_system_disease
5740,Irritable Bowel Syndrome Characterized by Constipation,Plecanatide,CC1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC(C)C)C(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)C)CC(=O)N)C(C)C)CC(C)C)CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)N)N,digestive_system_disease
5747,Eosinophilic Esophagitis,Beclomethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C,digestive_system_disease
5755,Wilson Disease,Bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,digestive_system_disease
5793,Hepatic Insufficiency,Alitretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,digestive_system_disease
5824,D842-related Mutant GIST,Crenolanib,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,digestive_system_disease
5860,Advanced Hepatocellular Carcinoma,Capmatinib,CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F,digestive_system_disease
5873,Chronic Hepatitis B,Telbivudine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,digestive_system_disease
5903,Hepatic Impairment,Iloperidone,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,digestive_system_disease
6057,Pancreatic Neoplasm,Antroquinonol,CC1C(C(C(=C(C1=O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)C,digestive_system_disease
6058,Colorectal Neoplasm,Modufolin,C1C2CN(CN2C3=C(N1)N=C(NC3=O)N)C4=CC=C(C=C4)C(=O)NC(CCC(=O)O)C(=O)O,digestive_system_disease
6131,Cystic Fibrosis,Fenretinide,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,digestive_system_disease
6141,Hepatic Impairment,Omaveloxolone,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)NC(=O)C(C)(F)F)C,digestive_system_disease
6155,Non Small Cell Lung Cancer (NSCLC),Alclometasone,CC1CC2C3C(CC4=CC(=O)C=CC4(C3C(CC2(C1(C(=O)CO)O)C)O)C)Cl,digestive_system_disease
6204,Gastroesophageal Reflux Disease,Pumosetrag,C1CN2CCC1C(C2)NC(=O)C3=CNC4=C(C3=O)SC=C4,digestive_system_disease
6290,Nonalcoholic Steatohepatitis,Proglumide,CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1,digestive_system_disease
6323,Bulimia Nervosa,Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N,digestive_system_disease
6330,Cholecystitis,Cefotetan,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O,digestive_system_disease
6349,Cirrhosis|Ascites|Nosocomial Spontaneous Bacterial Peritonitis,Daptomycin,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,digestive_system_disease
6367,Hepatitis|Hepatitis C,Filibuvir,CCC1=CC(=CC(=N1)CC)CCC2(CC(=C(C(=O)O2)CC3=NN4C(=CC(=NC4=N3)C)C)O)C5CCCC5,digestive_system_disease
6382,Pancreatic Cancer|Cancer of Pancreas|Cancer of the Pancreas|Pancreas Cancer,Tosedostat,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C1=CC=CC=C1)C(=O)OC2CCCC2,digestive_system_disease
6410,Intrahepatic Cholestasis of Pregnancy,Volixibat,CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)C(C1O)C3=CC(=CC=C3)NC(=O)NC4C(C(C(C(O4)COS(=O)(=O)O)O)OCC5=CC=CC=C5)O)CC,digestive_system_disease
6442,Hepatic Impairment,Tavapadon,CC1=C(C=CC(=C1)OC2=C(C=CC=N2)C(F)(F)F)C3=C(C(=O)NC(=O)N3C)C,digestive_system_disease
6446,Ulcerative Colitis,Dersalazine,CC1=NC2=C(N1CC3CCN(CC3)C(=O)C=C(C4=CC=CC=C4)C5=CC=C(C=C5)N=NC6=CC(=C(C=C6)O)C(=O)O)C=CN=C2,digestive_system_disease
6463,Liver Cancer,Irofulven,CC1=C(C2=C(C3(CC3)C(C(=O)C2=C1)(C)O)C)CO,digestive_system_disease
6477,Cryptosporidiosis|HIV Infections,Letrazuril,C1=CC(=CC=C1C(C#N)C2=C(C=C(C=C2Cl)N3C(=O)NC(=O)C=N3)Cl)F,digestive_system_disease
6485,Migraine|Pain|Nausea|Vomiting|Aura,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,digestive_system_disease
6555,Liver Failure,Lofexidine,CC(C1=NCCN1)OC2=C(C=CC=C2Cl)Cl,digestive_system_disease
6576,Metastatic Carcinoma in the Liver|Recurrent Colorectal Carcinoma|Stage IV Colorectal Cancer AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7,Rintatolimod,C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O,digestive_system_disease
6580,Breast Cancer|Colon Cancer,Eniluracil,C#CC1=CNC(=O)NC1=O,digestive_system_disease
6587,Advanced Malignant Solid Neoplasm|ALK Positive|Metastatic Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer,Ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,digestive_system_disease
6697,Pancreatic Cancer,Chlorphenesin,C1=CC(=CC=C1OCC(CO)O)Cl,digestive_system_disease
6746,Neoplasm Metastasis,Combretastatin,COC1=C(C=C(C=C1)CC(C2=CC(=C(C(=C2)OC)OC)OC)O)O,digestive_system_disease
6759,Anus Neoplasms,Indigo,C1=CC=C2C(=C1)C(=C(N2)C3=NC4=CC=CC=C4C3=O)O,digestive_system_disease
6863,Ileus,Ipamorelin,CC(C)(C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC3=CC=CC=C3C=C2)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCCN)C(=O)N)N,digestive_system_disease
6921,Metastatic Pancreatic Adenocarcinoma|Metastatic Pancreatic Cancer,Indoximod,CN1C=C(C2=CC=CC=C21)CC(C(=O)O)N,digestive_system_disease
6932,Cystic Fibrosis,Ataluren,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,digestive_system_disease
7009,HIV-1-infection|Hepatic Impairment,Dolutegravir,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,digestive_system_disease
7023,Colorectal Cancer Metastatic|mCRC,Aldoxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)CCCCCN6C(=O)C=CC6=O)CO)O)N)O,digestive_system_disease
7131,Gastric Ulcer,Lafutidine,C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC(=O)CS(=O)CC3=CC=CO3,digestive_system_disease
7132,Gastric Ulcer,Irsogladine,C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl,digestive_system_disease
7241,Cirrhosis|Hepatitis B Infection|Hepatitis C Infection|Metastatic Malignant Solid Neoplasm|Recurrent Hepatocellular Carcinoma|Recurrent Malignant Solid Neoplasm|Refractory Malignant Neoplasm|Stage IV Hepatocellular Carcinoma AJCC v7|Unresectable Solid Neoplasm,Navitoclax,CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C,digestive_system_disease
7294,Healthy|Hepatic Impairment,Favipiravir,C1=C(N=C(C(=O)N1)C(=O)N)F,digestive_system_disease
7352,Neoplasms,Streptozocin,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,digestive_system_disease
7361,Gastrointestinal Stromal Tumors (GIST)|Other Relapsed or Refractory Solid Tumors,Avapritinib,CC(C1=CC=C(C=C1)F)(C2=CN=C(N=C2)N3CCN(CC3)C4=NC=NN5C4=CC(=C5)C6=CN(N=C6)C)N,digestive_system_disease
7367,Primary Biliary Cirrhosis,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC,digestive_system_disease
7389,Cancer of Stomach|Gastroesophageal Cancer,Pegamotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)OC(=O)C(C)NC(=O)COCCOCC(=O)NC(C)C(=O)OC6(C7=C(COC6=O)C(=O)N8CC9=CC1=CC=CC=C1N=C9C8=C7)CC,digestive_system_disease
7406,"Feces, Impacted",Macrogol,C(CO)O,digestive_system_disease
7414,Diabetes Mellitus,Lixisenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC8=CNC=N8)N,digestive_system_disease
7452,Irritable Bowel Syndrome,Dextofisopam,CCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C,digestive_system_disease
7467,Irritable Bowel Syndrome,Trimebutine,CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C,digestive_system_disease
7582,NASH - Nonalcoholic Steatohepatitis,Ethinylestradiol,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,digestive_system_disease
7587,HIV Infections|Hepatitis C,Zidovudine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],digestive_system_disease
7588,HIV Infections|Hepatitis C,Zalcitabine,C1CC(OC1CO)N2C=CC(=NC2=O)N,digestive_system_disease
7589,HIV Infections|Hepatitis C,Didanosine,C1CC(OC1CO)N2C=NC3=C2N=CNC3=O,digestive_system_disease
7651,Head and Neck Neoplasms|Mucositis,Brilacidin,C1CNCC1OC2=C(C=C(C=C2NC(=O)C3=CC(=NC=N3)C(=O)NC4=CC(=CC(=C4OC5CCNC5)NC(=O)CCCCN=C(N)N)C(F)(F)F)C(F)(F)F)NC(=O)CCCCN=C(N)N,digestive_system_disease
7686,Hepatic Impairment,Tozadenant,CC1(CCN(CC1)C(=O)NC2=NC3=C(C=CC(=C3S2)N4CCOCC4)OC)O,digestive_system_disease
7721,Hepatitis B,Resiquimod,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N,digestive_system_disease
7744,"Alcoholism,|Alcoholic Liver Disease",Metadoxine,CC1=NC=C(C(=C1O)CO)CO.C1CC(=O)NC1C(=O)O,digestive_system_disease
7799,Ulcerative Colitis (UC),Upadacitinib,CCC1CN(CC1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F,digestive_system_disease
7848,Hepatitis C,Norethindrone,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,digestive_system_disease
7849,Hepatitis C,Norethisterone,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,digestive_system_disease
7896,Diabetes Mellitus Type 2|Non-alcoholic Fatty Liver Disease|Obesity,Amlexanox,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,digestive_system_disease
7911,Cannabinoid|Tetrahydrocannabinol|Chronic Pancreatitis|Abdominal Pain,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,digestive_system_disease
7956,Ulcerative Colitis,Terbinafine,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,digestive_system_disease
7964,Hepatic Failure,Latrepirdine,CC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CN=C(C=C4)C,digestive_system_disease
8148,Chemotherapy-Induced Nausea and Vomiting|Ovarian Cancer,Ramosetron,CN1C=C(C2=CC=CC=C21)C(=O)C3CCC4=C(C3)NC=N4,digestive_system_disease
8184,Non Alcoholic Steatohepatitis (NASH),Licogliflozin,CCC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC4=C(C=C3)OCCO4,digestive_system_disease
8237,Hepatic Impairment,Iptacopan,CCOC1CCN(C(C1)C2=CC=C(C=C2)C(=O)O)CC3=C(C=C(C4=C3C=CN4)C)OC,digestive_system_disease
8252,Cryptosporidiosis|HIV Infections,Spiramycin,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C,digestive_system_disease
8259,Hepatitis C|HIV,Abacavir,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,digestive_system_disease
8340,Cystic Fibrosis,Teicoplanin,CCCCCCCCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=C(C(=CC(=C7)O)OC8C(C(C(C(O8)CO)O)O)O)C9=C(C=CC(=C9)C(C(=O)N6)NC(=O)C4NC(=O)C1C2=CC(=CC(=C2)OC2=C(C=CC(=C2)C(C(=O)NC(CC2=CC(=C(O3)C=C2)Cl)C(=O)N1)N)O)O)O)C(=O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)Cl)CO)O)O,digestive_system_disease
8431,Primary Sclerosing Cholangitis,Vidofludimus,COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F,digestive_system_disease
8486,MALT Lymphoma,Chlorambucil,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,digestive_system_disease
8516,Colorectal Carcinoma,Dolcanatide,CC1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC(C)C)C(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)C)CC(=O)N)C(C)C)CC(C)C)CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)N)N,digestive_system_disease
8660,Irritable Colon,Alosetron,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C,digestive_system_disease
8674,Anti-Psychotic|Management of Manifestations of Psychotic Disorders|Treatment of Schizophrenia|Control Nausea and Vomiting|Relief of Restlessness and Apprehension Before Surgery|Acute Intermittent Porphyria|Adjunct in the Treatment of Tetanus|Control Manifestations of the Manic Type of Mani-depressive Illness|Relief of Intractable Hiccups,Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,digestive_system_disease
8689,Hepatic Impairment,Ivosidenib,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,digestive_system_disease
8690,Cancer Stem Cell,Fursultiamine,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCO)SSCC2CCCO2)C,digestive_system_disease
25,Mantle Cell Lymphoma,Mitoxantrone,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,immune_system_disease
64,HIV Infections,Enfuvirtide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(=O)N)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CC7=CC=CC=C7)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C,immune_system_disease
71,HIV Infections,Delavirdine,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C,immune_system_disease
74,HIV Infections,Stavudine,CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,immune_system_disease
97,HIV Infections,Amprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,immune_system_disease
103,HIV Infections,Saquinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,immune_system_disease
136,Relapsed Pediatric ALL|Relapsed Pediatric AML|Refractory Acute Myeloid Leukemia|Refractory Acute Lymphoblastic Leukemia,Daunorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,immune_system_disease
188,Asthma,Methacholine,CC(C[N+](C)(C)C)OC(=O)C,immune_system_disease
208,Rhinitis|Allergic|Seasonal,Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,immune_system_disease
254,HIV Infections,Rilpivirine,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,immune_system_disease
279,"Conjunctivitis, Allergic",Mapracorat,CC1=NC2=C(C=C1)C(=CC=C2)NCC(CC(C)(C)C3=CC(=CC4=C3OCC4)F)(C(F)(F)F)O,immune_system_disease
298,Human Immunodeficiency Virus Type 1,Etravirine,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,immune_system_disease
300,Non Hodgkins Lymphoma|Chronic Lymphocytic Leukaemia,Tirabrutinib,CC#CC(=O)N1CCC(C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N,immune_system_disease
364,"Adult Acute Lymphocytic Leukemia T-cell|Lymphoma, Lymphoblastic",Cladribine,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,immune_system_disease
378,Type 1 Diabetes,Eflornithine,C(CC(C(F)F)(C(=O)O)N)CN,immune_system_disease
444,Asthma,Zileuton,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,immune_system_disease
449,"Arthritis, Rheumatoid",Cantharidin,CC12C3CCC(C1(C(=O)OC2=O)C)O3,immune_system_disease
452,Mycobacterium Avium-intracellulare Infection,Streptomycin,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O,immune_system_disease
539,Multiple Sclerosis|Optic Nerve|Neuritis,Nerispirdine,CCCN(C1=C(C=NC=C1)F)N2C=C(C3=CC=CC=C32)C,immune_system_disease
572,Advanced Solid Tumors|Lymphoma,Quarfloxin,CN1CCCC1CCNC(=O)C2=CN3C4=CC5=CC=CC=C5C=C4OC6=C3C(=CC(=C6N7CCC(C7)C8=NC=CN=C8)F)C2=O,immune_system_disease
604,Sarcoidosis; Antimycobacterial Therapy,Ethambutol,CCC(CO)NCCNC(CC)CO,immune_system_disease
743,Indolent Non-hodgkin Lymphoma,Duvelisib,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,immune_system_disease
829,Seasonal Allergic Rhinitis,Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,immune_system_disease
843,Systemic Lupus Erythematosus,Triptorelin,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,immune_system_disease
850,Atopic Dermatitis,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,immune_system_disease
851,Allergic Rhinitis,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,immune_system_disease
871,Lymphoma,Parsaclisib,CCOC1=C(C(=C(C=C1C(C)N2C3=NC=NC(=C3C(=N2)C)N)Cl)F)C4CC(=O)NC4,immune_system_disease
928,T Cell Lymphoma,Tenalisib,CCC(C1=C(C(=O)C2=CC=CC=C2O1)C3=CC(=CC=C3)F)NC4=NC=NC5=C4NC=N5,immune_system_disease
938,Asthma|Common Cold|Picornavirus Infection|Rhinovirus,Pleconaril,CC1=CC(=CC(=C1OCCCC2=CC(=NO2)C)C)C3=NOC(=N3)C(F)(F)F,immune_system_disease
940,HIV Infections,Capravirine,CC(C)C1=C(N(C(=N1)COC(=O)N)CC2=CC=NC=C2)SC3=CC(=CC(=C3)Cl)Cl,immune_system_disease
1007,HIV Infections,Atevirdine,CCNC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)OC,immune_system_disease
1030,B-cell Chronic Lymphocytic Leukemia,Forodesine,C1=C(C2=C(N1)C(=O)NC=N2)C3C(C(C(N3)CO)O)O,immune_system_disease
1073,Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia,Aspacytarabine,C1=CN(C(=O)N=C1NC(=O)CC(C(=O)O)N)C2C(C(C(O2)CO)O)O,immune_system_disease
1074,"Dermatitis, Atopic",Branebrutinib,CC#CC(=O)NC1CCCN(C1)C2=C(C=C(C3=C2C(=C(N3)C)C)C(=O)N)F,immune_system_disease
1089,Chemotherapeutic Agent Toxicity|Cognitive/Functional Effects|Lymphoma|Neurotoxicity|Radiation Toxicity,Procarbazine,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,immune_system_disease
1109,HIV Infections,Raluridine,C1C(C(OC1N2C=C(C(=O)NC2=O)Cl)CO)F,immune_system_disease
1122,Multiple Sclerosis,Glatiramer,CC(C(=O)O)N.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N,immune_system_disease
1135,"Nystagmus, Congenital|Nystagmus, Acquired|Multiple Sclerosis",Neramexane,CC1(CC(CC(C1)(C)N)(C)C)C,immune_system_disease
1174,Peripheral T-cell Lymphoma,Vindesine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O,immune_system_disease
1287,Seasonal Allergic Rhinitis|Hay Fever|Rhinoconjunctivitis,Bilastine,CCOCCN1C2=CC=CC=C2N=C1C3CCN(CC3)CCC4=CC=C(C=C4)C(C)(C)C(=O)O,immune_system_disease
1338,Pulmonary Lymphangioleiomyomatosis,Saracatinib,CN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl,immune_system_disease
1348,Allergic Conjunctivitis,Lifitegrast,CS(=O)(=O)C1=CC=CC(=C1)CC(C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl,immune_system_disease
1408,"Tuberculosis, Pulmonary|Tuberculosis, Multidrug-Resistant|Tuberculosis, MDR|Tuberculosis|Drug-Resistant Tuberculosis",Pretomanid,C1C(COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F,immune_system_disease
1409,"Tuberculosis, Pulmonary|Tuberculosis, Multidrug-Resistant|Tuberculosis, MDR|Tuberculosis|Drug-Resistant Tuberculosis",Bedaquiline,CN(C)CCC(C1=CC=CC2=CC=CC=C21)(C(C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O,immune_system_disease
1411,"Tuberculosis, Pulmonary|Tuberculosis, Multidrug-Resistant|Tuberculosis, MDR|Tuberculosis|Drug-Resistant Tuberculosis",Pyrazinamide,C1=CN=C(C=N1)C(=O)N,immune_system_disease
1442,"Conjunctivitis, Allergic",Reproxalap,CC(C)(C1=C(C=C2C=C(C=CC2=N1)Cl)N)O,immune_system_disease
1563,Asthma,Vilanterol,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl,immune_system_disease
1588,Immune System Disorder (Healthy Volunteer),Belumosudil,CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5,immune_system_disease
1632,"Healthy Subjects|Infection, Human Immunodeficiency Virus",Flurbiprofen,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,immune_system_disease
1651,Cold Contact Urticaria,Rupatadine,CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2,immune_system_disease
1662,Hematologic Malignancy|Acute Lymphocytic Leukemia|Chronic Lymphocytic Leukemia|Myelodysplasia|Acute Myeloid Leukemia|Chronic Myelogenous Leukemia|Hodgkin's Disease,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,immune_system_disease
1684,B-cell Lymphoma Refractory,Ozogamicin,CCN(C1COC(CC1OC)OC2C(C(C(OC2OC3C#CC=CC#CC4(CC(=O)C(=C3C4=CCSSC(C)(C)CC(=O)NN=C(C)C5=CC=C(C=C5)OCCCC(=O)N)NC(=O)OC)O)C)NOC6CC(C(C(O6)C)SC(=O)C7=C(C(=C(C(=C7OC)OC)OC8C(C(C(C(O8)C)O)OC)O)I)C)O)O)C(=O)C,immune_system_disease
1714,HIV Infections,Emivirine,CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC=CC=C2,immune_system_disease
1824,Cutaneous T-cell Lymphoma|Cutaneous T-cell Lymphoma Stage I|Mycosis Fungoides|Folliculotropic Mycosis Fungoides|Granulomatous Slack Skin|Syringotropic Mycosis Fungoides|Mycosis Fungoides Variant|Transformed Mycosis Fungoides,Mechlorethamine,CN(CCCl)CCCl,immune_system_disease
1876,Asthma,Levosalbutamol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,immune_system_disease
1877,Asthma,Levalbuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,immune_system_disease
1887,Lymphoblastic Leukemia|Lymphoblastic Lymphoma,Nelarabine,COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N,immune_system_disease
2059,Invasive Pulmonary Aspergillosis|Lymphoblastic Leukaemia|Myeloblastic Leukaemia|Lymphoblastic Leukemia|Myeloblastic Leukemia,Amphotericin B,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,immune_system_disease
2114,"Diabetes Mellitus, Type 1",Albiglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC6=CN=CN6)N,immune_system_disease
2119,Pruritus|Atopic Dermatitis,Serlopitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2CCC3CN(CC3C2C4=CC=C(C=C4)F)C5=CC(=O)CC5,immune_system_disease
2122,HIV Infections,Dapivirine,CC1=CC(=C(C(=C1)C)NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C,immune_system_disease
2164,Asthma,Abediterol,C1=CC=C(C=C1)C(COCCCCCCNCC(C2=C3C=CC(=O)NC3=C(C=C2)O)O)(F)F,immune_system_disease
2278,Cutaneous T-Cell Lymphoma/Mycosis Fungoides,Cobomarsen,CC1=CN(C(=O)NC1=O)C2C3C(C(O2)(CO3)COP(=S)(O)OC4C5C(OC4(CO5)COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8C9C(OC8(CO9)COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1C2C(OC1(CO2)CO)N1C=C(C(=NC1=O)N)C)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=NC1=O)N)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC12COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC13COC(C1OP(=S)(O)OCC14COC(C1OP(=S)(O)OCC15COC(C1OP(=S)(O)OCC16COC(C1O)C(O6)N1C=NC6=C(N=CN=C61)N)C(O5)N1C=C(C(=O)NC1=O)C)C(O4)N1C=C(C(=O)NC1=O)C)C(O3)N1C=NC3=C(N=CN=C31)N)C(O2)N1C=NC2=C1N=C(NC2=O)N,immune_system_disease
2336,Asthma,Ciclesonide,CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6,immune_system_disease
2370,Multiple Sclerosis,Firategrast,CCOCC1=CC(=C(C(=C1)OC)C2=CC=C(C=C2)CC(C(=O)O)NC(=O)C3=C(C=CC=C3F)F)OC,immune_system_disease
2372,Insulin Sensitivity,Eritoran,CCCCCCCCCCCC(=O)CC(=O)NC1C(C(C(OC1OP(=O)(O)O)COC2C(C(C(C(O2)COC)OP(=O)(O)O)OCCC(CCCCCCC)OC)NC(=O)CCCCCCCCCC=CCCCCCC)O)OCCCCCCCCCC,immune_system_disease
2410,"Diabetes Mellitus, Type 1|Insulin-dependent Diabetes Mellitus",Pramlintide,CCC(C)C(C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC6=CNC=N6)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C8CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N8)C(C)O)C)C(C)O)CC(=O)N)NC(=O)C(CCCCN)N,immune_system_disease
2437,Rheumatoid Arthritis,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,immune_system_disease
2442,Seasonal Allergic Rhinitis,Epinastine,C1C2C3=CC=CC=C3CC4=CC=CC=C4N2C(=N1)N,immune_system_disease
2464,Rheumatoid Arthritis,Loxoprofen,CC(C1=CC=C(C=C1)CC2CCCC2=O)C(=O)O,immune_system_disease
2466,Vincristine Induced Neurotoxicity|Acute Lymphoblastic Leukaemia,Mecobalamin,[CH3-].CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co+3],immune_system_disease
2467,Vincristine Induced Neurotoxicity|Acute Lymphoblastic Leukaemia,Pyridoxine,CC1=NC=C(C(=C1O)CO)CO,immune_system_disease
2548,Thrombotic Thrombocytopenic Purpura,Danazol,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5,immune_system_disease
2606,Chronic Lymphocytic Leukemia,Talabostat,B(C1CCCN1C(=O)C(C(C)C)N)(O)O,immune_system_disease
2629,Infertility|Autoimmune Thyroiditis,Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,immune_system_disease
2671,Mantle-Cell Lymphoma,Obatoclax,CC1=CC(=C(N1)C=C2C(=CC(=C3C=C4C=CC=CC4=N3)N2)OC)C,immune_system_disease
2696,Cutaneous T-cell Lymphoma (CTCL),Sapacitabine,CCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)C#N,immune_system_disease
2730,Type 1 Diabetes,Terbutaline,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,immune_system_disease
2761,HIV Infections|HIV Wasting Syndrome,Nandrolone,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34,immune_system_disease
2776,"Lymphoma, Non-Hodgkin",Pixantrone,C1=CC(=C2C(=C1NCCN)C(=O)C3=C(C2=O)C=NC=C3)NCCN,immune_system_disease
2964,Mitochondrial Diseases|Drug Resistant Epilepsy|Leigh Disease|Leigh Syndrome|Mitochondrial Encephalopathy (MELAS)|Pontocerebellar Hypoplasia Type 6 (PCH6)|Alpers Disease|Alpers Syndrome,Vatiquinone,CC1=C(C(=O)C(=C(C1=O)C)CCC(C)(CCC=C(C)CCC=C(C)CCC=C(C)C)O)C,immune_system_disease
2971,Multiple Sclerosis,Rolipram,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,immune_system_disease
3013,Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia,Idarubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,immune_system_disease
3076,"Ultraviolet Rays|Immunosuppression|Hypersensitivity, Delayed|Immune Tolerance/Drug Effects",Diphencyprone,C1=CC=C(C=C1)C2=C(C2=O)C3=CC=CC=C3,immune_system_disease
3131,HIV Infections,Calanolide A,CCCC1=CC(=O)OC2=C1C3=C(C=CC(O3)(C)C)C4=C2C(C(C(O4)C)C)O,immune_system_disease
3158,Immune Thrombocytopenia (ITP),Lusutrombopag,CCCCCCOC(C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)C=C(C)C(=O)O)Cl,immune_system_disease
3311,Atopic Dermatitis,Fluocinonide,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C,immune_system_disease
3323,AIDS Dementia Complex|HIV Infections,Memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,immune_system_disease
3349,Hodgkins Lymphoma,Goserelin,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,immune_system_disease
3353,Methamphetamine Dependence|HIV Infection,Ibudilast,CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C,immune_system_disease
3354,Atopic Dermatitis,Calcipotriol,CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,immune_system_disease
3425,Asthma,Tofimilast,CCC1=NN(C2=C1CCN3C2=NN=C3C4=CC=CS4)C5CCCC5,immune_system_disease
3442,Status Asthmaticus,Ipratropium,CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C,immune_system_disease
3520,"Infection, Human Immunodeficiency Virus",Cabotegravir,CC1COC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,immune_system_disease
3573,Autoimmune Disease|Lymphatic Disease|Lymphoproliferative Disorder,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,immune_system_disease
3579,Asthma,Revamilast,C1=CC(=C2C(=C1C(=O)N=C3C(=CN(C=C3Cl)O)Cl)C4=C(O2)C=CN=C4)OC(F)F,immune_system_disease
3628,Allergic Reactions,Chlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,immune_system_disease
3657,Acute Lymphocytic Leukemia|Acute Myelogenous Leukemia,Annamycin,CC1C(C(C(C(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)CO)O)I)O)O,immune_system_disease
3770,"Lymphoma, Non-Hodgkin|HIV Infections",Mitoguazone,CC(=NN=C(N)N)C=NN=C(N)N,immune_system_disease
3805,"Rhinitis, Allergic, Perennial and Seasonal",Levocabastine,CC1CN(CCC1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F,immune_system_disease
3868,Myasthenia Gravis|Ocular Myasthenia Gravis,Apraclonidine,C1CN=C(N1)NC2=C(C=C(C=C2Cl)N)Cl,immune_system_disease
3892,Asthma,Oglemilast,CS(=O)(=O)NC1=CC2=C(C=C1)OC3=C(C=CC(=C23)C(=O)NC4=C(C=NC=C4Cl)Cl)OC(F)F,immune_system_disease
3916,Allergy,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,immune_system_disease
3980,Infectious Mononucleosis,Valomaciclovir,CC(C)C(C(=O)OCCC(CN1C=NC2=C1N=C(NC2=O)N)CO)N,immune_system_disease
4032,HIV/AIDS,Albuvirtide,CCC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)NC(CCCCNC(=O)COCCOCCNC(=O)CCN2C(=O)C=CC2=O)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CC3=CNC=N3)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)O)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC6=CNC7=CC=CC=C76)NC(=O)C,immune_system_disease
4056,Ebola|HIV/AIDS,Remdesivir,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,immune_system_disease
4064,Allergic Conjunctivitis,Ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,immune_system_disease
4101,Atopic Dermatitis,Ulobetasol,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C)F,immune_system_disease
4102,Atopic Dermatitis,Halobetasol,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C)F,immune_system_disease
4200,"Asthma, Exercise-Induced",Reproterol,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC(C3=CC(=CC(=C3)O)O)O,immune_system_disease
4204,Breast Cancer,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,immune_system_disease
4269,Lymphoma|Advanced Cancer,Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,immune_system_disease
4270,Lymphoma|Advanced Cancer,Tasisulam,C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br,immune_system_disease
4396,Acute Lymphoblastic Leukemia|Acute Lymphoblastic Lymphoma,Tioguanine,C1=NC2=C(N1)C(=S)N=C(N2)N,immune_system_disease
4397,Acute Lymphoblastic Leukemia|Acute Lymphoblastic Lymphoma,Thioguanine,C1=NC2=C(N1)C(=S)N=C(N2)N,immune_system_disease
4473,Atopic Dermatitis|Eczema|Chronic Pruritus,Tradipitant,C1=CC=C(C(=C1)C(=O)C2=C(N=CC=C2)C3=C(N(N=N3)CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=CC=NC=C5)Cl,immune_system_disease
4528,HIV Infections,Racivir,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,immune_system_disease
4559,Allergic Asthma,Pemirolast,CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3,immune_system_disease
4668,Atopic Dermatitis,Delgocitinib,CC1CN(C12CCN(C2)C3=NC=NC4=C3C=CN4)C(=O)CC#N,immune_system_disease
4742,Asthma,Laninamivir,CC(=O)NC1C(C=C(OC1C(C(CO)O)OC)C(=O)O)N=C(N)N,immune_system_disease
4745,HIV Infections|Human Immunodeficiency Virus,Dexelvucitabine,C1=CC(OC1CO)N2C=C(C(=NC2=O)N)F,immune_system_disease
4761,Multiple Sclerosis,Oxcarbazepine,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,immune_system_disease
4811,HIV Infections,Foscarnet,C(=O)(O)P(=O)(O)O,immune_system_disease
4976,"Diabetes Mellitus, Insulin-Dependent",Ladarixin,CC(C1=CC=C(C=C1)OS(=O)(=O)C(F)(F)F)C(=O)NS(=O)(=O)C,immune_system_disease
5309,HIV Infections,Amdoxovir,C1C(OC(O1)CO)N2C=NC3=C(N=C(N=C32)N)N,immune_system_disease
5398,Recurrent Anaplastic Large Cell Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Transformed Non-Hodgkin Lymphoma|Refractory Anaplastic Large Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Transformed Non-Hodgkin Lymphoma,Onalespib,CC(C)C1=CC(=C(C=C1O)O)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C,immune_system_disease
5460,Asthma,Olodaterol,CC(C)(CC1=CC=C(C=C1)OC)NCC(C2=C3C(=CC(=C2)O)NC(=O)CO3)O,immune_system_disease
5566,Chronic Lymphocytic Leukemia,Ceralasertib,CC1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=N)(=O)C)C4=C5C=CNC5=NC=C4,immune_system_disease
5585,Non-Hodgkin's Lymphoma,Dulanermin,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,immune_system_disease
5709,HIV Infections,Oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,immune_system_disease
5763,"Leukemia, Lymphocytic, Acute|Leukemia, Nonlymphocytic, Acute|Leukemia, Myeloid, Chronic|Myelodysplastic Syndromes",Vosaroxin,CNC1CN(CC1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(=O)O,immune_system_disease
5922,HIV Infections,Vesnarinone,COC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC4=C(C=C3)NC(=O)CC4)OC,immune_system_disease
5923,Leukemias|Acute Myeloid Leukemia (AML)|Acute Lymphocytic Leukemia (ALL)|Adult T Cell Leukemia (ATL)|Chronic Myeloid Leukemia (CML-BP)|Chronic Lymphocytic Leukemia (CLL)|Myelodysplastic Syndrome (MDS)|Chronic Myelomonocytic Leukemia (CMML),Terameprocol,CC(CC1=CC(=C(C=C1)OC)OC)C(C)CC2=CC(=C(C=C2)OC)OC,immune_system_disease
5976,Secondary Progressive Multiple Sclerosis,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,immune_system_disease
6459,HIV Infections,Simethicone,CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O,immune_system_disease
6544,HIV-1-infection,Lenacapavir,CC(C)(C#CC1=NC(=C(C=C1)C2=C3C(=C(C=C2)Cl)C(=NN3CC(F)(F)F)NS(=O)(=O)C)C(CC4=CC(=CC(=C4)F)F)NC(=O)CN5C6=C(C7CC7C6(F)F)C(=N5)C(F)(F)F)S(=O)(=O)C,immune_system_disease
6603,Sjgren Syndrome,Remibrutinib,CC1=C(C=C(C=C1NC(=O)C2=C(C=C(C=C2)C3CC3)F)F)C4=C(C(=NC=N4)N)OCCN(C)C(=O)C=C,immune_system_disease
6693,HIV Infections,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,immune_system_disease
6737,"Pneumonia, Pneumocystis Carinii|HIV Infections",Sitamaquine,CCN(CC)CCCCCCNC1=CC(=CC2=C(C=CN=C12)C)OC,immune_system_disease
6746,Hematopoietic and Lymphoid Cell Neoplasm|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Myelomonocytic Leukemia|Recurrent Myelodysplastic Syndrome|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Myelomonocytic Leukemia|Refractory Myelodysplastic Syndrome,Posaconazole,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,immune_system_disease
6806,HIV Infections|Peripheral Nervous System Disease,Benzatropine,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,immune_system_disease
6807,HIV Infections|Peripheral Nervous System Disease,Benztropine,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,immune_system_disease
6808,HIV Infections|Peripheral Nervous System Disease,Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,immune_system_disease
6820,Allergic Conjunctivitis,Loteprednol,CC12CC(C3C(C1CCC2(C(=O)OCCl)O)CCC4=CC(=O)C=CC34C)O,immune_system_disease
6848,Chronic Urticaria,Miltefosine,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,immune_system_disease
6849,Mild to Moderate Atopic Dermatitis,Crisaborole,B1(C2=C(CO1)C=C(C=C2)OC3=CC=C(C=C3)C#N)O,immune_system_disease
6993,Seasonal Allergic Rhinitis,Bepotastine,C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O,immune_system_disease
7060,"Pneumonia, Pneumocystis Carinii|HIV Infections",Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,immune_system_disease
7093,Atopic Dermatitis,Omiganan,CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC3C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)N8CCCC8C(=O)NC(CC9=CNC1=CC=CC=C19)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)N)N,immune_system_disease
7237,Multiple Sclerosis,Ponesimod,CCCN=C1N(C(=O)C(=CC2=CC(=C(C=C2)OCC(CO)O)Cl)S1)C3=CC=CC=C3C,immune_system_disease
7279,Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus,Ruboxistaurin,CN(C)CC1CCN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO1)C6=CC=CC=C65)C(=O)NC4=O,immune_system_disease
7355,Advanced Solid Tumors|Lymphomas,Camptothecin,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O,immune_system_disease
7413,Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus,Ebselen,C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3[Se]2,immune_system_disease
7453,HIV Infections,Glycovir,CCCCN1CC(C(C(C1COC(=O)CCC)OC(=O)CCC)OC(=O)CCC)OC(=O)CCC,immune_system_disease
7719,HIV Infections,Dinitrochlorobenzene,C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])Cl,immune_system_disease
7778,Asthma,Setipiprant,C1CN(CC2=C1N(C3=C2C=C(C=C3)F)CC(=O)O)C(=O)C4=CC=CC5=CC=CC=C54,immune_system_disease
7919,Allergic Rhinitis|Upper Respiratory Infection,Doxylamine,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C,immune_system_disease
7939,"Diabetes Mellitus, Type 1",Deoxyspergualin,C(CCCN=C(N)N)CCC(=O)NC(C(=O)NCCCCNCCCN)O,immune_system_disease
7974,Hodgkin Lymphoma,Mocetinostat,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4,immune_system_disease
7993,Relapsing Remitting Multiple Sclerosis,Flupirtine,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N,immune_system_disease
8058,Atopic Dermatitis,Tapinarof,CC(C)C1=C(C=C(C=C1O)C=CC2=CC=CC=C2)O,immune_system_disease
8063,Mantle Cell Lymphoma|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Elsamitrucin,CC1C(C(C(C(O1)OC2C(OC(C(C2(C)O)O)C)OC3=CC=CC4=C3C5=C6C7=C(C=CC(=C7C(=O)O5)C)OC(=O)C6=C4O)N)OC)O,immune_system_disease
8111,Human Immunodeficiency Virus (HIV) Infection,Islatravir,C#CC1(C(CC(O1)N2C=NC3=C(N=C(N=C32)F)N)O)CO,immune_system_disease
8199,Type 1 Diabetes|Hypoglycemia,Pitolisant,C1CCN(CC1)CCCOCCCC2=CC=C(C=C2)Cl,immune_system_disease
8277,HIV Infections,Bevirimat,CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)OC(=O)CC(C)(C)C(=O)O)C)C(=O)O,immune_system_disease
8333,Advanced Solid Tumor|Lymphoma,Milademetan,CC1(CCC2(CC1)C3(C(C(N2)C(=O)NC4CCC(OC4)C(=O)N)C5=C(C(=NC=C5)Cl)F)C6=C(C=C(C=C6)Cl)NC3=O)C,immune_system_disease
8432,Lymphoma,Tetracycline,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,immune_system_disease
8551,HIV Infections,Telinavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)C(CC(=O)N)NC(=O)C2=NC3=CC=CC=C3C=C2)O)C(=O)NC(C)(C)C,immune_system_disease
8579,Follicular Lymphoma (FL/Indolent NHL)|Aggressive NHL (a NHL)|Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)|T-cell Lymphoma (PTCL and CTCL)|B-cell Non Hodgkin Lymphoma (NHL),Cerdulatinib,CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N,immune_system_disease
8585,Muscle Spasticity,Tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,immune_system_disease
8769,HIV Infections,Peldesine,C1=CC(=CN=C1)CC2=CNC3=C2N=C(NC3=O)N,immune_system_disease
8813,Multiple Sclerosis,Isoxsuprine,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,immune_system_disease
8918,Type 1 Diabetes Mellitus,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,immune_system_disease
8999,Asthma,Nedocromil,CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)O)C(=O)C=C(N2CC)C(=O)O,immune_system_disease
9058,"Multiple Sclerosis, Relapsing-Remitting|Multiple Sclerosis",Guanabenz,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,immune_system_disease
9186,Burkitt Lymphoma|CD20-Positive Neoplastic Cells Present|Diffuse Large B-Cell Lymphoma|Indolent Non-Hodgkin Lymphoma|Mantle Cell Lymphoma|Recurrent B-Cell Non-Hodgkin Lymphoma|Refractory Mature B-Cell Non-Hodgkin Lymphoma,Biotin,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,immune_system_disease
9407,Impaired Processing Speed|Cognitive Impairment|Multiple Sclerosis,Amphetamine,CC(CC1=CC=CC=C1)N,immune_system_disease
9679,Healthy|Type 1 Diabetes,Lisofylline,CC(CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O,immune_system_disease
9837,Rheumatoid Arthritis,Cetrorelix,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCNC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C,immune_system_disease
9879,Progressive Multiple Sclerosis,Dexchlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,immune_system_disease
10175,Diffuse B-Cell Lymphoma,Avadomide,CC1=NC2=CC=CC(=C2C(=O)N1C3CCC(=O)NC3=O)N,immune_system_disease
10185,COVID-19,Nirmatrelvir,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)C(F)(F)F)C(=O)NC(CC3CCNC3=O)C#N)C,immune_system_disease
10494,"Eczema, Atopic",Palmidrol,CCCCCCCCCCCCCCCC(=O)NCCO,immune_system_disease
10641,Relapsed/Refractory B Cell Malignancies|Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma|Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|Treatment-Naive B Cell Malignancies,Navtemadlin,CC(C)C(CS(=O)(=O)C(C)C)N1C(C(CC(C1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC=C(C=C3)Cl,immune_system_disease
10657,HIV Infection,Tucaresol,C1=CC(=C(C(=C1)OCC2=CC=C(C=C2)C(=O)O)C=O)O,immune_system_disease
10785,"Leukemia, B-Cell, Chronic",Acadesine,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N,immune_system_disease
10940,Active Rheumatoid Arthritis,Tranilast,COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC,immune_system_disease
10968,Lymphoma,Granisetron,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,immune_system_disease
10978,B-cell Lymphoma Recurrent|B-cell Lymphoma Refractory,Orelabrutinib,C=CC(=O)N1CCC(CC1)C2=NC(=C(C=C2)C(=O)N)C3=CC=C(C=C3)OC4=CC=CC=C4,immune_system_disease
11002,HIV Infections,Lentinan,C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)O)O)OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)CO)O)OC5C(C(C(C(O5)COC6C(C(C(C(O6)CO)O)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)O)O)O)O)O)O)O)O,immune_system_disease
11006,Type 1 Diabetes,Leptin,CC(C)CC(C(=NC(CCC(=N)O)C(=NCC(=NC(CO)C(=NC(CC(C)C)C(=NC(CCC(=N)O)C(=NC(CC(=O)O)C(=NC(CCSC)C(=NC(CC(C)C)C(=NC(CC1=CNC2=CC=CC=C21)C(=NC(CCC(=N)O)C(=NC(CC(C)C)C(=NC(CC(=O)O)C(=NC(CC(C)C)C(=NC(CO)C(=O)N3CCCC3C(=NCC(=NC(CS)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N,immune_system_disease
11192,HIV Infections,Alovudine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)F,immune_system_disease
11293,Chronic Lymphocytic Leukemia,Oblimersen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)([O-])OC3CC(OC3COP(=O)(OC4CC(OC4COP(=S)([O-])OC5CC(OC5COP(=S)([O-])OC6CC(OC6COP(=S)([O-])OC7CC(OC7COP(=S)([O-])OC8CC(OC8COP(=S)([O-])OC9CC(OC9COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1CO)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)[S-])N1C=NC2=C(N=CN=C21)N)O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],immune_system_disease
11305,Latent Tuberculosis|Human Immunodeficiency Virus|Rifamycins Causing Adverse Effects in Therapeutic Use|Drug Interaction Potentiation,Rifapentine,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C6CCCC6)C,immune_system_disease
11306,Latent Tuberculosis|Human Immunodeficiency Virus|Rifamycins Causing Adverse Effects in Therapeutic Use|Drug Interaction Potentiation,Isoniazid,C1=CN=CC=C1C(=O)NN,immune_system_disease
11521,Polyarticular Course Juvenile Idiopathic Arthritis,Givinostat,CCN(CC)CC1=CC2=C(C=C1)C=C(C=C2)COC(=O)NC3=CC=C(C=C3)C(=O)NO,immune_system_disease
11825,Non-GCB/ABC Diffuse Large B-Cell Lymphoma|With and Without MyD88 and/or CD79B Mutations,Mivavotinib,CN1C=C(C=N1)C2=NC(=C(C3=C2C(=O)NC3)F)NC4CCCCC4N,immune_system_disease
12094,Neoplasms,Daniquidone,C1C2=C(C=CC(=C2)N)N=C3N1C(=O)C4=CC=CC=C43,immune_system_disease
12280,Solid Tumors and Lymphomas,Alobresib,CC1=C(C(=NO1)C)C2=CC(=C3C(=C2)NC(=N3)C4CC4)C(C5=CC=CC=N5)(C6=CC=CC=N6)O,immune_system_disease
12303,Skin Alterations Associated With Atopic Dermatitis,Sertaconazole,C1=CC2=C(C(=C1)Cl)SC=C2COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl,immune_system_disease
12304,Graves Disease|Thyroid Associated Ophthalmopathy,Methimazole,CN1C=CNC1=S,immune_system_disease
12468,Malignancies|B-Cell Lymphoma,Aroplatin,CC(C)(C)CCCCCC(=O)[O-].CC(C)(C)CCCCCC(=O)[O-].C1CCC(C(C1)N)N.[Pt+2],immune_system_disease
12725,Relapsing Multiple Sclerosis,Fenebrutinib,CC1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8,immune_system_disease
12829,HIV Infections,Thymopentin,CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N,immune_system_disease
12856,Immune Thrombocytopenia,Hetrombopag,CC1=C(C(=O)N(N1)C2=CC3=C(CCCC3)C=C2)N=NC4=CC=CC(=C4O)C5=CC=C(O5)C(=O)O,immune_system_disease
12882,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Chronic Lymphocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid Cell Neoplasm|Hodgkin Lymphoma|Lymphoblastic Lymphoma|Myelodysplastic Syndrome|Myelofibrosis|Myeloproliferative Neoplasm|Non-Hodgkin Lymphoma",Letermovir,COC1=C(C=C(C=C1)C(F)(F)F)N2C(C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,immune_system_disease
12885,"Lymphoma, T-Cell, Cutaneous",Quisinostat,CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO,immune_system_disease
12944,"Multiple Sclerosis, Relapsing-Remitting",Clemastine,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C,immune_system_disease
13101,Asthma,Gallopamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C(=C2)OC)OC)OC,immune_system_disease
13185,Asthma,Procaterol,CCC(C(C1=C2C=CC(=O)NC2=C(C=C1)O)O)NC(C)C,immune_system_disease
13222,Allergic Reactions,Brompheniramine,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2,immune_system_disease
13311,Asthma,Glycopyrronium,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,immune_system_disease
13543,Rheumatoid Arthritis,Diacerein,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C2=O)C=C(C=C3OC(=O)C)C(=O)O,immune_system_disease
13659,Asthma,Zavegepant,CC1=CC(=CC2=C1NN=C2)CC(C(=O)N3CCN(CC3)C4CCN(CC4)C)NC(=O)N5CCC(CC5)C6=CC7=CC=CC=C7NC6=O,immune_system_disease
13686,HIV Infections,Fostemsavir,CC1=NN(C=N1)C2=NC=C(C3=C2N(C=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)COP(=O)(O)O)OC,immune_system_disease
13793,Pain|Chronic Disease,Tropisetron,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,immune_system_disease
16,Attention Deficit Hyperactivity Disorder,Centanafadine,C1C2C1(CNC2)C3=CC4=CC=CC=C4C=C3,mental_and_behavioural_disorder
19,Major Depressive Disorder|Bipolar Disorder,Cycloserine,C1C(C(=O)NO1)N,mental_and_behavioural_disorder
25,Treatment Resistant Depression,Psilocybin,CN(C)CCC1=CNC2=C1C(=CC=C2)OP(=O)(O)O,mental_and_behavioural_disorder
58,Major Depressive Disorder,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,mental_and_behavioural_disorder
63,Autism Spectrum Disorders,Arbaclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,mental_and_behavioural_disorder
66,Alcohol-Related Disorders|Anxiety Disorders,Venlafaxine,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,mental_and_behavioural_disorder
78,"Depressive Disorder, Major",Seltorexant,CC1=CC(=NC(=N1)N2CC3CN(CC3C2)C(=O)C4=C(C=CC=C4F)N5N=CC=N5)C,mental_and_behavioural_disorder
80,"Depressive Disorder, Major",Zopiclone,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,mental_and_behavioural_disorder
85,Attention Deficit Hyperactivity Disorder,Dasotraline,C1CC(C2=CC=CC=C2C1C3=CC(=C(C=C3)Cl)Cl)N,mental_and_behavioural_disorder
87,Alcohol Use Disorder,Cyproheptadine,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,mental_and_behavioural_disorder
93,"Depressive Disorder, Major",Radafaxine,CC1C(OCC(N1)(C)C)(C2=CC(=CC=C2)Cl)O,mental_and_behavioural_disorder
117,Alcohol Abuse|Impulsive Behavior,Tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],mental_and_behavioural_disorder
126,REM Sleep Behavior Disorder,Clonazepam,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,mental_and_behavioural_disorder
142,"Depressive Disorder|Depression|Depression, Postpartum|Behavioral Symptoms|Mood Disorders|Mental Disorder|Pregnancy Complications|Postpartum Blues|PPD|Postpartum Disorder",Ganaxolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C)O)C)C,mental_and_behavioural_disorder
150,Major Depressive Disorder,Brexpiprazole,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,mental_and_behavioural_disorder
160,Schizophrenia|Major Depressive Disorder|Bipolar I Disorder,Aripiprazole,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,mental_and_behavioural_disorder
173,Depression,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,mental_and_behavioural_disorder
178,Autism,Risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,mental_and_behavioural_disorder
188,Attention Deficit Hyperactivity Disorder,Edivoxetine,COC1=C(C=C(C=C1)F)CC(C2CCOCC2)(C3CNCCO3)O,mental_and_behavioural_disorder
192,Major Depressive Disorder,Gaboxadol,C1CNCC2=C1C(=O)NO2,mental_and_behavioural_disorder
198,"Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder|Psychosis NOS|Autistic Disorder|Asperger Syndrome|Child Development Disorders, Pervasive|Bipolar I Disorder|Bipolar II Disorder|Mood Disorder NOS|Severe Major Depression With Psychotic Features|Single Episode Major Depression Without Psychotic Symptoms|Severe Mood Disorder With Psychotic Features",Lurasidone,C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O,mental_and_behavioural_disorder
219,Major Depression,Cimicoxib,COC1=C(C=C(C=C1)C2=C(N=CN2C3=CC=C(C=C3)S(=O)(=O)N)Cl)F,mental_and_behavioural_disorder
226,"Depression, Bipolar",Cariprazine,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,mental_and_behavioural_disorder
238,Pathological Gambling,Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,mental_and_behavioural_disorder
239,Pathological Gambling,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,mental_and_behavioural_disorder
251,"Depressive Disorder, Major",Rapastinel,CC(C(C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)N)N)O,mental_and_behavioural_disorder
257,Bipolar Depression,Uridine,C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O,mental_and_behavioural_disorder
263,Attention Deficit Hyperactivity Disorder,Solriamfetol,C1=CC=C(C=C1)CC(COC(=O)N)N,mental_and_behavioural_disorder
268,Bipolar Disorder,Felbamate,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,mental_and_behavioural_disorder
269,Sleep Initiation and Maintenance Disorders,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,mental_and_behavioural_disorder
273,Attention Deficit Disorder With Hyperactivity,Tipepidine,CN1CCCC(=C(C2=CC=CS2)C3=CC=CS3)C1,mental_and_behavioural_disorder
300,"Major Depressive Disorder, Healthy Volunteer",Basimglurant,CC1=C(N=C(N1C2=CC=C(C=C2)F)C)C#CC3=CC(=NC=C3)Cl,mental_and_behavioural_disorder
303,"Depressive Disorder, Major",Quetiapine,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,mental_and_behavioural_disorder
305,"Depressive Disorder, Major",Serotonin,C1=CC2=C(C=C1O)C(=CN2)CCN,mental_and_behavioural_disorder
327,Psychotic Disorders|Schizophrenia|Bipolar Disorder|Depressive Disorder,Olanzapine,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,mental_and_behavioural_disorder
352,"Depression, Postpartum|Analgesia, Obstetrical|Anesthesia, Obstetrical",Meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,mental_and_behavioural_disorder
358,Major Depressive Disorder,Levomilnacipran,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2,mental_and_behavioural_disorder
374,Treatment of Depression in Adults With Parkinson's Disease (PD),Pimavanserin,CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C,mental_and_behavioural_disorder
395,Major Depressive Disorder,Vilazodone,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N,mental_and_behavioural_disorder
431,Drug Abuse,Ramelteon,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,mental_and_behavioural_disorder
433,Schizophrenia|Alcohol Use Disorder,Samidorphan,C1CC1CN2CCC34CC(=O)CCC3(C2CC5=C4C(=C(C=C5)C(=O)N)O)O,mental_and_behavioural_disorder
451,Major Depressive Disorder,Pexacerfont,CCC(C)NC1=NC(=NC2=C(C(=NN21)C)C3=C(N=C(C=C3)OC)C)C,mental_and_behavioural_disorder
471,Cocaine Addiction,Vigabatrin,C=CC(CCC(=O)O)N,mental_and_behavioural_disorder
500,Cocaine-Related Disorders,Tryptophan,C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N,mental_and_behavioural_disorder
503,Disorder of Consciousness,Apomorphine,CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O,mental_and_behavioural_disorder
510,Pathological Gambling,Ecopipam,CN1CCC2=CC(=C(C=C2C3C1CCC4=CC=CC=C34)O)Cl,mental_and_behavioural_disorder
532,Alcohol Use Disorders|Bipolar Disorder,Zonisamide,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,mental_and_behavioural_disorder
539,Attention Deficit Disorder With Hyperactivity,Betahistine,CNCCC1=CC=CC=N1,mental_and_behavioural_disorder
540,Behavior and Mental Disorders|Methamphetamine Disorders,Methamphetamine,CC(CC1=CC=CC=C1)NC,mental_and_behavioural_disorder
541,Behavior and Mental Disorders|Methamphetamine Disorders,Metamfetamine,CC(CC1=CC=CC=C1)NC,mental_and_behavioural_disorder
601,Bipolar Depression,Asenapine,CN1CC2C(C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24,mental_and_behavioural_disorder
604,"Major Depressive Disorder, Recurrent",Filorexant,CC1CCC(CN1C(=O)C2=C(C=CC(=C2)C)C3=NC=CC=N3)COC4=NC=C(C=C4)F,mental_and_behavioural_disorder
12,Light Chain (AL) Amyloidosis|Cardiac Involvement,Epigallocatechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O,metabolic_disease
69,Type 2 Diabetes,Tesaglitazar,CCOC(CC1=CC=C(C=C1)OCCC2=CC=C(C=C2)OS(=O)(=O)C)C(=O)O,metabolic_disease
74,"Hereditary Tyrosinemia, Type I",Nitisinone,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],metabolic_disease
97,Spinal Cord Injury|Bone Loss|Osteoporosis,Teriparatide,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CNC=N1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CNC=N2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CNC=N5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N,metabolic_disease
112,Post Menopausal Osteoporosis,Abaloparatide,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC1=CN=CN1)C(=O)NC(C(C)O)C(=O)NC(C)C(=O)N)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(C)N,metabolic_disease
124,Primary Hypercholesterolemia,Eprotirome,CC(C)C1=C(C=CC(=C1)OC2=C(C=C(C=C2Br)NC(=O)CC(=O)O)Br)O,metabolic_disease
153,"Niemann-Pick Disease, Type C",Adrabetadex,CC(COCC1C2CC(C(O1)OC3C(OC(C(C3O)OCC(C)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(O2)C(C8O)O)COCC(C)O)CO)COCC(C)O)CO)CO)CO)O)O,metabolic_disease
205,Hyperlipidemia|HIV,Pitavastatin,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)O)O)O)C4=CC=C(C=C4)F,metabolic_disease
209,Amyotrophic Lateral Sclerosis (ALS),Rasagiline,C#CCNC1CCC2=CC=CC=C12,metabolic_disease
282,Alzheimer Disease,Azeliragon,CCCCC1=NC(=CN1C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)C4=CC=C(C=C4)OCCCN(CC)CC,metabolic_disease
288,"Diabetes Mellitus, Type 2",Dorzagliatin,CC(C)CC(C(=O)NC1=NN(C=C1)CC(CO)O)N2CC(=CC2=O)OC3=CC=CC=C3Cl,metabolic_disease
384,Type 2 Diabetes,Teneligliptin,CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5,metabolic_disease
387,Dyslipidemia,Muraglitazar,CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CN(CC(=O)O)C(=O)OC4=CC=C(C=C4)OC,metabolic_disease
452,"Gaucher Disease, Type 1|Gaucher Disease, Type 3",Arimoclomol,C1CCN(CC1)CC(CON=C(C2=C[N+](=CC=C2)[O-])Cl)O,metabolic_disease
489,Dyslipidemias|High Cholesterol|Hypercholesterolemia,Obicetrapib,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C4=NC=C(C=N4)OCCCC(=O)O,metabolic_disease
517,Osteoporosis,Apomine,CC(C)OP(=O)(C(CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)P(=O)(OC(C)C)OC(C)C)OC(C)C,metabolic_disease
537,"Diabetes Mellitus, Type 2",Glimepiride,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,metabolic_disease
558,Type 2 Diabetes Mellitus,Alogliptin,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N,metabolic_disease
588,Amyotrophic Lateral Sclerosis,Perampanel,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,metabolic_disease
589,Amyotrophic Lateral Sclerosis,Clenbuterol,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,metabolic_disease
594,Sarcopenia|Osteopenia,Anamorelin,CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC(C3)(CC4=CC=CC=C4)C(=O)N(C)N(C)C)N,metabolic_disease
602,Post-menopausal Osteoporosis,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,metabolic_disease
603,Post-menopausal Osteoporosis,Risedronate,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,metabolic_disease
628,Menopause|Postmenopausal Bone Loss|Breast Cancer,Tibolone,CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O,metabolic_disease
638,Type 2 Diabetes,Rivoglitazone,CN1C2=C(C=CC(=C2)OC)N=C1COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4,metabolic_disease
659,Metabolic Syndrome,Treamid,C1=CN=C(N1)CCNC(=O)CCCC(=O)NCCC2=NC=CN2,metabolic_disease
699,Type 2 Diabetes Mellitus,Tesofensine,CCOCC1C2CCC(N2C)CC1C3=CC(=C(C=C3)Cl)Cl,metabolic_disease
731,Gout,Arhalofenate,CC(=O)NCCOC(=O)C(C1=CC=C(C=C1)Cl)OC2=CC=CC(=C2)C(F)(F)F,metabolic_disease
737,"Diabetes Mellitus, Type II",Lobeglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC(=NC=N3)OC4=CC=C(C=C4)OC,metabolic_disease
772,Familial Hypercholesterolemia,Implitapide,CC1=CC(=NC2=C1C3=CC=CC=C3N2CC4=CC(=CC=C4)C(C5CCCC5)C(=O)NC(CO)C6=CC=CC=C6)C,metabolic_disease
787,Motor Neuron Disease|Amyotrophic Lateral Sclerosis|Primary Lateral Sclerosis|Progressive Muscular Atrophy,Levetiracetam,CCC(C(=O)N)N1CCCC1=O,metabolic_disease
825,Osteoporosis,Odanacatib,CC(C)(CC(C(=O)NC1(CC1)C#N)NC(C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F,metabolic_disease
827,Hypertriglyceridemia,Diazoxide,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl,metabolic_disease
942,Hypercholesterolemia,Lapaquistat,CC(C)(CN1C2=C(C=C(C=C2)Cl)C(OC(C1=O)CC(=O)N3CCC(CC3)CC(=O)O)C4=C(C(=CC=C4)OC)OC)CO,metabolic_disease
944,"Diabetes Mellitus, Type 2",Zanamivir,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,metabolic_disease
960,Osteoarthritis,Relacatib,CC1CCC(C(=O)CN1S(=O)(=O)C2=CC=CC=N2)NC(=O)C(CC(C)C)NC(=O)C3=CC4=CC=CC=C4O3,metabolic_disease
987,Psoriasis|Type 2 Diabetes Mellitus,Gliclazide,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,metabolic_disease
1025,Pompe Disease,Duvoglustat,C1C(C(C(C(N1)CO)O)O)O,metabolic_disease
1034,Type 2 Diabetes Mellitus,Mitiglinide,C1CCC2CN(CC2C1)C(=O)CC(CC3=CC=CC=C3)C(=O)O,metabolic_disease
1052,Osteoporosis,Bazedoxifene,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O,metabolic_disease
1096,Hyperlipidemia,Tetraethylammonium,CC[N+](CC)(CC)CC,metabolic_disease
1161,Hyperphosphatemia,Tenapanor,CN1CC(C2=C(C1)C(=CC(=C2)Cl)Cl)C3=CC(=CC=C3)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C4=CC=CC(=C4)C5CN(CC6=C5C=C(C=C6Cl)Cl)C,metabolic_disease
1283,Metabolic Acidosis,Meglumine,CNCC(C(C(C(CO)O)O)O)O,metabolic_disease
1310,"Gaucher Disease, Type 1|Type 1 Gaucher Disease|Gaucher Disease",Afegostat,C1C(C(C(CN1)O)O)CO,metabolic_disease
1492,Beta-Thalassemia,Deferitrin,CC1(CSC(=N1)C2=C(C=C(C=C2)O)O)C(=O)O,metabolic_disease
1494,Osteoporosis,Raloxifene,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,metabolic_disease
1529,Lipid Disorder|Triglycerides High|Dyslipidemias,Icosapent,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,metabolic_disease
1558,Hyperlipoproteinemia,Coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCS)O,metabolic_disease
1589,Type 2 Diabetes Mellitus,Fasiglifam,CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC4=C(C=C3)C(CO4)CC(=O)O)C)OCCCS(=O)(=O)C,metabolic_disease
1606,Bone Loss,Lasofoxifene,C1CCN(C1)CCOC2=CC=C(C=C2)C3C(CCC4=C3C=CC(=C4)O)C5=CC=CC=C5,metabolic_disease
1625,Gout and Asymptomatic Hyperuricemia,Benzbromarone,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,metabolic_disease
1649,Pre-Diabetes,Clindamycin,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,metabolic_disease
1757,Prostate Cancer,Apalutamide,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,metabolic_disease
1899,Amyotrophic Lateral Sclerosis,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,metabolic_disease
1940,Congenital Adrenal Hyperplasia,Nevanimibe,CC(C)C1=C(C(=CC=C1)C(C)C)NC(=O)NCC2(CCCC2)C3=CC=C(C=C3)N(C)C,metabolic_disease
2029,Amyotrophic Lateral Sclerosis,Ezogabine,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,metabolic_disease
2054,Malaria,Primaquine,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,metabolic_disease
2124,Amyotrophic Lateral Sclerosis,Talampanel,CC1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3,metabolic_disease
2152,"Gaucher Disease, Type 1",Ambroxol,C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O,metabolic_disease
2202,"Gaucher Disease, Type 1|Cerebroside Lipidosis Syndrome|Glucocerebrosidase Deficiency Disease|Glucosylceramide Beta-Glucosidase Deficiency Disease|Gaucher Disease, Non-Neuronopathic Form",Eliglustat,CCCCCCCC(=O)NC(CN1CCCC1)C(C2=CC3=C(C=C2)OCCO3)O,metabolic_disease
2211,Alzheimer's Disease,Tricaprylin,CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,metabolic_disease
2246,Abdominal Obesity|Insulin Resistance|Hypertriglyceridemia,Acipimox,CC1=CN=C(C=[N+]1[O-])C(=O)O,metabolic_disease
2311,Homozygous Familial Hypercholesterolemia,Lomitapide,C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F,metabolic_disease
2324,Cancer Cachexia,Macimorelin,CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CNC4=CC=CC=C43)NC=O)N,metabolic_disease
2398,Type 2 Diabetes Mellitus,Voglibose,C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO,metabolic_disease
2456,Osteoporosis,Ronacaleret,CC(C)(CC1CC2=CC=CC=C2C1)NCC(COC3=C(C(=CC(=C3)CCC(=O)O)F)F)O,metabolic_disease
2515,"Blood Glucose, Low|Hypoglycemia",Gemifloxacin,CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F,metabolic_disease
2532,Amyotrophic Lateral Sclerosis,Verdiperstat,CC(C)OCCN1C2=C(C(=O)NC1=S)NC=C2,metabolic_disease
2568,Body Weight|Impaired Glucose Tolerance in Obese,Cabergoline,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C,metabolic_disease
2574,Dyslipidemia|HIV Infections,Policosanol,CCCO,metabolic_disease
2576,Anorexia|Weight Loss|Cachexia,Flurandrenolone,CC1(OC2CC3C4CC(C5=CC(=O)CCC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,metabolic_disease
2726,Type II Diabetes Mellitus,Glipizide,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,metabolic_disease
2739,Anatomic Stage IV Breast Cancer AJCC v8|Invasive Breast Lobular Carcinoma|Metastatic Breast Lobular Carcinoma|Prognostic Stage IV Breast Cancer AJCC v8,Fluciclovine,C1C(CC1(C(=O)O)N)F,metabolic_disease
2776,ALS (Amyotrophic Lateral Sclerosis),Lunasine,CC(C)C1CC2=C(C3=C(C(=CC=C3)OC)[N+](=C2O1)C)OC,metabolic_disease
2792,Fungal Disease,Ibrexafungerp,CC(C)C(C)C1(CCC2(C3CCC4C5(COCC4(C3=CCC2(C1C(=O)O)C)CC(C5OCC(C)(C(C)(C)C)N)N6C(=NC=N6)C7=CC=NC=C7)C)C)C,metabolic_disease
2815,Schizophrenia|Schizoaffective Disorder|Obesity|Hypertension|Smoking,Rimonabant,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl,metabolic_disease
2867,Type 2 Diabetes Mellitus,Rebaudioside A,CC12CCCC(C1CCC34C2CCC(C3)(C(=C)C4)OC5C(C(C(C(O5)CO)O)OC6C(C(C(C(O6)CO)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)(C)C(=O)OC8C(C(C(C(O8)CO)O)O)O,metabolic_disease
2925,FAP|Familial Amyloid Polyneuropathy|TTR|Transthyretin|Amyloidosis,Inotersen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5C(OC(C5OCCOC)N6C=NC7=C6N=C(NC7=O)N)COP(=S)(O)OC8C(OC(C8OCCOC)N9C=C(C(=O)NC9=O)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)COP(=O)(OC1C(OC(C1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)CO)S)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)O,metabolic_disease
3143,Amyotrophic Lateral Sclerosis,Reldesemtiv,C1C(CC1(CNC2=NC=C(C=N2)N3C=CC(=C3)C(=O)N)C4=C(C=CC=N4)F)F,metabolic_disease
3177,Amyotrophic Lateral Sclerosis,Pridopidine,CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C,metabolic_disease
3353,Gout,Bucillamine,CC(C)(C(=O)NC(CS)C(=O)O)S,metabolic_disease
3366,Frontotemporal Dementia,Flortaucipir,C1=CC2=C(C=C1C3=CN=C(C=C3)F)NC4=C2C=NC=C4,metabolic_disease
3369,Albinism|Oculocutaneous Albinism,Levodopa,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,metabolic_disease
3420,Type 2 Diabetes Mellitus,Dihydromyricetin,C1=C(C=C(C(=C1O)O)O)C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O,metabolic_disease
3475,Type 2 Diabetes Mellitus,Retagliptin,COC(=O)C1=C2CN(CCN2C(=N1)C(F)(F)F)C(=O)CC(CC3=CC(=C(C=C3F)F)F)N,metabolic_disease
3489,Diabetes Mellitus Type 2,Taspoglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C)(C)C(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,metabolic_disease
3592,Insulin Resistance|Type 2 Diabetes Mellitus|Obesity|Androgen Deficiency|Metabolic Disease,Acyline,CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C,metabolic_disease
3735,Insulin Resistance,Triflusal,CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(=O)O,metabolic_disease
3741,Amyotrophic Lateral Sclerosis,Enoxacin,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,metabolic_disease
38,Neuropathic Pain,Priralfinamide,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC=CC=C2F,nervous_system_disease
47,Breast Cancer,Tesetaxel,CC1=C2C3C(C4(CCC5C(C4C(C(C2(C)C)(CC1OC(=O)C(C(C6=C(C=CC=N6)F)NC(=O)OC(C)(C)C)O)O)OC(=O)C7=CC=CC=C7)(CO5)OC(=O)C)C)OC(O3)CN(C)C,nervous_system_disease
54,Epilepsy,Muscimol,C1=C(ONC1=O)CN,nervous_system_disease
149,Epilepsy,Eslicarbazepine,C1C(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O,nervous_system_disease
184,"Muscular Atrophy, Spinal",Risdiplam,CC1=CC(=NN2C1=NC(=C2)C)C3=CC(=O)N4C=C(C=CC4=N3)N5CCNC6(C5)CC6,nervous_system_disease
193,Epilepsy,Sulthiame,C1CCS(=O)(=O)N(C1)C2=CC=C(C=C2)S(=O)(=O)N,nervous_system_disease
198,Migraine|Acute Treatment of Migraine,Rimegepant,C1CC(C2=C(C=CC=N2)C(C1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6,nervous_system_disease
221,Craniocerebral Injury,Oxiracetam,C1C(CN(C1=O)CC(=O)N)O,nervous_system_disease
235,Epilepsy,Brivaracetam,CCCC1CC(=O)N(C1)C(CC)C(=O)N,nervous_system_disease
238,Acute Migraine,Zolmitriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3,nervous_system_disease
296,Creutzfeldt-Jakob Disease,Quinacrine,CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,nervous_system_disease
309,Newly Diagnosed High Grade Glioma,Lomustine,C1CCC(CC1)NC(=O)N(CCCl)N=O,nervous_system_disease
340,Diabetic Neuropathies,Carisbamate,C1=CC=C(C(=C1)C(COC(=O)N)O)Cl,nervous_system_disease
342,Migraine|Migraine With Aura|Migraine Without Aura,Dihydroergotamine,CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,nervous_system_disease
346,Migraine Disorders,Eletriptan,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4,nervous_system_disease
385,Back Pain|Sciatica,Desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,nervous_system_disease
436,Tinnitus,Acamprosate,CC(=O)NCCCS(=O)(=O)O,nervous_system_disease
462,Idiopathic Parkinson Disease,Trimethobenzamide,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC,nervous_system_disease
481,Parkinson's Disease|Psychotic Disorders,Melperone,CC1CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F,nervous_system_disease
493,Tourette Syndrome,Valbenazine,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C(C(C)C)N)OC)OC,nervous_system_disease
538,Back Pain|Acute Pain|Back Spasm Upper Back|Back Strain|Muscle Cramp|Muscle Spasm|Low Back Pain,Tolperisone,CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2,nervous_system_disease
544,Postherpetic Neuralgia,Prilocaine,CCCNC(C)C(=O)NC1=CC=CC=C1C,nervous_system_disease
545,Alzheimer Disease|Healthy,Lecozotan,CC(CN(C1=CC=CC=N1)C(=O)C2=CC=C(C=C2)C#N)N3CCN(CC3)C4=C5C(=CC=C4)OCCO5,nervous_system_disease
578,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Neoplasm,Cilengitide,CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N,nervous_system_disease
588,Brain and Central Nervous System Tumors,Pamiparib,CC12CCCN1CC3=NNC(=O)C4=C5C3=C2NC5=CC(=C4)F,nervous_system_disease
598,Migraine Without Aura|Migraine With Aura,Tonabersat,CC(=O)C1=CC2=C(C=C1)OC(C(C2NC(=O)C3=CC(=C(C=C3)F)Cl)O)(C)C,nervous_system_disease
605,Primary Insomnia,Eszopiclone,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,nervous_system_disease
609,Familial Dysautonomia,Kinetin,C1=COC(=C1)CNC2=NC=NC3=C2NC=N3,nervous_system_disease
645,Migraine Disorders,Rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,nervous_system_disease
763,Duchenne Muscular Dystrophy,Viltolarsen,CC1=CN(C(=O)NC1=O)C2CN(CC(O2)COP(=O)(N3CC(OC(C3)N4C=C(C(=O)NC4=O)C)COP(=O)(N5CC(OC(C5)N6C=NC7=C6N=C(NC7=O)N)COP(=O)(N8CC(OC(C8)N9C=C(C(=O)NC9=O)C)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C(N=CN=C21)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C(N=CN=C21)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)CO)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)P(=O)(N(C)C)OCC1CNCC(O1)N1C=CC(=NC1=O)N,nervous_system_disease
783,Hypersomnia|Primary Hypersomnia|Idiopathic Hypersomnia|Narcolepsy Without Cataplexy,Flumazenil,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,nervous_system_disease
788,Persistent Developmental Stuttering,Pagoclone,CC(C)CCC(=O)CC1C2=CC=CC=C2C(=O)N1C3=NC4=C(C=C3)C=CC(=N4)Cl,nervous_system_disease
795,Acute Pain,Lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,nervous_system_disease
798,Dravet Syndrome,Clemizole,C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl,nervous_system_disease
800,Parkinson's Disease|Dyskinesia,Sarizotan,C1CC2=CC=CC=C2OC1CNCC3=CC(=CN=C3)C4=CC=C(C=C4)F,nervous_system_disease
806,"Obstructive Sleep Apnea|Tonsillitis|Pain, Procedural",Hydromorphone,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(=O)CC4,nervous_system_disease
865,Vertigo,Levophencynonate,CN1CC2CCCC(C1)C2OC(=O)C(C3CCCC3)(C4=CC=CC=C4)O,nervous_system_disease
867,Dementia With Lewy Bodies (DLB),Neflamapimod,C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl,nervous_system_disease
872,Pain|Diabetic Neuropathies|Neuralgia|Postherpetic Neuralgia,Tapentadol,CCC(C1=CC(=CC=C1)O)C(C)CN(C)C,nervous_system_disease
878,Parkinson Disease|Healthy,Foliglurax,C1COCCN1CCCC2=CC3=C(C=C2)OC(=CC3=NO)C4=NC=C5C=CSC5=C4,nervous_system_disease
894,"Muscular Dystrophy, Duchenne",Rimeporide,CC1=CC(=C(C=C1C(=O)N=C(N)N)S(=O)(=O)C)S(=O)(=O)C,nervous_system_disease
944,Fragile X-associated Tremor/Ataxia Syndrome,Pregnanolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,nervous_system_disease
945,Fragile X-associated Tremor/Ataxia Syndrome,Brexanolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,nervous_system_disease
946,Fragile X-associated Tremor/Ataxia Syndrome,Allopregnanolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,nervous_system_disease
959,Parkinson's Disease,Nebicapone,C1=CC=C(C=C1)CC(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],nervous_system_disease
989,Progressive Supranuclear Palsy,Davunetide,CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C2CCCN2C(=O)C(C)NC(=O)C(CC(=O)N)N,nervous_system_disease
991,Alzheimer's Disease,Idalopirdine,C1=CC(=CC(=C1)OCC(C(F)F)(F)F)CNCCC2=CNC3=C2C=CC(=C3)F,nervous_system_disease
992,Spinocerebellar Ataxias|Spinocerebellar Ataxia Genotype Type 1|Spinocerebellar Ataxia Genotype Type 2|Spinocerebellar Ataxia Genotype Type 3|Spinocerebellar Ataxia Genotype Type 6|Spinocerebellar Ataxia Genotype Type 7|Spinocerebellar Ataxia Genotype Type 8|Spinocerebellar Ataxia Genotype Type 10,Troriluzole,CN(CC(=O)NC1=NC2=C(S1)C=C(C=C2)OC(F)(F)F)C(=O)CNC(=O)CN,nervous_system_disease
995,Alzheimer Disease|Agitation|Weight Loss|Pain|Oxidative Stress,Nabilone,CCCCCCC(C)(C)C1=CC(=C2C3CC(=O)CCC3C(OC2=C1)(C)C)O,nervous_system_disease
1061,"Prolonged First Stage of Labor|Failure of Cervical Dilation as Antepartum Condition|Labor Pain|Mild Birth Asphyxia, APGAR 4-7",Drotaverine,CCOC1=C(C=C(C=C1)C=C2C3=CC(=C(C=C3CCN2)OCC)OCC)OCC,nervous_system_disease
1069,"Medulloblastoma|Astrocytoma, Grade III|Glioblastoma|Anaplastic Astrocytoma|Brain Stem Neoplasms, Malignant|Oligodendroblastoma|Anaplastic Oligodendroglioma|Malignant Glioma",Mebendazole,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,nervous_system_disease
1099,Myotonic Dystrophy 1,Tideglusib,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,nervous_system_disease
1106,Insomnia Disorder,Flurazepam,CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F,nervous_system_disease
1129,Parkinson Disease,Opicapone,CC1=C(C(=[N+](C(=C1Cl)C)[O-])Cl)C2=NOC(=N2)C3=CC(=C(C(=C3)O)O)[N+](=O)[O-],nervous_system_disease
1165,Alzheimer Disease,Talsaclidine,C#CCOC1CN2CCC1CC2,nervous_system_disease
1197,Cognitive Disorders|HIV Infections,Selegiline,CC(CC1=CC=CC=C1)N(C)CC#C,nervous_system_disease
1198,Mental Disorder Diagnosed in Childhood|Obsessive Compulsive Disorder|Streptococcal Infection|Tic Disorder,Penicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,nervous_system_disease
1199,Mental Disorder Diagnosed in Childhood|Obsessive Compulsive Disorder|Streptococcal Infection|Tic Disorder,Phenoxymethylpenicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,nervous_system_disease
1251,Sleep Apnea,Danavorexton,COC(=O)N1CCCC(C1COC2CCC(CC2)C3=CC=CC=C3)NS(=O)(=O)C,nervous_system_disease
1380,Rett Syndrome,Trofinetide,CC1(CCCN1C(=O)CN)C(=O)NC(CCC(=O)O)C(=O)O,nervous_system_disease
1406,Pediatric Brain Tumor|Diffuse Intrinsic Pontine Glioma,Veledimex,CCCC(C(C)(C)C)N(C(=O)C1=CC(=CC(=C1)C)C)NC(=O)C2=C(C(=CC=C2)OC)CC,nervous_system_disease
1410,Migraine,Telcagepant,C1CC(C(=O)N(CC1C2=C(C(=CC=C2)F)F)CC(F)(F)F)NC(=O)N3CCC(CC3)N4C5=C(NC4=O)N=CC=C5,nervous_system_disease
1412,Plexiform Neurofibroma|Neurofibromatosis Type 1 (NF1),Mirdametinib,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,nervous_system_disease
1431,Insomnia,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,nervous_system_disease
1437,Strabismus,Thiopental,CCCC(C)C1(C(=O)NC(=S)NC1=O)CC,nervous_system_disease
1451,Acromegaly,Paltusotine,C1CN(CCC1N)C2=C3C=C(C=CC3=NC=C2C4=CC(=CC(=C4)F)F)C5=CC=CC(=C5O)C#N,nervous_system_disease
1454,Tinnitus,Vestipitant,CC1=C(C=CC(=C1)F)C2CNCCN2C(=O)N(C)C(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,nervous_system_disease
1470,Causalgia|Polyneuropathy|Postherpetic Neuralgia|Peripheral Nerve Injury|Radiculopathy,Etoricoxib,CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C,nervous_system_disease
1502,"Muscular Atrophy, Spinal",Olesoxime,CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4=CC(=NO)CCC34C)C,nervous_system_disease
1527,Alzheimer Disease,Huperzine A,CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3,nervous_system_disease
1569,Migraine,Tezampanel,C1CC2CNC(CC2CC1CCC3=NNN=N3)C(=O)O,nervous_system_disease
1583,Alzheimers Disease,Lornoxicam,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,nervous_system_disease
1623,HER2 Positive Metastatic Breast Cancer,Pyrotinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CC5CCCN5C,nervous_system_disease
1632,"Epilepsy, Partial",Seletracetam,CCC(C(=O)N)N1CC(CC1=O)C=C(F)F,nervous_system_disease
1675,Melanoma,Meprednisone,CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C,nervous_system_disease
1710,Alzheimer's Disease,Verubecestat,CC1(CS(=O)(=O)N(C(=N1)N)C)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)F)F,nervous_system_disease
1780,Dementia With Lewy Bodies|REM Sleep Behavior Disorder|Parkinson's Disease Dementia,Nelotanserin,CN1C(=C(C=N1)Br)C2=C(C=CC(=C2)NC(=O)NC3=C(C=C(C=C3)F)F)OC,nervous_system_disease
1802,Neuropathic Pain,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,nervous_system_disease
1812,Chronic Pain|Diabetic Neuropathies|Diabetes Mellitus,Cebranopadol,CN(C)C1(CCC2(CC1)C3=C(CCO2)C4=C(N3)C=CC(=C4)F)C5=CC=CC=C5,nervous_system_disease
1852,Alzheimer Disease|Parkinson Disease,Posiphen,CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC4=CC=CC=C4)C)C,nervous_system_disease
1872,Medication Overuse Headache|Analgesic Overuse Headache,Frovatriptan,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N,nervous_system_disease
1914,Leukemia|Lymphoma|Meningeal Neoplasm,Mafosfamide,C1COP(=O)(NC1SCCS(=O)(=O)O)N(CCCl)CCCl,nervous_system_disease
1967,Mild to Moderate Diabetic Sensorimotor Polyneuropathy,Ranirestat,C1C(=O)NC(=O)C12C(=O)N(C(=O)C3=CC=CN23)CC4=C(C=C(C=C4)Br)F,nervous_system_disease
2127,Parkinson Disease,Mesdopetam,CCCNCCOC1=CC(=CC(=C1)S(=O)(=O)C)F,nervous_system_disease
2161,Spinal Muscular Atrophy,Nusinersen,CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)OP(=S)(O)OCC3C(C(C(O3)N4C=C(C(=NC4=O)N)C)OCCOC)OP(=S)(O)OCC5C(C(C(O5)N6C=NC7=C(N=CN=C76)N)OCCOC)OP(=S)(O)OCC8C(C(C(O8)N9C=C(C(=NC9=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)O)OCCOC,nervous_system_disease
2186,Neurocysticercosis|Epilepsy,Praziquantel,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,nervous_system_disease
2187,Neurocysticercosis|Epilepsy,Albendazole,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,nervous_system_disease
2241,Endometriosis|Pelvic Pain,Nafarelin,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,nervous_system_disease
2265,Glioma|Glioblastoma|Glioblastoma Multiforme|GBM|Brain Cancer,Dianhydrogalactitol,C1C(O1)C(C(C2CO2)O)O,nervous_system_disease
2308,Duchenne Muscular Dystrophy,Vamorolone,CC1CC2C3CCC4=CC(=O)C=CC4(C3=CCC2(C1(C(=O)CO)O)C)C,nervous_system_disease
2321,Osteoarthritis|Low Back Pain,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,nervous_system_disease
2351,Brain Tumor|Astrocytoma|Astroglioma|Glioblastoma|Gliosarcoma,Zotiraciclib,CN1CC=CCCOC2=CC=CC(=C2)C3=NC(=NC=C3)NC4=CC=CC(=C4)C1,nervous_system_disease
2385,Mild Cognitive Impairment|MCI|Aging|Alzheimer's Disease|AD,Phenazopyridine,C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N,nervous_system_disease
2462,Muscle Atrophy,Amifampridine,C1=CN=CC(=C1N)N,nervous_system_disease
2517,Duchenne Muscular Dystrophy,Ezutromid,CCS(=O)(=O)C1=CC2=C(C=C1)OC(=N2)C3=CC4=CC=CC=C4C=C3,nervous_system_disease
2576,Movement Disorders|Parkinson Disease,Eliprodil,C1CN(CCC1CC2=CC=C(C=C2)F)CC(C3=CC=C(C=C3)Cl)O,nervous_system_disease
2685,Obstructive Sleep Apnea of Adult,Daridorexant,CC1=C(C=CC2=C1N=C(N2)C3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl,nervous_system_disease
2781,Drug-Resistant Epilepsy|Focal-Onset Seizures,Padsevonil,COCC1=NN2C(=C(N=C2S1)C(F)(F)F)CN3CC(CC3=O)CC(F)(F)Cl,nervous_system_disease
2851,"Muscular Dystrophy, Duchenne",Edasalonexent,CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)NCCNC(=O)C1=CC=CC=C1O,nervous_system_disease
2882,Agitation,Levosulpiride,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,nervous_system_disease
2904,Early Manifest Huntington Disease,Branaplam,CC1(CC(CC(N1)(C)C)OC2=NN=C(C=C2)C3=C(C=C(C=C3)C4=CNN=C4)O)C,nervous_system_disease
2924,Muscular Dystrophies,Drisapersen,COC1C(C(OC1N2C=CC(=O)NC2=O)COP(=S)(O)OC3C(OC(C3OC)N4C=CC(=NC4=O)N)COP(=S)(O)OC5C(OC(C5OC)N6C=CC(=O)NC6=O)COP(=S)(O)OC7C(OC(C7OC)N8C=CC(=O)NC8=O)COP(=S)(O)OC9C(OC(C9OC)N1C=CC(=O)NC1=O)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=CC(=NC1=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=CC(=O)NC1=O)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=O)(OC1C(OC(C1OC)N1C=CC(=NC1=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=CC(=O)NC1=O)CO)S)O,nervous_system_disease
2958,Chronic Peripheral Neuropathy Pain in Diabetics,Bicifadine,CC1=CC=C(C=C1)C23CC2CNC3,nervous_system_disease
3076,Epilepsy,Clobazam,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,nervous_system_disease
3185,Solid Tumors|Brain Tumors|Brain Metastases,Satraplatin,CC(=O)O.CC(=O)O.C1CCC(CC1)N.N.Cl[Pt]Cl,nervous_system_disease
3225,Osteomyelitis|Septic Arthritis|Pyomyositis,Cefadroxil,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,nervous_system_disease
3272,Fatigue|Musculoskeletal Pain|Cognitive Decline,Pregnenolone,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C,nervous_system_disease
3278,Infantile Spasms (IS),Radiprodil,C1CN(CCC1CC2=CC=C(C=C2)F)C(=O)C(=O)NC3=CC4=C(C=C3)NC(=O)O4,nervous_system_disease
3416,Brain and Central Nervous System Tumors,Mibefradil,CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F,nervous_system_disease
3436,Migraine,Atogepant,CC1C(CC(C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(CC4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=C(C=CC(=C6F)F)F,nervous_system_disease
3437,Migraine,Ubrogepant,CC1C(CC(C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(CC4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=CC=CC=C6,nervous_system_disease
3511,Fibromyalgia,Esreboxetine,CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3,nervous_system_disease
3548,Musculoskeletal Pain,Codeine,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O,nervous_system_disease
3695,Brain and Central Nervous System Tumors,Laromustine,CNC(=O)N(N(CCCl)S(=O)(=O)C)S(=O)(=O)C,nervous_system_disease
3726,Migraine,Prochlorperazine,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,nervous_system_disease
3756,Alzheimer's Disease,Avagacestat,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl,nervous_system_disease
3765,Brain Cancer,Dexanabinol,CCCCCCC(C)(C)C1=CC(=C2C3CC(=CCC3C(OC2=C1)(C)C)CO)O,nervous_system_disease
3783,Sleep Initiation and Maintenance Disorders,Eplivanserin,CN(C)CCON=C(C=CC1=CC=C(C=C1)O)C2=CC=CC=C2F,nervous_system_disease
3824,Corneal Abrasions,Proparacaine,CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N,nervous_system_disease
3841,Alzheimer Disease,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,nervous_system_disease
3907,Brain and Central Nervous System Tumors,Cytochlor,C1C(C(OC1N2C=C(C(=NC2=O)N)Cl)CO)O,nervous_system_disease
3971,Alzheimer's Disease,Nefiracetam,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O,nervous_system_disease
3989,Alzheimers Disease,Lanabecestat,CC#CC1=CC(=CN=C1)C2=CC3=C(CC4(C35N=C(C(=N5)N)C)CCC(CC4)OC)C=C2,nervous_system_disease
4027,Parkinson Disease,Lisuride,CCN(CC)C(=O)NC1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C,nervous_system_disease
4040,"Sleep Apnea, Obstructive",Tiagabine,CC1=C(SC=C1)C(=CCCN2CCCC(C2)C(=O)O)C3=C(C=CS3)C,nervous_system_disease
4099,Pain|Peripheral Neuropathy|Neuropathic Pain,Tetrodotoxin,C(C1(C2C3C(N=C(NC34C(C1OC(C4O)(O2)O)O)N)O)O)O,nervous_system_disease
4210,Alzheimer's Disease,Flutemetamol,CNC1=C(C=C(C=C1)C2=NC3=C(S2)C=C(C=C3)O)F,nervous_system_disease
4214,Chorioamnionitis|Puerperal Endometritis|Neonatal Early Onset Sepsis|Neonatal Meningitis|Neonatal Pneumonia,Ampicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C,nervous_system_disease
4268,"Brain Neoplasms|Malignant Neoplasms, Brain|Brain Tumors",Cositecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CC[Si](C)(C)C)O,nervous_system_disease
4274,Postherpetic Neuralgia,Zucapsaicin,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,nervous_system_disease
4314,Restless Legs Syndrome,Aplindore,C1C(OC2=C(O1)C=CC3=C2CC(=O)N3)CNCC4=CC=CC=C4,nervous_system_disease
4376,Alzheimer's Disease,Piromelatine,COC1=CC2=C(C=C1)NC=C2CCNC(=O)C3=CC(=O)C=CO3,nervous_system_disease
4502,Tourette Syndrome|Tourette Syndrome in Adolescence,Sepranolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,nervous_system_disease
4531,Cushing Disease,Seliciclib,CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3,nervous_system_disease
4688,Hyperalgesia|Allodynia,Fenobam,CN1CC(=O)NC1=NC(=O)NC2=CC(=CC=C2)Cl,nervous_system_disease
4753,Shoulder Pain|Post-operative Pain,Parecoxib,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C,nervous_system_disease
4807,Primary Insomnia|Chronic Insomnia,Chamomile,C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O,nervous_system_disease
4849,Asymptomatic Amyloid-positive,Atabecestat,CC1(C=CSC(=N1)N)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)C#N)F,nervous_system_disease
4875,Primary Insomnia,Adipiplon,CCCC1=C(N=CN2C1=NC(=N2)C)CN3C=CN=C3C4=C(C=CC=N4)F,nervous_system_disease
4962,Orthostatic Intolerance,Ganirelix,CCNC(=NCCCCC(C(=O)NC(CC(C)C)C(=O)NC(CCCCN=C(NCC)NCC)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC,nervous_system_disease
5049,"Hyperalgesia|Pain, Postoperative|Pain, Chronic Disease",Nefopam,CN1CCOC(C2=CC=CC=C2C1)C3=CC=CC=C3,nervous_system_disease
5109,Narcolepsy With Cataplexy|Narcolepsy|Narcolepsy Without Cataplexy,Mazindol,C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O,nervous_system_disease
5134,Congenital Muscular Dystrophy,Omigapil,CN(CC#C)CC1=CC2=CC=CC=C2OC3=CC=CC=C31,nervous_system_disease
5350,Vestibular Schwannoma|Neurofibromatosis Type 2,Endostatin,CN(CC(=O)C1=CC=CC=C1)N=O,nervous_system_disease
5380,"Tinnitus, Subjective",Sulodexide,CNC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)OC,nervous_system_disease
5509,"Muscular Dystrophy, Duchenne",Oxatomide,C1CN(CCN1CCCN2C3=CC=CC=C3NC2=O)C(C4=CC=CC=C4)C5=CC=CC=C5,nervous_system_disease
5560,Sleep Initiation and Maintenance Disorders|Pain,Cyclobenzaprine,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,nervous_system_disease
5686,Alzheimer's Disease,Equol,C1C(COC2=C1C=CC(=C2)O)C3=CC=C(C=C3)O,nervous_system_disease
5692,"Toxoplasmosis, Cerebral|HIV Infections",Sulfadiazine,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,nervous_system_disease
5829,Parkinson Disease,Altropane,COC(=O)C1C2CCC(N2CC=CI)CC1C3=CC=C(C=C3)F,nervous_system_disease
5943,Bipolar Disorder|Schizoaffective Disorder|Manic Disorder|Mania|Manic State,Pentazocine,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,nervous_system_disease
5963,Neurocysticercosis,Oxfendazole,COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3,nervous_system_disease
6044,Neuralgia,Carfentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CC=C3)C(=O)OC,nervous_system_disease
6216,"Diffuse Intrinsic Pontine Glioma|Pediatric Brainstem Glioma|Pediatric Brainstem Gliosarcoma, Recurrent|Pediatric Cancer|Pediatric Brain Tumor|Diffuse Glioma",Marizomib,CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl,nervous_system_disease
6218,Parkinson Disease,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,nervous_system_disease
50,"Infections, Gram-Positive Bacterial|Abscess|Burns|Cellulitis|Ulcer|Wound Infections",Telavancin,CCCCCCCCCCNCCNC1(CC(OC(C1O)C)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)CNCP(=O)(O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)C,skin_and_connective_tissue_disease
122,Community Acquired Pneumonia|Staphylococcal Skin Infections,Friulimicin B,CC1C(C(=O)N2CCCCC2C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)N1)C(C)C)C(C)N)CC(=O)O)CC(=O)O)C(C)C(=O)O)NC(=O)C(CC(=O)N)NC(=O)CC=CCCCCCCCC(C)C,skin_and_connective_tissue_disease
151,"Skin Infections, Bacterial",Retapamulin,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CC5CCC(C4)N5C)C,skin_and_connective_tissue_disease
167,Infectious Skin Diseases|Bacterial Skin Diseases|Staphylococcal Skin Infections|Streptococcal Infections|Abscess,Radezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=C(C=C3)CNCC4=NNN=C4)F,skin_and_connective_tissue_disease
